WO2010009938A1 - Polymers with polysaccharide grafts, cosmetic compositions and treatment method - Google Patents
Polymers with polysaccharide grafts, cosmetic compositions and treatment method Download PDFInfo
- Publication number
- WO2010009938A1 WO2010009938A1 PCT/EP2009/057039 EP2009057039W WO2010009938A1 WO 2010009938 A1 WO2010009938 A1 WO 2010009938A1 EP 2009057039 W EP2009057039 W EP 2009057039W WO 2010009938 A1 WO2010009938 A1 WO 2010009938A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- branched
- linear
- meth
- cyclic
- group
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 120
- 239000000203 mixture Substances 0.000 title claims abstract description 97
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 64
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 64
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 10
- 238000011282 treatment Methods 0.000 title claims abstract description 10
- 150000004676 glycans Chemical class 0.000 title abstract 2
- 210000004209 hair Anatomy 0.000 claims abstract description 41
- -1 alkyl radicals Chemical class 0.000 claims description 87
- 229920002307 Dextran Polymers 0.000 claims description 79
- 229960002086 dextran Drugs 0.000 claims description 73
- 150000004804 polysaccharides Chemical class 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 56
- 239000000178 monomer Substances 0.000 claims description 35
- 238000006243 chemical reaction Methods 0.000 claims description 33
- 125000004122 cyclic group Chemical group 0.000 claims description 29
- 150000001720 carbohydrates Chemical class 0.000 claims description 25
- 238000006116 polymerization reaction Methods 0.000 claims description 22
- FLCAEMBIQVZWIF-UHFFFAOYSA-N 6-(dimethylamino)-2-methylhex-2-enamide Chemical compound CN(C)CCCC=C(C)C(N)=O FLCAEMBIQVZWIF-UHFFFAOYSA-N 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 229920006395 saturated elastomer Polymers 0.000 claims description 14
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 13
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 125000005647 linker group Chemical group 0.000 claims description 13
- 150000003926 acrylamides Chemical class 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 11
- 125000005842 heteroatom Chemical group 0.000 claims description 11
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 9
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 8
- 125000000304 alkynyl group Chemical group 0.000 claims description 8
- 150000001412 amines Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 229960000633 dextran sulfate Drugs 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 230000003020 moisturizing effect Effects 0.000 claims description 8
- 229920000856 Amylose Polymers 0.000 claims description 7
- 150000001299 aldehydes Chemical group 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 229920001296 polysiloxane Polymers 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 7
- 229920002554 vinyl polymer Polymers 0.000 claims description 7
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 6
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 6
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 239000002304 perfume Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- 229920002567 Chondroitin Polymers 0.000 claims description 5
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 5
- 102000011782 Keratins Human genes 0.000 claims description 5
- 108010076876 Keratins Proteins 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 235000010980 cellulose Nutrition 0.000 claims description 5
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 claims description 5
- 229920003089 ethylhydroxy ethyl cellulose Polymers 0.000 claims description 5
- 210000000720 eyelash Anatomy 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 5
- 150000002576 ketones Chemical class 0.000 claims description 5
- 229920000609 methyl cellulose Polymers 0.000 claims description 5
- 235000010981 methylcellulose Nutrition 0.000 claims description 5
- 210000000282 nail Anatomy 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 5
- 159000000000 sodium salts Chemical class 0.000 claims description 5
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 claims description 4
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 229920005862 polyol Polymers 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 150000003254 radicals Chemical class 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 3
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims description 3
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 claims description 3
- NIXVAPHNPNMUIX-UHFFFAOYSA-N 6-amino-2-methylhex-2-enamide Chemical compound NC(=O)C(C)=CCCCN NIXVAPHNPNMUIX-UHFFFAOYSA-N 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002670 Fructan Polymers 0.000 claims description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 230000001166 anti-perspirative effect Effects 0.000 claims description 3
- 239000003213 antiperspirant Substances 0.000 claims description 3
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims description 3
- OIWOHHBRDFKZNC-UHFFFAOYSA-N cyclohexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1CCCCC1 OIWOHHBRDFKZNC-UHFFFAOYSA-N 0.000 claims description 3
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 229920002545 silicone oil Polymers 0.000 claims description 3
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 claims description 3
- 230000000475 sunscreen effect Effects 0.000 claims description 3
- 239000000516 sunscreening agent Substances 0.000 claims description 3
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 claims description 3
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 2
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 claims description 2
- OZCMOJQQLBXBKI-UHFFFAOYSA-N 1-ethenoxy-2-methylpropane Chemical compound CC(C)COC=C OZCMOJQQLBXBKI-UHFFFAOYSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- PGMMQIGGQSIEGH-UHFFFAOYSA-N 2-ethenyl-1,3-oxazole Chemical class C=CC1=NC=CO1 PGMMQIGGQSIEGH-UHFFFAOYSA-N 0.000 claims description 2
- JDCUKFVNOWJNBU-UHFFFAOYSA-N 2-ethenyl-1,3-thiazole Chemical class C=CC1=NC=CS1 JDCUKFVNOWJNBU-UHFFFAOYSA-N 0.000 claims description 2
- MLMGJTAJUDSUKA-UHFFFAOYSA-N 2-ethenyl-1h-imidazole Chemical class C=CC1=NC=CN1 MLMGJTAJUDSUKA-UHFFFAOYSA-N 0.000 claims description 2
- ZDHWTWWXCXEGIC-UHFFFAOYSA-N 2-ethenylpyrimidine Chemical class C=CC1=NC=CC=N1 ZDHWTWWXCXEGIC-UHFFFAOYSA-N 0.000 claims description 2
- BKBJXABYOCBGED-UHFFFAOYSA-N 2-methylidenetridecanamide Chemical compound CCCCCCCCCCCC(=C)C(N)=O BKBJXABYOCBGED-UHFFFAOYSA-N 0.000 claims description 2
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 claims description 2
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 claims description 2
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 claims description 2
- LVGSUQNJVOIUIW-UHFFFAOYSA-N 5-(dimethylamino)-2-methylpent-2-enamide Chemical compound CN(C)CCC=C(C)C(N)=O LVGSUQNJVOIUIW-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 229920000189 Arabinogalactan Polymers 0.000 claims description 2
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 125000006725 C1-C10 alkenyl group Chemical group 0.000 claims description 2
- 240000008886 Ceratonia siliqua Species 0.000 claims description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 229920002558 Curdlan Polymers 0.000 claims description 2
- 239000001879 Curdlan Substances 0.000 claims description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 claims description 2
- 208000001840 Dandruff Diseases 0.000 claims description 2
- 229920000926 Galactomannan Polymers 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- 229920002581 Glucomannan Polymers 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 240000006568 Lathyrus odoratus Species 0.000 claims description 2
- 240000003183 Manihot esculenta Species 0.000 claims description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 2
- 229920000057 Mannan Polymers 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 229920002230 Pectic acid Polymers 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000004642 Polyimide Substances 0.000 claims description 2
- 229920002396 Polyurea Polymers 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004902 Softening Agent Substances 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 240000001058 Sterculia urens Species 0.000 claims description 2
- 235000015125 Sterculia urens Nutrition 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 2
- 229920002000 Xyloglucan Polymers 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000005529 alkyleneoxy group Chemical group 0.000 claims description 2
- 239000002518 antifoaming agent Substances 0.000 claims description 2
- 235000019312 arabinogalactan Nutrition 0.000 claims description 2
- 229920000617 arabinoxylan Polymers 0.000 claims description 2
- 150000004783 arabinoxylans Chemical class 0.000 claims description 2
- 239000003899 bactericide agent Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 235000019316 curdlan Nutrition 0.000 claims description 2
- 229940078035 curdlan Drugs 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 238000004043 dyeing Methods 0.000 claims description 2
- 125000006575 electron-withdrawing group Chemical group 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 claims description 2
- ZBVWCAOHSBLHRP-UHFFFAOYSA-N ethenyl 2-tert-butylbenzoate Chemical compound CC(C)(C)C1=CC=CC=C1C(=O)OC=C ZBVWCAOHSBLHRP-UHFFFAOYSA-N 0.000 claims description 2
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 229920005610 lignin Polymers 0.000 claims description 2
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 claims description 2
- AWGZKFQMWZYCHF-UHFFFAOYSA-N n-octylprop-2-enamide Chemical compound CCCCCCCCNC(=O)C=C AWGZKFQMWZYCHF-UHFFFAOYSA-N 0.000 claims description 2
- XFHJDMUEHUHAJW-UHFFFAOYSA-N n-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 claims description 2
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 2
- 125000004437 phosphorous atom Chemical group 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920001721 polyimide Polymers 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 235000012015 potatoes Nutrition 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000005956 quaternization reaction Methods 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 235000010487 tragacanth Nutrition 0.000 claims description 2
- 239000000196 tragacanth Substances 0.000 claims description 2
- 229940116362 tragacanth Drugs 0.000 claims description 2
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 claims description 2
- 229920001567 vinyl ester resin Polymers 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 229920001221 xylan Polymers 0.000 claims description 2
- 150000004823 xylans Chemical class 0.000 claims description 2
- PPBAWVJOPQUAMY-UHFFFAOYSA-N 3-tris(trimethylsilyloxy)silylpropyl prop-2-enoate Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)CCCOC(=O)C=C PPBAWVJOPQUAMY-UHFFFAOYSA-N 0.000 claims 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 1
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229940106189 ceramide Drugs 0.000 claims 1
- 150000001783 ceramides Chemical class 0.000 claims 1
- 239000003349 gelling agent Substances 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 210000000088 lip Anatomy 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 68
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 62
- 239000000243 solution Substances 0.000 description 42
- 230000015572 biosynthetic process Effects 0.000 description 37
- 238000003786 synthesis reaction Methods 0.000 description 34
- 239000012429 reaction media Substances 0.000 description 31
- 239000000843 powder Substances 0.000 description 24
- 238000001035 drying Methods 0.000 description 23
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- 238000001914 filtration Methods 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 239000004793 Polystyrene Substances 0.000 description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 229920001577 copolymer Polymers 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 230000003381 solubilizing effect Effects 0.000 description 14
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 13
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 13
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 13
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 10
- 238000010511 deprotection reaction Methods 0.000 description 10
- 239000002243 precursor Substances 0.000 description 10
- 239000006210 lotion Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 229910052786 argon Inorganic materials 0.000 description 8
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 230000008034 disappearance Effects 0.000 description 7
- 229920000193 polymethacrylate Polymers 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 5
- 238000004040 coloring Methods 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- SHZGCJCMOBCMKK-SVZMEOIVSA-N D-fucopyranose Chemical compound C[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O SHZGCJCMOBCMKK-SVZMEOIVSA-N 0.000 description 4
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- PNNNRSAQSRJVSB-KCDKBNATSA-N aldehydo-L-fucose Chemical compound C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-KCDKBNATSA-N 0.000 description 4
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 4
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 238000007334 copolymerization reaction Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N hydroxylamine group Chemical group NO AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 4
- 150000002443 hydroxylamines Chemical class 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- SOPMNBJIVBUQMC-UHFFFAOYSA-N 2-[(4-ethenylphenyl)methoxy]isoindole-1,3-dione Chemical compound C1=CC(C=C)=CC=C1CON1C(=O)C2=CC=CC=C2C1=O SOPMNBJIVBUQMC-UHFFFAOYSA-N 0.000 description 3
- VFXXTYGQYWRHJP-UHFFFAOYSA-N 4,4'-azobis(4-cyanopentanoic acid) Chemical compound OC(=O)CCC(C)(C#N)N=NC(C)(CCC(O)=O)C#N VFXXTYGQYWRHJP-UHFFFAOYSA-N 0.000 description 3
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 0 CC(C)(CC1(C(*)(*)C1)C(NCCCNC(CON=C[C@@](C(C(C(CC(C)(C)OC(C(C1O)O)OC(CC2(C)OC(C(C3O)O)OC(CO)C3O)C12O)O)O)O)O)=O)=O)N Chemical compound CC(C)(CC1(C(*)(*)C1)C(NCCCNC(CON=C[C@@](C(C(C(CC(C)(C)OC(C(C1O)O)OC(CC2(C)OC(C(C3O)O)OC(CO)C3O)C12O)O)O)O)O)=O)=O)N 0.000 description 3
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 229920000578 graft copolymer Polymers 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- WYKYCHHWIJXDAO-UHFFFAOYSA-N tert-butyl 2-ethylhexaneperoxoate Chemical compound CCCCC(CC)C(=O)OOC(C)(C)C WYKYCHHWIJXDAO-UHFFFAOYSA-N 0.000 description 3
- ZRZHXNCATOYMJH-UHFFFAOYSA-N 1-(chloromethyl)-4-ethenylbenzene Chemical compound ClCC1=CC=C(C=C)C=C1 ZRZHXNCATOYMJH-UHFFFAOYSA-N 0.000 description 2
- QBXODCKYUZNZCY-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]oxyacetic acid Chemical compound CC(C)(C)OC(=O)NOCC(O)=O QBXODCKYUZNZCY-UHFFFAOYSA-N 0.000 description 2
- UOXIMXKYGJYCOV-UHFFFAOYSA-N 2-aminooxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCON UOXIMXKYGJYCOV-UHFFFAOYSA-N 0.000 description 2
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 2
- BRONALLIAIBEPV-UHFFFAOYSA-N 4-(2-hydroxyethyl)isoindole-1,3-dione Chemical compound OCCC1=CC=CC2=C1C(=O)NC2=O BRONALLIAIBEPV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010019049 Hair texture abnormal Diseases 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000003973 alkyl amines Chemical group 0.000 description 2
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 description 2
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000006872 enzymatic polymerization reaction Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 150000002366 halogen compounds Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012948 isocyanate Chemical group 0.000 description 2
- 150000002513 isocyanates Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical class CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 125000005543 phthalimide group Chemical group 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- NCXUNZWLEYGQAH-UHFFFAOYSA-N 1-(dimethylamino)propan-2-ol Chemical compound CC(O)CN(C)C NCXUNZWLEYGQAH-UHFFFAOYSA-N 0.000 description 1
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 1
- ZNOVTXRBGFNYRX-UHFFFAOYSA-N 2-[[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-UHFFFAOYSA-N 0.000 description 1
- VKPHHYUEMRNFSX-UHFFFAOYSA-N 2-aminobutan-2-ol Chemical compound CCC(C)(N)O VKPHHYUEMRNFSX-UHFFFAOYSA-N 0.000 description 1
- XSHISXQEKIKSGC-UHFFFAOYSA-N 2-aminoethyl 2-methylprop-2-enoate;hydron;chloride Chemical compound Cl.CC(=C)C(=O)OCCN XSHISXQEKIKSGC-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OROGUZVNAFJPHA-UHFFFAOYSA-N 3-hydroxy-2,4-dimethyl-2H-thiophen-5-one Chemical compound CC1SC(=O)C(C)=C1O OROGUZVNAFJPHA-UHFFFAOYSA-N 0.000 description 1
- LZKGFGLOQNSMBS-UHFFFAOYSA-N 4,5,6-trichlorotriazine Chemical compound ClC1=NN=NC(Cl)=C1Cl LZKGFGLOQNSMBS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XXYNZSATHOXXBJ-UHFFFAOYSA-N 4-hydroxyisoindole-1,3-dione Chemical compound OC1=CC=CC2=C1C(=O)NC2=O XXYNZSATHOXXBJ-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- UCRGPXDEIRHGBF-UHFFFAOYSA-N C(C(=C)C)(=O)O.OCCC1=C2C(C(=O)NC2=O)=CC=C1 Chemical compound C(C(=C)C)(=O)O.OCCC1=C2C(C(=O)NC2=O)=CC=C1 UCRGPXDEIRHGBF-UHFFFAOYSA-N 0.000 description 1
- BVKBKGRNVUEHCB-UHFFFAOYSA-N CC(C(OCCNC(CON)=O)=O)=C Chemical compound CC(C(OCCNC(CON)=O)=O)=C BVKBKGRNVUEHCB-UHFFFAOYSA-N 0.000 description 1
- HIRMFNNZJACSQN-UHFFFAOYSA-N CC(C(OCCON(C(c1c2cccc1)=O)C2=O)=O)=C Chemical compound CC(C(OCCON(C(c1c2cccc1)=O)C2=O)=O)=C HIRMFNNZJACSQN-UHFFFAOYSA-N 0.000 description 1
- WLFUOJSKAGPHDH-UHFFFAOYSA-N CC(C)COC(NOCC(NCCOC(C(C)=C)=O)=O)=O Chemical compound CC(C)COC(NOCC(NCCOC(C(C)=C)=O)=O)=O WLFUOJSKAGPHDH-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010015133 Galactose oxidase Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 1
- 101710142062 Leukemia inhibitory factor receptor Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 238000006751 Mitsunobu reaction Methods 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001364096 Pachycephalidae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 1
- 108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical group CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-O [OH2+]N(C(c1c2cccc1)=O)C2=O Chemical compound [OH2+]N(C(c1c2cccc1)=O)C2=O CFMZSMGAMPBRBE-UHFFFAOYSA-O 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-N alpha-mercaptoacetic acid Natural products OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004202 carbamide Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000037310 combination skin Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000012718 coordination polymerization Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- VQLXCAHGUGIEEL-FAOVPRGRSA-L disodium;[(2r,3r,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl] phosphate Chemical compound [Na+].[Na+].[O-]P(=O)([O-])OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O VQLXCAHGUGIEEL-FAOVPRGRSA-L 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DCBBWYIVFRLKCD-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-2-methylprop-2-enamide Chemical compound CN(C)CCNC(=O)C(C)=C DCBBWYIVFRLKCD-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- GINSRDSEEGBTJO-UHFFFAOYSA-N thietane 1-oxide Chemical compound O=S1CCC1 GINSRDSEEGBTJO-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 125000002348 vinylic group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F251/00—Macromolecular compounds obtained by polymerising monomers on to polysaccharides or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/91—Graft copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F251/00—Macromolecular compounds obtained by polymerising monomers on to polysaccharides or derivatives thereof
- C08F251/02—Macromolecular compounds obtained by polymerising monomers on to polysaccharides or derivatives thereof on to cellulose or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L51/02—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D151/00—Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
- C09D151/02—Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers grafted on to polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
Definitions
- the present invention relates to novel polysaccharide graft polymers, the compositions comprising them being especially cosmetic and to their use in cosmetics, especially in the hair field.
- water-soluble, synthetic cationic polymers known to provide good hair cosmetics are used. Mention may in particular be made of the commercial products “Merquat 550" and “Merquat 100", as well as the poly (vinylpyrrolidone / dimethylaminoethyl methacrylate quaternized) or poly (vinylpyrrolidone / imidazolinium methochloride) copolymers.
- these polymers are generally not used in post-coloring conditioner or care compositions, for which disentangling of wet hair must be very easy. Indeed, these polymers do not provide enough cosmetic properties.
- hair sensitized hair in particular having undergone coloring
- hair sensitized that is to say damaged and / or weakened, to varying degrees by the action of atmospheric agents, including light, as well as by repeated action different mechanical or chemical treatments, such as perms, straightening, coloring and discoloration
- the hair can be more hydrophilic, losing part of the scales, which results in great difficulty in disentangling and styling the hair, and a loss of softness.
- cetyltrimethylammonium cationic surfactants in oil-in-water emulsion, in the presence of fatty alcohols.
- the cosmetic properties are not optimal and the formulation of these compositions is complicated: compromise between the stability of the emulsion and the non-greasy feel to be found, in particular.
- compositions comprising polysaccharides, especially cationic polysaccharides, to improve the properties of the fiber.
- polysaccharides especially cationic polysaccharides
- the application WO02 / 055034 which describes cosmetic compositions containing a fructan, a polysaccharide and a beneficial agent for improving the properties of the fiber
- the application WO06 / 017589 which describes the use of polycationic graft polysaccharides for conditioning the fiber.
- the cationic polymers may be deposited in excessive amounts on the hair, in particular on damaged hair, which can lead to charged touches.
- these cationically charged polymers may cause formulation problems (incompatibility, precipitation) in the presence of anionic component usually used in cosmetics, such as surfactant or anionic styling polymer.
- the object of the present invention is to provide polymers, and the cosmetic compositions comprising them, which provide conditioning properties, and in particular make it possible to protect and repair keratin materials, in particular damaged keratin materials; in the case of the hair, this results among other things by an improvement of the disentangling properties on dry and wet hair and an improvement of the touch, in particular of the softness.
- An object of the present invention is therefore a polymer of structure (POL) - (L-PS) x where
- POL represents a polymeric backbone
- L represents a linker
- PS represents a (poly) saccharide grafted onto POL via the linker L
- x represents a non-zero integer characteristic of the number of PS grafts.
- Another subject of the invention is a cosmetic composition
- a cosmetic composition comprising, in a cosmetically acceptable medium, at least one such polymer.
- the polymers according to the invention can be represented by the following structure: (POL) - (L-PS) x where
- POL represents the polymeric backbone
- L represents a linker (or linker)
- PS represents a polysaccharide grafted onto POL via the linker L
- x represents a non-zero integer characteristic of the number of PS grafts.
- POL will be called the polymeric backbone on which the polysaccharide grafts are present. It can be of natural origin (extraction of certain plants, crustaceans or insects for example) or synthetic. This polymer can be obtained by radical polymerization, controlled radical polymerization, anionic polymerization, cationic polymerization, ring opening polymerization, metathesis, polycondensation, coordination or enzymatic polymerization. Said polymeric backbone can have a statistical structure, with a gradient, a block, star, branched, hyperbranched, grafted, reticulated. It may be a homopolymer or a copolymer resulting from the copolymerization of several monomers, preferably between 2 and 5 different monomers.
- a C2-C10 linear or branched alkenyl or alkynyl group which may be substituted by one or more halogen atoms
- a C3-8 cycloalkyl group which may be substituted with one or more halogen atoms
- Y is NR 8, S or O
- R 6 and R 7 represent, independently of one another, a hydrogen atom or a linear, branched or cyclic alkyl group, saturated or unsaturated, Ci -2 O or form with the nitrogen atom to which they are attached a ring with 3 to 8 members
- R 8 represents a hydrogen atom, a linear, branched or cyclic alkyl group, saturated or unsaturated , Ci -2 O, or an aryl group,
- R 9 represents a radical valent di- (hydro) carbonaceous Ci -20 saturated or unsaturated, linear, branched or cyclic, optionally halogen and which may comprise one or more heteroatoms
- X represents a NR 10 group or an oxygen atom
- Z represents a group - N (R 10 ) 2 , -SR 10 or P (R 10 ) 2 with R 10 representing independently of one another, a hydrogen atom or a saturated or unsaturated, linear, branched or cyclic, optionally halogenated C 2 -C hydrocarbon group, optionally halogenated and possibly containing one or more heteroatoms, the nitrogen atom present in X and / or Z (when present) capable of being protonated or quaternized by C 1 -C 2 alkyl radicals,
- a radical comprising at least one silicon atom and in particular a radical-R-siloxane, -CONHR-siloxane, -COOR-siloxane, or OCO-R-siloxane, in which R is a linear alkyl, alkylthio or alkoxy radical, branched or cyclic, saturated or unsaturated, C 1 -C 20, aryloxy or heterocyclyloxy.
- the unsaturated monomers are chosen from acrylates, methacrylates, acrylamides, methacrylamides, vinyls, allylic and styrenics, and mixtures thereof. It can act even more preferably, (meth) acrylates, (meth) acrylamides and / or styrenics.
- acrylic acid, methacrylic acid, straight-chain, branched or cyclic C 1-20 alkyl (meth) acrylates such as methyl methacrylate, ethyl methacrylate, methacrylate of pro pyl, butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate and cyclohexyl methacrylate; methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, isobutyl acrylate and tert-butyl acrylate,
- - C1-4 hydroxyalkyl (meth) acrylates such as 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate,
- vinyl ethers such as vinylisobutyl ether
- heterocyclic monomers such as N-vinylpyrrolidone, vinylcaprolactam, vinyl-N- (C 1-6 alkyl) -pyrroles, vinyloxazoles, vinylthiazoles, vinylpyrimidines, vinylimidazoles, (meth) acrylamide,
- aliphatic, cycloaliphatic or aromatic (meth) acrylamides such as tert-butylacrylamide, undecylacrylamide or N-octylacrylamide; and di (C 1-4 alkyl) (meth) acrylamides,
- styrene and its derivatives (meth) acrylic, (meth) acrylamide or vinyl monomers containing a fluorinated or perfluorinated group, in particular (meth) acrylic esters with a perfluoroalkyl chain, such as perfluorooctylethyl (meth) acrylate,
- the ethylenic carboxybetaines or sulfobetaines obtained, for example, by quaternization of ethylenically unsaturated monomers containing an amine function by sodium salts of a mobile halogen carboxylic acid (for example sodium chloroacetate) or by cyclic sulphones (p. eg propanesultone).
- a mobile halogen carboxylic acid for example sodium chloroacetate
- cyclic sulphones p. eg propanesultone
- linear, branched or cyclic C 1 -C 2 alkyl (meth) acrylates such as methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, methacrylate, isobutyl, tert-butyl methacrylate and cyclohexyl methacrylate; methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, isobutyl acrylate and tert-butyl acrylate,
- - C1-4 hydroxyalkyl (meth) acrylates such as 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate,
- the (meth) acrylic or vinyl monomers comprising an optionally neutralized or quaternized amine functional group, such as dimethylaminoethyl (meth) acrylate, dimethylaminoethyl methacrylamide, dimethylaminopropyl methacrylamide, 3-aminopropyl methacrylamide, 2-aminoethyl methacrylate; styrene and its derivatives.
- an optionally neutralized or quaternized amine functional group such as dimethylaminoethyl (meth) acrylate, dimethylaminoethyl methacrylamide, dimethylaminopropyl methacrylamide, 3-aminopropyl methacrylamide, 2-aminoethyl methacrylate; styrene and its derivatives.
- the polymeric backbone POL may also be a polyester, polycarbonate, polyamide, polyimide, polyurethane, polyurea, polysaccharide, polysiloxane, polyphenol, polyether, polypeptide.
- said backbone is chosen from (co) polymers derived from the polymerization of (meth) acrylates, (meth) acrylamides, styrenics or represents a polyurethane, a polypeptide, a polysaccharide or a polyether. More preferably still, said backbone is chosen from (co) polymers resulting from the polymerization of (meth) acrylates, (meth) acrylamides and / or styrene.
- the polymeric backbone has a number-average molecular weight (Mn) of between 1,000 and 5,000,000, especially between 2,000 and 1,000,000 and more preferably between 2,000 and 100,000 g / mol.
- Mn number-average molecular weight
- the polymers according to the invention preferably have a degree of grafting of between 1 and 100%, especially between 20 and 100%, and even more preferentially between 40 and 100%.
- grafting rate is meant the ratio (x 100) between the number of repeating units of the polymeric backbone POL grafted by polysaccharide grafts (x), and the total number of repeating units of the polymeric backbone (or degree of polymerization).
- the polysaccharide grafts can be distributed on the polymeric backbone of statistically, alternately (1 graft every 2, 3 or n repetitive units of the polymer skeleton), or even in blocks (no grafts on a part of the skeleton, then all the repetitive units of a part of the grafted skeleton). Preferably, they are distributed statistically.
- PS represents a polysaccharide graft or a saccharide (consisting of one or two sugar units).
- the polysaccharides of the present invention are preferably selected from those described in "Encyclopedia of Chemical Technology, Kirk-Othmer, 3rd editions tion, 1982, Volume 3, pp. 896-900, and Volume 15, pp 439-458” , in “Polymers in Nature by MacGREGOR and GREENWOOD, John Wiley & Sons edition, Chapter 6, pp 240-328, 1980” and in “Industrial Gums-Polysaccharides and their Derivatives, edited by Roy L. WHISTLER, 2 nd edition , Academy Press Publishing Inc. ", the contents of these three books are included in this application for reference.
- the polysaccharides may be of natural origin or obtained enzymatically or chemically.
- the polysaccharides of the present invention may be chosen from, alone or as a mixture:
- fructans including inulin; glucans;
- modified or unmodified starches such as those derived, for example, from cereals such as wheat, corn or rice, from vegetables such as sweet pea, from tubers such as potatoes or cassava;
- amylose, amylopectin, glycogen dextrans and their derivatives, such as dextran sulfate, dextran diethylaminoethyl and carboxymethyl dextran;
- celluloses and their derivatives such as methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethylcelluloses;
- mannans xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucoronoxylans, arabinoxylans, xyloglucans, glucomannans, pectic acids and pectins; - ginic and alginates, arabinogalactans, carrageenans, agars,
- glycosaminoglucans such as hyaluronic acid, chondroitins and chondroitin sulphates;
- - Arabic gums Tragacanth gums, Ghatti gums, Karaya gums, locust bean gums, gellan gums, curdlan gums, xanthan gums;
- galactomannans such as guar gums and their derivatives, in particular hydroxypropylguar).
- saccharides or polysaccharides may optionally be modified chemically or enzymatically to introduce hydroxyethyl, hydroxypropyl, oligo (oxyethyl), oligo (oxypropyl), carboxylic and derivatives, sulphates groups. and derivatives, phosphates and derivatives, amino and derivatives (including nitro), esters, ether, amides. These groups can also be naturally present in the polysaccharides considered or present in protected form (N-acetyl in the case of chitin).
- Ra to Re is -O- (repeating unit of the polysaccharide) or OH, and one of Ra to Re is a covalent bond with the One- ker L; preferably only one of Ra to Re across the (poly) saccharide is a covalent bond.
- the polysaccharides according to the invention are constituted by the sequence of units (Ia) and / or (Ma) of formula, alone or as a mixture:
- the acid groups may be neutralized with a mineral base, such as LiOH NaOH, KOH, Ca (OH) 2 , Ba (OH) 2 , NH 4 OH or Zn (OH) 2 ; or with an organic base such as a primary, secondary or tertiary alkylamine, especially triethylamine, isopropylamine or butylamine.
- a mineral base such as LiOH NaOH, KOH, Ca (OH) 2 , Ba (OH) 2 , NH 4 OH or Zn (OH) 2
- organic base such as a primary, secondary or tertiary alkylamine, especially triethylamine, isopropylamine or butylamine.
- This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and / or oxygen atoms and may therefore comprise, for example, one or more alcohol functions; mention may especially be made of 2-amino-methyl-2-propanol, triethanolamine and dimethylamino-2-propanol. Mention may also be made of lysine or 3- (dimethylamino) propylamine.
- the -NH 2 groups can be neutralized with salts of mineral acids, such as sulfuric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, phosphoric acid and boric acid. Mention may also be made of organic acid salts, which may comprise one or more carboxylic acid, sulfonic or phosphonic acid groups. It may be linear, branched or cyclic aliphatic acids or aromatic acids. These acids may furthermore comprise one or more heteroatoms chosen from O and N, for example in the form of hydroxyl groups.
- mineral acids such as sulfuric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, phosphoric acid and boric acid. Mention may also be made of organic acid salts, which may comprise one or more carboxylic acid, sulfonic or phosphonic acid groups. It may be linear, branched or cyclic aliphatic acids or aromatic acids. These acids may furthermore comprise one or more heteroatoms chosen from O and N, for example in the form of hydroxyl groups
- Amino groups may be quaternized with mobile halogen compounds, including:
- - halides such as alkyl chlorides or alkyl bromides Ci-Ci 2, for example methyl bromide, methyl iodide or ethyl chloride,
- Quaternizing agents include, for example, sodium chloroacetate, dimethyl sulphate, diethyl sulphate or cyclic sulphones, for example propanesulphone.
- the polysaccharide grafts are chosen from dextrans and their derivatives (dextran sulfate, dextran diethylaminoethyl, carboxymethyl dextran), glycosaminoglucans and their derivatives (hyaluronic acid, chondroitins and chondroitin sulphates), celluloses and their derivatives (methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses, carboxymethyl- celluloses), amylose and its derivatives, chitins and their derivatives, carrageenans and their derivatives, oligomaltoses and their derivatives; and their mixtures.
- dextrans and their derivatives dextrans and their derivatives
- glycosaminoglucans and their derivatives hyaluronic acid, chondroitins and chondroitin sulphates
- celluloses and their derivatives methyl
- the polysaccharide grafts may be of the same nature or of different natures.
- Each (poly) saccharide graft PS preferably has a number-average molecular weight (Mn) of between 100 and 100,000 g / mol, in particular between 150 and 50,000 g / mol and preferably between 200 and 20,000 g / mol.
- Mn number-average molecular weight
- linker L is conditioned by the chemical reaction involved in grafting the (poly) saccharides onto the repeating unit of the polymeric backbone. All chemical reactions known to those skilled in the art can be implemented. Different types of chemical reactions can be used to graft the (poly) saccharides onto the polymeric backbone.
- the polymers according to the invention are prepared by Chemo-Selective Ligation reaction between aldehyde or ketone functions carried especially by the (poly) saccharide or the polymer backbone and at least one of the compounds following: H 2 N-LI-R, HR 1 N-L 1 -R, H 2 N-O-L 1 -R, H 2 NO- (O) C-LI-R, H 2 NO- (O) C-NH -LI-R, H 2 NO- (S) C-NH-LI-R, HR 1 N-O-L 1 -R, HR 1 NO- (O) C-LI-R, HR 1 NO- (O) C-NH 1H-R, HR 1 NO- (S) C-NH-Li-R, H 2 N-NH-LI-R, H 2 N-NH- (O) C-LI-R, H 2 N-NH- (O) CO-LI-R, H 2 N-NH- (O) C-NH-Li-R, H
- X and X ' are electron-withdrawing groups (esters, ketones, acids, nitro, halogens in particular);
- - L1 is a covalent bond or a group selected from (i) linear, branched or cyclic C1 to C30 alkyl, preferably linear or branched C1 to C10; (ii) linear, branched or cyclic C2-C30 alkenyl, preferably linear or branched C1-C10, (iii) linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; this group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH , SH;
- R or R1 represent, independently of one another, the polymeric backbone POL or a (poly) saccharide graft PS or a hydrogen atom or a group chosen from (i) linear, branched or cyclic C1-C alkyl C30, preferably linear or branched C1-C10; (ii) linear, branched or cyclic C2-C30 alkenyl, preferably linear or branched C1-C10, (iii) linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; this group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH, SH; it being understood that only one of the groups R or R1 represents a (poly) saccharide PS or a polymeric backbone POL.
- the polymers according to the invention are prepared by Chemo-Selective Ligation reaction between aldehyde functions or ketones carried by the (poly) saccharide and at least one of the following compounds:
- hydroxylamine derivatives H 2 NO-LI -R, H 2 NO- (O) C-LI-R, H 2 NO- (O) C -NH-L 1 -R, H 2 NO- (S) C -NH-LI-R, HR1 NO-L1-R, HR1 NO- (O) C-LI-R, HRI NO- (O) C-NH-L1-R, HR1 NO- (S) C-NH- LI -R,
- L1 is preferably a single covalent bond (CC)
- R is the polymeric backbone
- R1 is H or an alkyl group as defined above
- the reducing end of the (poly) saccharides may act as an aldehyde and, preferably, the role of aldehyde is played by the reducing end of the (poly) saccharide PS.
- the linker in the case of reactions between the reducing end of the polysaccharides and preferred compounds, in particular derivatives of hydroxylamines or ⁇ -aminothiols above, the linker can be schematised by the following general formulas:
- Ra to Re represent, independently of each other, -OH, -CH 3 , NHCOCH 3 , NH 2 , OCH 2 COOH, COOH, OSO 3 H, OPO 3 H, or -O-linked to the polysaccharide graft; at least one of Ra to Re representing -O-linked to the polysaccharide graft;
- Rf represents (i) a covalent bond with the polymeric backbone POL or (ii) a group bonded to said polymeric backbone POL chosen from linear, branched or cyclic C1-C30, preferably linear or branched C1-C10 alkyl divalent groups; ; linear, branched or cyclic C 2 -C 30, preferably linear or branched C 1 -C 10 alkenyl; and linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; said group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH , SH.
- Ra to Re represent, independently of each other, -OH, -CH 3 , NHCOCH 3 , NH 2, OCH 2 COOH, COOH, OSO 3 H, OPO 3 H; and Rf is as defined above, and therefore formulas (III), (MIa), (IV), (Iva), (V), (Va), (VI) and (VIa) represent L-PS.
- the polymers according to the present invention comprise:
- POL a polymeric backbone POL resulting from the (co) polymerization of (meth) acrylates, (meth) acrylamides and / or styrenic monomers, or else POL represents a polysaccharide, preferably said backbone having a number-average molecular weight ( Mn) between 2000g / mol and 100,000 g / mol with
- PS polysaccharide grafts chosen from dextrans and their derivatives (dextran sulfate, dextran diethylaminoethyl, carboxymethyl dextran), glycosaminoglucans and their derivatives (hyaluronic acid, chondroitins and chondroitin sulphates), celluloses and their derivatives (methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses, carboxymethylcelluloses), amylose and its derivatives, chitins and their derivatives, carrageenans and their derivatives, oligomaltoses and their derivatives, and their mixtures; said grafts preferably having a number-average molecular weight (Mn) of between 200 and 20000 g / mol; a grafting rate of between 1 and 100%, especially between 20 and 100%, and even more preferentially between 40 and 100%; and
- Mn number-average molecular weight
- the polymer according to the invention corresponds to one of the following structures:
- the polymer according to the invention comprises at least one repeating unit represented by one of the following formulas, in which the backbone has a number-average molecular mass (Mn) of between 2000 g / mol and 100,000 g / mol and the grafts have a number-average molecular mass (Mn) of between 200 and 20000 g / mol:
- the polymer may further comprise any comonomer including ethylenic.
- the (poly) saccharide PS grafts may be introduced into the final polymer by any method known to those skilled in the art, and in particular: by direct reaction on the already formed polymeric POL skeleton, as illustrated by Scheme 1; it is then a synthesis called 'grafting onto'; by polymerization of monomers carrying a PS polysaccharide graft, alone or in admixture with other monomers (copolymerization); it is a synthesis from macromonomers as illustrated by Scheme 2; by growth of a PS polysaccharide graft from a polysaccharide precursor grafted onto the POL polymer backbone or grafted onto one or more constituent monomers of said polymeric backbone POL; this is illustrated by diagram 3, it is about a synthesis known as 'grafting from'.
- Rf has the same meaning as before.
- dextran and amylose have been used, but this in no way represents a limitation of the scope of the invention.
- US2002 / 0016304 discloses the synthesis of cationic hydrophilic graft polypeptides used to carry nucleic acids.
- hydrophilic grafts are dextrans, glycosaminoglycans and polyethylene glycols.
- the dextran is grafted onto the cationic polyamino acid by reductive amination.
- this reductive amination requires the use of reducing agents (NaCNBH 3 ), which can pose problems of toxicity, degradation of the polymer backbone and purification of the synthesized polymer.
- the polymer according to the present invention can be obtained in different ways.
- SUBSTITUTE SHEET (RULE 26)
- a first step it is possible, in a first step, to prepare a functionalized polymer skeleton, that is to say carrying the reactive chemical functions described above, then, in a second step, to graft the functionalized or non-functionalized polysaccharide grafts. reacting the reactive functions carried by the polysaccharide grafts or their reducing end with the reactive functions carried by the polymer backbone.
- This technique is known to those skilled in the art under the name of 'grafting onto'.
- a functionalized monomer that is to say carrying the reactive chemical functions described above
- graft the functionalized or non-functionalized polysaccharide grafts.
- a "macromonomer” carries the polysaccharide graft which is then polymerized to give the polymer of the invention.
- This macromonomer may be copolymerized in the presence of one or more other monomers or macromonomers carrying polysaccharide grafts.
- Polysaccharides can be polymerized enzymatically from an oligosaccharide precursor.
- amylose can be obtained by enzymatic polymerization using maltoheptaose as a precursor, potassium salt of ⁇ - (D) -glucose-1-phosphate as a monomer and a potato phosphorylase. as a catalyst (see BioMacromolecules 2002, 3, pp. 368-373).
- a third mode of preparation may consist in polymerizing a monomer carrying a polysaccharide polymerization precursor: a polymeric backbone carrying polysaccharide precursor grafts is thus obtained.
- the polymer with polysaccharide grafts is then obtained by polymerization from the polymer skeleton carrying the precursor grafts, catalyzed by an enzyme or a bacterium in the presence of a sugar which acts as a monomer.
- a functionalized polymeric backbone that is to say carrying the reactive chemical functions described above
- a functionalised polysaccharide precursor can be grafted, while react the reactive functions carried by this polysaccharide precursor or its reducing end (if it is an oligosaccharide such as maltoheptaose) with the reactive functions carried by the polymer backbone.
- a polymeric backbone carrying polysaccharide precursor grafts is thus obtained.
- the polymer with polysaccharide grafts is then obtained by polymerization from the polymer skeleton carrying the precursor grafts, catalyzed by an enzyme or a bacterium in the presence of a sugar which acts as a monomer.
- the third and fourth embodiments are known to those skilled in the art as 'grafting from'.
- the polymer according to the invention finds a very particular application in the cosmetic field, particularly in the hair field.
- the amount of polymer present in the compositions depends, of course, on the type of composition and the desired properties and can vary within a very wide range, generally between 0.01 and 30% by weight, preferably between 0, 1 and 20% by weight, especially between 0.5 and 10% by weight, or even between 1 and 5% by weight, relative to the weight of the final cosmetic composition.
- compositions according to the invention may be in any of the galenical forms conventionally used for topical application and especially in the form of an aqueous or alcoholic or aqueous-alcoholic solution or suspension, or of an oily solution or suspension, or of a solution.
- a dispersion of the lotion or serum type of a liquid or semi-liquid consistency emulsion of the milk type, obtained by dispersion of a fatty phase in an aqueous phase (O / W) or conversely (W / O) , or a suspension or emulsion of soft consistency of the cream (O / W) or (W / O) type, or of an aqueous or anhydrous gel, of an ointment, of a free or compacted powder to be used such which or to incorporate in an excipient, or any other cosmetic form.
- the cosmetic compositions according to the invention comprise, in addition to said polymers, a cosmetically acceptable medium, in particular a cosmetically acceptable medium, that is to say a medium which is compatible with cutaneous tissues such as the skin of the face or of the body, and keratin materials such as hair, eyelashes, eyebrows and nails.
- a cosmetically acceptable medium comprises a solvent or dispersion medium of the polymers according to the invention, which may comprise at least one compound chosen from water, alcohols, polyols, esters, carbonaceous oils, silicone, fluorinated silicone oils, and mixtures thereof.
- the cosmetically acceptable medium of the compositions according to the invention may comprise water or a mixture of water and hydrophilic organic solvent (s), such as alcohols and especially linear or branched monoalcohols.
- C Ce, such as ethanol, tert-butanol, n-butanol, isopropanol or n-propanol, or 2-butoxyethanol; and polyols such as glycerine, di-glycerine, ethylene glycol, propylene glycol, sorbitol, pentylene glycol, and polyethylene glycols, or alternatively ethers of polyols or glycols, especially C2, such as monoethyl ether. and diethylene glycol monomethyl ether and hydrophilic C 2 -C 4 aldehydes.
- composition according to the invention may also comprise at least one cosmetically acceptable adjuvant conventionally used in cosmetic compositions, in particular intended to be applied to keratinous fibers.
- a cosmetically acceptable adjuvant it is possible to mention thickeners and / or thickeners; polymers, associative or not; anionic, nonionic, cationic and / or amphoteric surfactants; propenetrating agents, emulsifiers, perfumes, preservatives, fillers, sunscreens; dyestuffs, proteins, vitamins, provitamins; polymers, fixing or non-fixing, anionic, nonionic, cationic or amphoteric; moisturizing agents, emollients, softening agents; mineral, vegetable or synthetic oils; hydrophilic or lipophilic active agents such as ceramics and pseudoceramides; anti-foam agents, antiperspirants, anti-free radical agents, bactericidal agents and anti-dandruff agents.
- the composition according to the invention may be in the form of a lotion, thickened or not, a cream, thickened or not, a gel, a foam or any other suitable form. It can optionally be packaged in a pump bottle or in an aerosol container.
- the cosmetic composition according to the invention may be in the form of a product for the care, cleaning and / or make-up of the skin of the body or of the face, the lips, the eyelashes, the nails and the hair, a suntan or self-tanning product, a personal hygiene product, a hair product, especially care, cleaning, styling or hair dyeing.
- the hair compositions are preferably shampoos, conditioners, body care or gelling gels, lotions or care creams, conditioners, styling lotions, blow-dry lotions, fixing and styling such as lacquers or spray.
- the lotions may be packaged in various forms, in particular in vaporizers, pump-bottles or in aerosol containers to ensure application of the composition in vaporized form or in the form of foam.
- It may especially be in the form of a hair coloring product; or in the form of a composition for permanent, straightening, or discoloration, or in the form of compositions to be rinsed, to be applied before or after a coloring, a discoloration, a permanent or a straightening or between the two stages of a permanent or a straightening.
- composition according to the invention may also be in the form of a care composition, in particular a moisturizing composition, for the skin, the lips and / or the phageres, or in the form of a composition for cleaning the skin, for example a makeup remover or a gel for the bath or shower.
- a care composition in particular a moisturizing composition, for the skin, the lips and / or the phageres
- a composition for cleaning the skin for example a makeup remover or a gel for the bath or shower.
- It can also be in the form of a care product, not colored, intended to treat the skin and in particular to moisturize it, smooth it, depigment it, nourish it, protect it from the sun's rays, or give it a specific treatment. . It may also be in the form of a personal hygiene composition, especially in the form of a deodorant product, antiperspirant, or in the form of a depilatory composition.
- a makeup product in particular colored, the skin of the body or face, or hair, especially a foundation, possibly with care properties, a blush, a blush, eye shadow, concealer, eye liner; a lipstick makeup product such as a lipstick, possibly with skincare properties, a lip gloss, lip pencils; a make-up product of integuments such as nails, eyelashes, in particular in the form of bread mascara, eyebrows and hair; a temporary tattoo product of the body skin.
- the composition according to the invention is a hair styling or conditioning hair composition, and may be in the form of a gel, a mousse, a lotion, a cream or a spray; shampoos or conditioners.
- the subject of the invention is also a process for the cosmetic treatment, in particular of makeup, care, cleaning, coloring, shaping of keratin materials, in particular of the skin of the body or face, nails, hair, bristles and / or eyelashes, comprising the application on said materials of a cosmetic composition as defined above.
- it is a cosmetic treatment method for shaping, holding, care and / or conditioning the hair, comprising applying a composition according to the invention to said hair; possibly followed by a rinsing step.
- KPS potassium persulfate
- N- [O- (p-vinylbenzyl) oxy] amine grafted with maltotriose is solubilized in 1.16 g of water. After solubilization, 5 mg of potassium persulfate are added. The mixture is brought to 90 ° C. After 6 hours, the reaction medium is precipitated in ethanol.
- reaction medium is then diluted with 1 liter of dichloromethane and then washed with water until complete disappearance of the orange color in the aqueous phase.
- organic phase is then concentrated under reduced pressure and then purified on a silica column (eluent: 70/30 heptane / ethyl acetate).
- the polymerization of this monomer is carried out by solubilizing 0.5 g of 2- (aminooxyacetamido) ethyl methacrylate grafted Dextran T1 in 2 ml of water and then adding 10 mg from ABCVA.
- the pH of the solution is adjusted to 7 by adding a solution 1 N sodium hydroxide solution and then the reaction medium is heated at 70 ° C. for 4 hours.
- the polymerization is controlled by the disappearance of the double bonds in 1 H NMR.
- the mixture is then precipitated in 50 ml of THF and after filtration and drying, 0.4 g of a white powder is recovered, giving a yield of 80%.
- the deprotection is carried out by solubilizing 330 mg of the above polymer in 1 g of water and 2 g of water. , 98 g of trifluoroacetic acid. After 5 hours, the reaction medium is evaporated; a total deprotection of the polymer is confirmed by 1 H NMR.
- the whole of the above 3- (aminooxyacetamido) propyl polymethacrylamide is solubilized in 5 ml of water.
- the pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH.
- 4.19 g of Dextran T5 is added and then allowed to react at room temperature for 48 hours.
- the reaction medium is precipitated in 50 ml of ethanol. After filtration and drying, 4 g of a white powder are recovered.
- the degree of grafting of Dextran T5 is estimated at 65% by 1 H NMR.
- Example 7 Synthesis of polv (methacrylamide of 3- (aminooxyacetamido) propyl) grafted with Dextran of Mn 10000q / mol (Dextran T10) The protocol of Example 6 is repeated until the grafting of Dextran.
- the grafting of the polysaccharide is carried out by solubilizing 330 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 20 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 8.37 g of Dextran T10 are then added and the mixture is left to react at ambient temperature for 72 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 8.1 g of a white powder are recovered. The degree of grafting of Dextran T10 is estimated at 40% by 1 H NMR
- Example 8 Synthesis of a 3- (aminooxyacetamido) propyl methacrylamide copolymer with dimethylaminopropyl methacrylamide followed by grafting with a Dextran of Mn 5000q / mol (Dextran T5)
- the polymer is precipitated in 200 ml of diethyl ether. After filtration and drying, 5.3 g of polymer is recovered, the 1 H NMR of which makes it possible to determine the composition: 76 mol% of 3- (Boc-aminooxyacetamido) propyl methacrylamide and 24 mol% of dimethylaminopropylmethacrylamide (yield 76%).
- the reaction medium is precipitated in 600 ml of THF; after filtration and drying, 10 g of a copolymer containing 76 mol% of 3- (aminooxyacetamido) propyl methacrylamide and 24 mol% of dimethylaminopropyl methacrylamide were grafted onto which 59% of Dextran T5 was grafted (confirmed by 1 H NMR). ).
- Example 9 Synthesis of a copolymer of 3- (aminooxyacetamido) propyl methacrylamide with dimethylaminopropyl methacrylamide followed by grafting with a Dextran of Mn 10,000q / mol (Dextran T10)
- Example 8 The protocol of Example 8 is repeated until the grafting of Dextran.
- the grafting of the polysaccharide is carried out by solubilizing 510 mg of the methacrylamide copolymer of 3- (aminooxyacetamido) propyl (76%) and dimethylaminopropyl methacrylamide (24%) in 20 ml of water.
- the pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH.
- Dextran T10 (15.2 g) is added and allowed to react at room temperature for 48 hours.
- the reaction medium is then precipitated in 600 ml of THF; after filtration and drying, 16.3 g of a white powder are obtained.
- the degree of grafting of Dextran T10 is estimated at 54% by 1 H NMR.
- Example 8 The protocol of Example 8 is repeated until the grafting of Dextran.
- the grafting of the polysaccharide is carried out by solubilizing 3 g of the methacrylamide copolymer of 3- (aminooxyacetamido) propyl (76%) and of dimethylaminopropyl methacrylamide (24%) in 17 ml of water.
- the pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH.
- 6.2 g of Dextran T1 are then added, and the reaction is left at room temperature for 24 hours.
- the reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 8 g of a white powder are recovered.
- the degree of grafting of Dextran T1 is estimated at 95% by 1 H NMR.
- Example 11 Synthesis of a copolymer of 3- (aminooxyacetamido) propyl methacrylamide (48 mol%) with dimethylaminopropyl methacrylamide (52 mol%) and then grafting with a dextran of 1000 g / mol (Dextran TD
- the polymer is precipitated in 200 ml of diethyl ether. After filtration and drying, 4.2 g of polymer are recovered, the 1 H NMR of which makes it possible to determine the composition: 48 mol% of 3- (Boc-aminooxyacetamido) propyl methacrylamide and 52 mol% of dimethylaminopropylmethacrylamide (yield 71%). 2 / deprotection and grafting of Dextran T1
- the reaction medium is precipitated in 600 ml of ethanol; after filtration and drying, 6.5 g of a copolymer containing 48 mol% of 3- (aminooxyacetamido) propyl methacrylamide and 52 mol% of dimethylaminopropylmethacrylamide were grafted onto which 89% of Dextran T1 (NMR-confirmed) was grafted. 1H).
- Example 12 Synthesis of a methacrylamide copolymer of 3- (aminooxyacetamido) propyl (48 mol%) with dimethylaminopropyl methacrylamide (52 mol%) and then grafting with a Dextran of Mn 5000q / mol (Dextran T5)
- Example 11 The protocol of Example 11 is repeated until the grafting of Dextran.
- the grafting of the polysaccharide is carried out by solubilizing 1 g of the copolymer of 3- (aminooxyacetamido) propyl methacrylamide (48 mol%) and of dimethylaminopropyl methacrylamide (52 mol%) in 17 ml of water.
- the pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH.
- 6.58 g of Dextran T5 are then added, and the reaction is left at room temperature for 24 hours.
- the reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 6.5 g of a white powder are recovered.
- the degree of grafting of Dextran T5 is estimated at 76% by 1 H NMR.
- Example 13 Synthesis of Polv (3- (Aminooxyacetamido) Propyl Methacrylamide) Grafted with D-Glucuronic Acid
- the procedure of Example 6 is repeated until the sugar is grafted.
- the grafting of D-glucuronic acid is carried out by solubilizing 800 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 475 mg of sodium salt of D-glucuronic acid are then added, and the reaction is then left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 650 mg of a white powder are recovered. The grafting of D-glucuronic acid is complete (confirmed by 1 H NMR)
- Example 6 The protocol of Example 6 is repeated until the sugar is grafted.
- the grafting of D (+) mannose is carried out by solubilizing 800 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by adding a solution of 5N NaOH. 366 mg of D - (+) - Mannose are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 650 mg of a white powder is recovered. The grafting of D (+) mannose is complete (confirmed by 1 H NMR)
- Example 6 The protocol of Example 6 is repeated until the sugar is grafted.
- the grafting of the sodium salt of D - (+) glucose-6-phosphate is carried out by solubilizing 800 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 573 mg of sodium salt of D - (+) glucose-6-phosphate are then added, and the reaction is then left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 1.24 g of a white powder are recovered. The grafting of D - (+) glucose-6-phosphate is complete (confirmed by
- Example 6 The protocol of Example 6 is repeated until the sugar is grafted.
- the grafting of D (+) Fucose is carried out by solubilizing 1.5 g of poly (3- (aminooxyacetamido) propyl methacrylamide) in 8 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 915 mg of D - (+) - Fucose are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 1.25 g of a white powder are recovered. The grafting of D (+) Fucose is complete (confirmed by 1 H NMR).
- Example 6 The protocol of Example 6 is repeated until the sugar is grafted.
- the grafting of L (-) Fucose is carried out by solubilizing 1.5 g of poly (3- (aminooxyacetamido) propyl methacrylamide) in 8 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 915 mg of L - (-) - Fucose are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 0.96 g of a white powder is recovered. The grafting of L (-) Fucose is total (confirmed by 1 H NMR)
- Example 8 The protocol of Example 8 is repeated until the grafting of Dextran.
- the grafting of the polysaccharide is carried out by solubilizing 90 mg of the 3- (aminooxyacetamido) propyl methacrylamide copolymer (76%) and dimethylaminopropyl methacrylamide (24%) in 2 ml of water.
- the pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH.
- the reaction medium is then precipitated in 60 ml of ethanol. After filtration and drying, 700 mg of a white powder are recovered.
- the degree of grafting of Dextran sulfate T5 is estimated at 33% by 1 H NMR.
- Example 6 The protocol of Example 6 is repeated until the sugar is grafted.
- the grafting of D (+) Galactose is carried out by solubilizing 1.5 g of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 970 mg of D (+) Galactose are then added and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 300 ml of ethanol. After filtration and drying, 2 g of a white powder are recovered. The grafting of D (+) Galactose is complete (confirmed by 1 H NMR).
- the sliding character of the polymers according to the invention is evaluated using a pion-disk type tribometer; a solution of 3% by weight of polymer is deposited on a moving substrate which is brought into contact with a ball. The friction force between the ball and the moving substrate is then measured. The lower the friction force between the two surfaces, the greater the slipperiness of the polymer.
- Friction in the presence of water (in the absence of polymer) is used as a reference.
- a shampoo comprising (% by weight) is prepared:
- a styling lotion is obtained.
- a similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
- a hydroalcoholic solution comprising, in g of active material: polyvinylpyrrolidone 2.5 g - polymer of Example 6 0.65 g
- water 36 g - DME 36 g A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
- a mascara is prepared having the following composition: - waxes 24 g
- Preservatives qs - Water qs 100 g A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
- composition comprising (% by weight) is prepared: polymer of Example 6 (MA) 7%
- N-octanoyl-5-salicylic acid (Mexoryl SAB from CHIMEX) 0.3% - Glyceryl stearate SE 5%
- cocoyl-glucoside (at 50% active ingredient) (ie 1% of MA) 2%
- the aqueous phase consisting of water-soluble ingredients (water, preservatives, EDTA, PEG-8, polymer of example 1) is brought to 80 ° C.
- the fatty phase consisting of fatty acids, glyceryl stearate and n -octanoyl-5 salicylic, is heated to 80 0 C and added with stirring to the aqueous phase.
- the cocoyl glucoside is then added and the KOH is solubilized in part of the water. Stirring is maintained for 10 minutes at 80 ° C., then the mixture is cooled with stirring.
- a similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
- a composition comprising (% by weight of MA) is prepared:
- a similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
- composition for Permanent Hair Deformation A composition comprising (% by weight) is prepared:
- the permanent deformation compositions above are applied for 15 minutes. on wet hair previously wrapped on styling rollers, then rinsed thoroughly with water. A solution of oxygenated water at 8 volumes and pH 3 is then applied for 5 minutes, then rinsed again, the rollers are removed and dried.
- a similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
- a moisturizing oil for dry skin is prepared using the following constituents:
- caprylic / capric triglycerides 6.5 g
- a moisturizing care cream for normal and combination skin is prepared using the following constituents:
- Example 31 Moisturizing cosmetic composition
- a moisturizing composition is prepared using the following constituents
- Phases A1 and B are brought to 65 ° C before being mixed with stirring.
- the dispersion is homogenized (between 20 ⁇ 10 6 Pa and 60 ⁇ 10 6 Pa) to obtain a dispersion whose oil globule size is less than 500 nm.
- Phase A2 is dispersed at room temperature in the first dispersion, with vigorous stirring.
- Phase C previously prepared, is then added.
- a moisturizing emulsion adapted for dry skin is obtained.
- a similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
- composition comprising (% by weight) is prepared:
- the conditioner is applied to damp hair. Let it sit for 2 minutes and rinse.
- a similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to polymers which have a polymeric backbone bearing polysaccharide grafts. The invention also relates to the cosmetic compositions, in particular hair compositions, comprising said polymers, and also to a cosmetic treatment method using same.
Description
Polymères à greffons polysaccharidiques, compositions cosmétiques et procédé de traitement Polysaccharide graft polymers, cosmetic compositions and method of treatment
La présente invention concerne des nouveaux polymères à greffons polysacchari- des, les compositions notamment cosmétiques les comprenant et leur utilisation en cosmétique, notamment dans le domaine capillaire.The present invention relates to novel polysaccharide graft polymers, the compositions comprising them being especially cosmetic and to their use in cosmetics, especially in the hair field.
Dans le domaine des compositions capillaires dites "rincées", telles que les sham- pooings ou après-shampooings, on utilise des polymères cationiques synthétiques, solubles dans l'eau, connus pour apporter une bonne cosmétique aux cheveux. On peut notamment citer les produits commerciaux "Merquat 550" et "Mer- quat 100", ainsi que les copolymères poly(vinylpyrrolidone/diméthylaminoéthyl mé- thacrylate quaternisé) ou poly(vinylpyrrolidone/imidazolinium méthochloride). Tou- tefois, ces polymères ne sont généralement pas utilisés dans les compositions d'après-shampooing ou de soin après coloration, pour lesquelles le démêlage des cheveux mouillés doit être très facile. En effet, ces polymères n'apportent pas suffisamment de propriétés cosmétiques. Dans le domaine du soin du cheveu, en particulier du cheveu sensibilisé, notam- ment ayant subi des colorations, on cherche à apporter des propriétés cosmétiques sur cheveux mouillés, notamment un toucher amélioré, ainsi que de la brillance, de la douceur et du démêlage en milieu sec (sur cheveux secs). En effet, on sait que les cheveux sensibilisés, c'est-à-dire abîmés et/ou fragilisés, à des degrés divers par l'action d'agents atmosphériques, notamment de la lumière, ain- si que par l'action répétée de différents traitements mécaniques ou chimiques, tels que les permanentes, le défrisage, la coloration et la décoloration, peuvent présenter une altération de la fibre capillaire, notamment une diminution de leurs propriétés mécaniques comme la résistance à la traction, la charge à la rupture et l'élasticité. Le cheveu peut être plus hydrophile, perdre une partie des écailles, ce qui se traduit par une grande difficulté à démêler et à coiffer la chevelure, ainsi qu'une perte de douceur. Pour y remédier, on peut employer des tensioactifs cationiques du type cétyltriméthylammonium, en émulsion huile-dans-eau, en présence d'alcools gras. Toutefois, les propriétés cosmétiques ne sont pas optimales et la formulation de ces compositions est compliquée: compromis entre la stabilité de l'émulsion et le toucher non gras à trouver, notamment.In the field of so-called "rinsed" hair compositions, such as shampoos or hair conditioners, water-soluble, synthetic cationic polymers known to provide good hair cosmetics are used. Mention may in particular be made of the commercial products "Merquat 550" and "Merquat 100", as well as the poly (vinylpyrrolidone / dimethylaminoethyl methacrylate quaternized) or poly (vinylpyrrolidone / imidazolinium methochloride) copolymers. However, these polymers are generally not used in post-coloring conditioner or care compositions, for which disentangling of wet hair must be very easy. Indeed, these polymers do not provide enough cosmetic properties. In the field of hair care, in particular of sensitized hair, in particular having undergone coloring, it is sought to provide cosmetic properties on wet hair, in particular an improved feel, as well as shine, softness and disentangling. in dry environment (on dry hair). Indeed, it is known that hair sensitized, that is to say damaged and / or weakened, to varying degrees by the action of atmospheric agents, including light, as well as by repeated action different mechanical or chemical treatments, such as perms, straightening, coloring and discoloration, may exhibit an alteration of the hair fiber, in particular a reduction in their mechanical properties such as tensile strength, tensile strength and elasticity. The hair can be more hydrophilic, losing part of the scales, which results in great difficulty in disentangling and styling the hair, and a loss of softness. To remedy this, it is possible to use cetyltrimethylammonium cationic surfactants, in oil-in-water emulsion, in the presence of fatty alcohols. However, the cosmetic properties are not optimal and the formulation of these compositions is complicated: compromise between the stability of the emulsion and the non-greasy feel to be found, in particular.
Il est également été proposé d'utiliser des compositions comprenant des polysac- charides, notamment des polysaccharides cationiques, pour améliorer les propriétés de la fibre. On peut citer la demande WO02/055034 qui décrit des compositions cosmétiques contenant un fructane, un polysaccharide et un agent bénéfique pour améliorer les propriétés de la fibre; ainsi que la demande WO06/017589 qui décrit l'utilisation de polysaccharides à greffons polycationiques pour conditionner la fibre. Cependant, on a constaté que dans certains cas, les polymères cationiques peuvent se déposer en quantité trop importante sur les cheveux, notamment
sur les cheveux abîmés, ce qui peut conduire à des touchers chargés. De plus, ces polymères à charge cationique peuvent poser des problèmes de formulation (incompatibilité, précipitation) en présence de composant anionique habituellement utilisé en cosmétique, tel que tensioactif ou polymère de coiffage anioniques.It has also been proposed to use compositions comprising polysaccharides, especially cationic polysaccharides, to improve the properties of the fiber. There may be mentioned the application WO02 / 055034 which describes cosmetic compositions containing a fructan, a polysaccharide and a beneficial agent for improving the properties of the fiber; as well as the application WO06 / 017589 which describes the use of polycationic graft polysaccharides for conditioning the fiber. However, it has been found that, in certain cases, the cationic polymers may be deposited in excessive amounts on the hair, in particular on damaged hair, which can lead to charged touches. In addition, these cationically charged polymers may cause formulation problems (incompatibility, precipitation) in the presence of anionic component usually used in cosmetics, such as surfactant or anionic styling polymer.
II existe donc toujours le besoin de disposer de polymères susceptibles d'améliorer la qualité du cheveu notamment en terme de toucher, de douceur, de démêlage, et de propriétés mécaniques de la fibre, que cela soit sur cheveux mouillés (en milieu humide) ou sur cheveux secs (en milieu sec).There is therefore still a need for polymers that can improve the quality of the hair, particularly in terms of touch, softness, disentangling, and mechanical properties of the fiber, whether it is on wet hair (in a humid environment) or on dry hair (in dry conditions).
Le but de la présente invention est de proposer des polymères, et les compositions cosmétiques les comprenant, qui apportent des propriétés de conditionnement, et en particulier permettent de protéger et de réparer les matières kératini- ques, notamment les matières kératiniques abîmées; dans le cas des cheveux, ceci se traduit entre autre par une amélioration des propriétés de démêlage sur cheveux secs et humides et une amélioration du toucher, notamment de la douceur.The object of the present invention is to provide polymers, and the cosmetic compositions comprising them, which provide conditioning properties, and in particular make it possible to protect and repair keratin materials, in particular damaged keratin materials; in the case of the hair, this results among other things by an improvement of the disentangling properties on dry and wet hair and an improvement of the touch, in particular of the softness.
Un objet de la présente invention est donc un polymère de structure (POL)-(L-PS)x oùAn object of the present invention is therefore a polymer of structure (POL) - (L-PS) x where
- POL représente un squelette polymérique,POL represents a polymeric backbone,
- L représente un linker,L represents a linker,
- PS représente un (poly)saccharide greffé sur POL via le linker L, etPS represents a (poly) saccharide grafted onto POL via the linker L, and
- x représente un entier non nul caractéristique du nombre de greffons PS.x represents a non-zero integer characteristic of the number of PS grafts.
Un autre objet de l'invention est une composition cosmétique, comprenant, dans un milieu cosmétiquement acceptable, au moins un tel polymère.Another subject of the invention is a cosmetic composition comprising, in a cosmetically acceptable medium, at least one such polymer.
Les polymères selon l'invention peuvent être représentés par la structure sui- vante : (POL)-(L-PS)x oùThe polymers according to the invention can be represented by the following structure: (POL) - (L-PS) x where
- POL représente le squelette polymérique,POL represents the polymeric backbone,
- L représente un linker (ou bras de liaison),L represents a linker (or linker),
- PS représente un polysaccharide greffé sur POL via le linker L, etPS represents a polysaccharide grafted onto POL via the linker L, and
- x représente un entier non nul caractéristique du nombre de greffons PS.x represents a non-zero integer characteristic of the number of PS grafts.
Dans la suite du texte, on appellera POL le squelette polymérique sur lequel sont présents les greffons polysaccharides. Il peut être d'origine naturelle (extraction de certains végétaux, crustacés ou insectes par exemple) ou synthétique. Ce polymère peut être obtenu par polymérisation radicalaire, polymérisation radi- calaire contrôlée, polymérisation anionique, polymérisation cationique, polymérisation par ouverture de cycle, par métathèse, par polycondensation, par coordination ou par polymérisation enzymatique. Ledit squelette polymérique peut avoir une structure statistique, à gradient, à bloc,
étoile, branchée, hyperbranchée, à greffons, réticulée. Il peut s'agir d'un homopo- lymère ou d'un copolymère issu de la copolymérisation de plusieurs monomères, préférentiellement entre 2 et 5 monomères différents.In the rest of the text, POL will be called the polymeric backbone on which the polysaccharide grafts are present. It can be of natural origin (extraction of certain plants, crustaceans or insects for example) or synthetic. This polymer can be obtained by radical polymerization, controlled radical polymerization, anionic polymerization, cationic polymerization, ring opening polymerization, metathesis, polycondensation, coordination or enzymatic polymerization. Said polymeric backbone can have a statistical structure, with a gradient, a block, star, branched, hyperbranched, grafted, reticulated. It may be a homopolymer or a copolymer resulting from the copolymerization of several monomers, preferably between 2 and 5 different monomers.
Ce squelette polymérique peut être issu de la polymérisation d'un ou de plusieurs monomères éthyléniques choisis parmi ceux de formule : R1R2C=CR3R4 dans laquelle R1, R2, R3 et R4 représentent indépendamment l'un de l'autre,This polymer backbone may be derived from the polymerization of one or more ethylenic monomers chosen from those of formula: R 1 R 2 C = CR 3 R 4 wherein R 1, R 2, R 3 and R 4 are independently one of the other,
- un atome d'hydrogène ou d'halogène, - un groupe alkyle en C1-20, linéaires, ramifiés et/ou cycliques, saturés ou insaturés, pouvant être substitués par 1 ou plusieurs atomes d'halogène et/ou un ou plusieurs groupes OH,a linear or branched and / or cyclic, saturated or unsaturated, linear or branched C1-20 alkyl, which may be substituted with 1 or more halogen atoms and / or one or more groups; OH,
- un groupe alcényle ou alcynyle, linéaire ou ramifié, en C2-C10, pouvant être substitué par un ou plusieurs atomes d'halogène, - un groupe cycloalkyle en C3-8 pouvant être substitué par un ou plusieurs atomes d'halogène,a C2-C10 linear or branched alkenyl or alkynyl group which may be substituted by one or more halogen atoms; a C3-8 cycloalkyl group which may be substituted with one or more halogen atoms,
- un groupe cyano,- a cyano group,
- un groupe aryle,an aryl group,
- un groupe hétérocyclique à 4 à 12 chaînons comprenant un ou plusieurs atomes de N, O, S et P,a 4- to 12-membered heterocyclic group comprising one or more N, O, S and P atoms,
- un groupe -C(=Y)R5, -CH2C(=Y)R5, -C(=Y)NR6R7, -YC(=Y)R5, -NR6C(=Y)R5, - SOR5, -SO2R5, -OSO2R5, -NR8SO2R5, -P(R5)2, -P(=Y)(R5)2, -YP(R5)2, -YP(=Y)(R5)2 ou -N(R8)2 éventuellement quaternisé par un R8 supplémentaire, dans lequel :a group -C (= Y) R 5 , -CH 2 C (= Y) R 5 , -C (= Y) NR 6 R 7 , -YC (= Y) R 5 , -NR 6 C (= Y) ) R 5 , -OR 5 , -SO 2 R 5 , -OSO 2 R 5 , -NR 8 SO 2 R 5 , -P (R 5 ) 2 , -P (= Y) (R 5 ) 2 , -YP (R 5 ) 2 , -YP (= Y) (R 5 ) 2 or -N (R 8 ) 2 optionally quaternized with an additional R 8 , wherein:
Y représente un groupe NR8, S ou O, R5 représente un groupe alkyle, alcoxy ou alkylthio, linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-2O éventuellement hydroxylé, mono- ou poly(alkylèneoxy) éventuellement éthérifié, hydroxylé, -OM (avec M = métal alcalin), aryloxy ou hété- rocyclyloxy, R6 et R7 représentent indépendamment l'un de l'autre, un atome d'hydrogène ou un groupe alkyle, linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-2O ou forment avec l'atome d'azote auquel ils sont liés un cycle à 3 à 8 chaînons, R8 représente un atome d'hydrogène, un groupe alkyle linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-2O, ou un groupe aryle,Y is NR 8, S or O, R 5 is alkyl, alkoxy or alkylthio, linear, branched or cyclic, saturated or unsaturated, optionally hydroxylated Ci -2 O, mono- or poly (alkyleneoxy) optionally etherified, hydroxyl, -OM (with M = alkali metal), aryloxy or heterocyclyloxy, R 6 and R 7 represent, independently of one another, a hydrogen atom or a linear, branched or cyclic alkyl group, saturated or unsaturated, Ci -2 O or form with the nitrogen atom to which they are attached a ring with 3 to 8 members, R 8 represents a hydrogen atom, a linear, branched or cyclic alkyl group, saturated or unsaturated , Ci -2 O, or an aryl group,
- un groupe -C(=O)-X-R9-Z ou bien -R9-Z dans lequel R9 représente un radical di- valent (hydro)carboné en Ci-20 saturé ou insaturé, linéaire, ramifié ou cyclique, éventuellement halogène et pouvant comporter un ou plusieurs hétéroatomes, X représente un groupe NR10 ou un atome d'oxygène, et Z représente un groupe - N(R10)2, -S-R10 ou P(R10)2 avec R10 représentant, indépendamment l'un de l'autre, un atome d'hydrogène ou un groupe hydrocarboné en Ci-2O saturé ou insaturé, linéaire, ramifié ou cyclique, éventuellement halogène et pouvant comporter un ou plusieurs hétéroatomes, l'atome d'azote présent dans X et/ou Z (quand il est présent) pouvant être protoné ou quaternisé par des radicaux alkyle en Ci-2O,- -C (= O) -XR 9 -Z or -Z -R 9 wherein R 9 represents a radical valent di- (hydro) carbonaceous Ci -20 saturated or unsaturated, linear, branched or cyclic, optionally halogen and which may comprise one or more heteroatoms, X represents a NR 10 group or an oxygen atom, and Z represents a group - N (R 10 ) 2 , -SR 10 or P (R 10 ) 2 with R 10 representing independently of one another, a hydrogen atom or a saturated or unsaturated, linear, branched or cyclic, optionally halogenated C 2 -C hydrocarbon group, optionally halogenated and possibly containing one or more heteroatoms, the nitrogen atom present in X and / or Z (when present) capable of being protonated or quaternized by C 1 -C 2 alkyl radicals,
- un groupe -R9-NR10-Acide ou -C(=O)-X-R9-NR10-Acide dans lequel X, R9 et R10
sont tels que définis ci-dessus, et Acide représente une fonction acide carboxyli- que, sulfonique ou phosphonique;a group -R 9 -NR 10 -Acide or -C (= O) -XR 9 -NR 10 -Acide in which X, R 9 and R 10 are as defined above, and Acid represents a carboxylic, sulfonic or phosphonic acid function;
- un radical comprenant au moins un atome de silicium et notamment un radical - R-siloxane, -CONHR-siloxane, -COOR-siloxane, ou OCO-R-siloxane, dans lequel R est un radical alkyle, alkylthio ou alcoxy, linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-2o, aryloxy ou hétérocyclyloxy.a radical comprising at least one silicon atom and in particular a radical-R-siloxane, -CONHR-siloxane, -COOR-siloxane, or OCO-R-siloxane, in which R is a linear alkyl, alkylthio or alkoxy radical, branched or cyclic, saturated or unsaturated, C 1 -C 20, aryloxy or heterocyclyloxy.
Les monomères insaturés sont choisis parmi les acrylates, les méthacrylates, les acrylamides, les méthacrylamides, les vinyliques, les allyliques, les styréniques, et leurs mélanges. Il peut d'agir de façon encore plus préférée, de (méth)acrylates, de (méth)acrylamides et/ou de styréniques.The unsaturated monomers are chosen from acrylates, methacrylates, acrylamides, methacrylamides, vinyls, allylic and styrenics, and mixtures thereof. It can act even more preferably, (meth) acrylates, (meth) acrylamides and / or styrenics.
On peut tout particulièrement citer, seul ou en mélange:We can especially mention, alone or in mixture:
- l'acide acrylique, l'acide méthacrylique, - les (méth)acrylates d'alkyle en C 1-20 à chaîne linéaire, ramifiée ou cyclique, tels que le méthacrylate de méthyle, le méthacrylate d'éthyle, le méthacrylate de pro- pyle, le méthacrylate de butyle, le méthacrylate d'isobutyle, le méthacrylate de tert- butyle et le méthacrylate de cyclohexyle; l'acrylate de méthyle, l'acrylate d'éthyle, l'acrylate de propyle, l'acrylate de butyle, l'acrylate de 2-éthylhexyle, l'acrylate d'isobutyle et l'acrylate de tert-butyle,acrylic acid, methacrylic acid, straight-chain, branched or cyclic C 1-20 alkyl (meth) acrylates, such as methyl methacrylate, ethyl methacrylate, methacrylate of pro pyl, butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate and cyclohexyl methacrylate; methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, isobutyl acrylate and tert-butyl acrylate,
- les (méth)acrylates d'aryle en C6-20,C 6-20 aryl (meth) acrylates,
- les (méth)acrylates d'hydroxyalkyle en C1-4, tel que le (méth)acrylate de 2- hydroxyéthyle, le (méth)acrylate de 2-hydroxypropyle,- C1-4 hydroxyalkyl (meth) acrylates, such as 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate,
- les esters de vinyle et notamment l'acétate de vinyle, le propionate de vinyle, le benzoate de vinyle et le tert-butylbenzoate de vinyle,vinyl esters and especially vinyl acetate, vinyl propionate, vinyl benzoate and vinyl tert-butylbenzoate,
- les éthers de vinyle tels que le vinylisobutyléther,vinyl ethers, such as vinylisobutyl ether,
- les monomères hétérocycliques tels que la N-vinylpyrrolidone, le vinylcaprolac- tame, les vinyl-N-(alkyle en C1 -6)-pyrroles, les vinyloxazoles, les vinylthiazoles, les vinylpyrimidines, les vinylimidazoles, - le (méth)acrylamide,heterocyclic monomers such as N-vinylpyrrolidone, vinylcaprolactam, vinyl-N- (C 1-6 alkyl) -pyrroles, vinyloxazoles, vinylthiazoles, vinylpyrimidines, vinylimidazoles, (meth) acrylamide,
- les (méth)acrylamides aliphatiques, cycloaliphatiques ou aromatiques, tels que le tert-butylacrylamide, l'undécylacrylamide ou le N-octylacrylamide; et les di(alkyle en C1 -4) (méth)acrylamides,aliphatic, cycloaliphatic or aromatic (meth) acrylamides, such as tert-butylacrylamide, undecylacrylamide or N-octylacrylamide; and di (C 1-4 alkyl) (meth) acrylamides,
- le styrène et ses dérivés, - les monomères (méth)acryliques, (méth)acrylamides ou vinyliques à groupe fluoré ou perfluoré, notamment les esters (méth)acryliques à chaîne perfluoroalkyle tels que le (méth)acrylate de perfluorooctyléthyle,styrene and its derivatives, (meth) acrylic, (meth) acrylamide or vinyl monomers containing a fluorinated or perfluorinated group, in particular (meth) acrylic esters with a perfluoroalkyl chain, such as perfluorooctylethyl (meth) acrylate,
- les monomères (méth)acryliques, (méth)acrylamides ou vinyliques siliconés tels que le (méth)acryloxypropylths(thméthylsiloxy)silane, - les monomères (méth)acryliques ou vinyliques comportant une fonction aminé éventuellement neutralisée ou quaternisée, tels que le (méth)acrylate de diméthy- laminoéthyle, le diméthylaminoéthylméthacrylamide, la vinylamine, la vinylpyridine, le chlorure de diallyldiméthylammonium, le diméthylaminopropyl méthacrylamide,
le 3-aminopropyl méthacrylamide, le 2-aminoéthyl méthacrylate;- (meth) acrylic, (meth) acrylamides or vinylic silicone monomers such as (meth) acryloxypropylths (thmethylsiloxy) silane, - (meth) acrylic or vinyl monomers comprising an optionally neutralized or quaternized amine function, such as (meth) acrylate ) dimethylaminoethyl acrylate, dimethylaminoethylmethacrylamide, vinylamine, vinylpyridine, diallyldimethylammonium chloride, dimethylaminopropyl methacrylamide, 3-aminopropyl methacrylamide, 2-aminoethyl methacrylate;
- les carboxybétaïnes ou sulfobétaïnes éthyléniques obtenues par exemple par quaternisation de monomères à insaturation éthylénique comportant une fonction aminé par des sels de sodium d'acide carboxylique à halogène mobile (p. ex. chlo- roacétate de sodium) ou par des sulfones cycliques (p. ex. propanesultone).the ethylenic carboxybetaines or sulfobetaines obtained, for example, by quaternization of ethylenically unsaturated monomers containing an amine function by sodium salts of a mobile halogen carboxylic acid (for example sodium chloroacetate) or by cyclic sulphones (p. eg propanesultone).
On préfère tout particulièrement, seul ou en mélange, :Most preferably, alone or as a mixture,
- les (méth)acrylates d'alkyle en Ci-2O à chaîne linéaire, ramifiée ou cyclique, tels que le méthacrylate de méthyle, le méthacrylate d'éthyle, le méthacrylate de pro- pyle, le méthacrylate de butyle, le méthacrylate d'isobutyle, le méthacrylate de tert- butyle et le méthacrylate de cyclohexyle; l'acrylate de méthyle, l'acrylate d'éthyle, l'acrylate de propyle, l'acrylate de butyle, l'acrylate de 2-éthylhexyle, l'acrylate d'isobutyle et l'acrylate de tert-butyle,linear, branched or cyclic C 1 -C 2 alkyl (meth) acrylates, such as methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, methacrylate, isobutyl, tert-butyl methacrylate and cyclohexyl methacrylate; methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, isobutyl acrylate and tert-butyl acrylate,
- les (méth)acrylates d'hydroxyalkyle en C1-4, tel que le (méth)acrylate de 2- hydroxyéthyle, le (méth)acrylate de 2-hydroxypropyle,- C1-4 hydroxyalkyl (meth) acrylates, such as 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate,
- les monomères (méth)acryliques ou vinyliques comportant une fonction aminé éventuellement neutralisée ou quaternisée, tels que le (méth)acrylate de diméthy- laminoéthyle, le diméthylaminoéthylméthacrylamide, le diméthylaminopropyl méthacrylamide, le 3-aminopropyl méthacrylamide, le 2-aminoéthyl méthacrylate - le styrène et ses dérivés.the (meth) acrylic or vinyl monomers comprising an optionally neutralized or quaternized amine functional group, such as dimethylaminoethyl (meth) acrylate, dimethylaminoethyl methacrylamide, dimethylaminopropyl methacrylamide, 3-aminopropyl methacrylamide, 2-aminoethyl methacrylate; styrene and its derivatives.
Le squelette polymérique POL peut également représenter un polyester, un poly- carbonate, un polyamide, un polyimide, un polyuréthane, une polyurée, un poly- saccharide, un polysiloxane, un polyphénol, un polyéther, un polypeptide. Préférentiellement, ledit squelette est choisi parmi les (co)polymères issus de la polymérisation de (méth)acrylates, de (méth)acrylamides, de styréniques ou représente un polyuréthane, un polypeptide, un polysaccharide ou un polyéther. Plus préférentiellement encore, ledit squelette est choisi parmi les (co)polymères issus de la polymérisation de (méth)acrylates, de (méth)acrylamides et/ou de sty- réniques.The polymeric backbone POL may also be a polyester, polycarbonate, polyamide, polyimide, polyurethane, polyurea, polysaccharide, polysiloxane, polyphenol, polyether, polypeptide. Preferably, said backbone is chosen from (co) polymers derived from the polymerization of (meth) acrylates, (meth) acrylamides, styrenics or represents a polyurethane, a polypeptide, a polysaccharide or a polyether. More preferably still, said backbone is chosen from (co) polymers resulting from the polymerization of (meth) acrylates, (meth) acrylamides and / or styrene.
De préférence, le squelette polymérique a un poids moléculaire en nombre (Mn) compris entre 1000 et 5,000,000, notamment entre 2000 et 1 ,000,000 et plus préférentiellement entre 2000 et 100,000 g/mol.Preferably, the polymeric backbone has a number-average molecular weight (Mn) of between 1,000 and 5,000,000, especially between 2,000 and 1,000,000 and more preferably between 2,000 and 100,000 g / mol.
Les polymères selon l'invention présentent de préférence un taux de greffage compris entre 1 et 100%, notamment entre 20 et 100%, et encore plus préférentiellement entre 40 et 100%. On entend dans la présente description par taux de greffage, le rapport (x 100) entre le nombre d'unités répétitives du squelette polymérique POL greffées par des greffons polysaccharides (x), et le nombre total d'unités répétitives du squelette polymérique (ou degré de polymérisation). Les greffons polysaccharides peuvent être répartis sur le squelette polymérique de
façon statistique, alternée (1 greffon tous les 2, 3 ou n unités répétitives du squelette polymérique), voire en blocs (pas de greffons sur une partie du squelette, puis toutes les unités répétitives d'une partie du squelette greffées). De préférence, ils sont répartis de manière statistique.The polymers according to the invention preferably have a degree of grafting of between 1 and 100%, especially between 20 and 100%, and even more preferentially between 40 and 100%. In the present description by grafting rate is meant the ratio (x 100) between the number of repeating units of the polymeric backbone POL grafted by polysaccharide grafts (x), and the total number of repeating units of the polymeric backbone (or degree of polymerization). The polysaccharide grafts can be distributed on the polymeric backbone of statistically, alternately (1 graft every 2, 3 or n repetitive units of the polymer skeleton), or even in blocks (no grafts on a part of the skeleton, then all the repetitive units of a part of the grafted skeleton). Preferably, they are distributed statistically.
PS représente un greffon polysaccharide ou un saccharide (constitué d'un ou de deux motifs sucre).PS represents a polysaccharide graft or a saccharide (consisting of one or two sugar units).
Les polysaccharides de la présente invention sont de préférence choisis parmi ceux décrits dans "Encyclopedia of Chemical Technology, Kirk-Othmer, 3eme édi- tion, 1982, volume 3, pp. 896-900, et volume 15, pp 439-458", dans "Polymers in Nature par MacGREGOR et GREENWOOD, édition John Wiley & Sons, Chapiter 6, pp 240-328, 1980" et dans "Industriel Gums -Polysaccharides and their Deriva- tives, édité par Roy L. WHISTLER, 2ème édition, Edition Académie Press Inc.", le contenu de ces trois ouvrages étant inclus dans la présente demande à titre de référence.The polysaccharides of the present invention are preferably selected from those described in "Encyclopedia of Chemical Technology, Kirk-Othmer, 3rd editions tion, 1982, Volume 3, pp. 896-900, and Volume 15, pp 439-458" , in "Polymers in Nature by MacGREGOR and GREENWOOD, John Wiley & Sons edition, Chapter 6, pp 240-328, 1980" and in "Industrial Gums-Polysaccharides and their Derivatives, edited by Roy L. WHISTLER, 2 nd edition , Academy Press Publishing Inc. ", the contents of these three books are included in this application for reference.
Les polysaccharides peuvent être d'origine naturelle ou obtenus par voie enzyma- tique ou chimique. De façon non limitative, les polysaccharides de la présente invention peuvent être choisis parmi, seuls ou en mélange :The polysaccharides may be of natural origin or obtained enzymatically or chemically. In a nonlimiting manner, the polysaccharides of the present invention may be chosen from, alone or as a mixture:
- des fructanes dont l'inuline; - des glucanes;fructans including inulin; glucans;
- des amidons modifiés ou non, tels que ceux issus, par exemple, de céréales comme le blé, le maïs ou le riz, de légumes comme le pois blond, de tubercules comme les pommes de terre ou le manioc;modified or unmodified starches, such as those derived, for example, from cereals such as wheat, corn or rice, from vegetables such as sweet pea, from tubers such as potatoes or cassava;
- l'amylose, l'amylopectine, le glycogène; - les dextranes et leurs dérivés, tels que le dextrane sulfate, le dextrane diethyla- minoethyl et le carboxymethyl dextrane;amylose, amylopectin, glycogen; dextrans and their derivatives, such as dextran sulfate, dextran diethylaminoethyl and carboxymethyl dextran;
- les celluloses et leurs dérivés tels que les méthylcelluloses, les hydroxyalkylcellu- loses, les éthylhydroxyéthylcelluloses, les carboxyméthylcelluloses;celluloses and their derivatives such as methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethylcelluloses;
- les mannanes, les xylanes, les lignines, les arabanes, les galactanes, les galac- turonanes, la chitine, les chitosanes, les glucoronoxylanes, les arabinoxylanes, les xyloglucanes, les glucomannanes, les acides pectiques et les pectines, l'acide al- ginique et les alginates, les arabinogalactanes, les carraghénines, les agars,mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucoronoxylans, arabinoxylans, xyloglucans, glucomannans, pectic acids and pectins; - ginic and alginates, arabinogalactans, carrageenans, agars,
- les glycosaminoglucanes tels que l'acide hyaluronique, les chondroitines et les chondroitines sulfates; - les gommes arabiques, les gommes Tragacanthe, les gommes Ghatti, les gommes Karaya, les gommes de caroube, les gommes de gellane, les gommes de curdlan, les gommes de xanthane;glycosaminoglucans such as hyaluronic acid, chondroitins and chondroitin sulphates; - Arabic gums, Tragacanth gums, Ghatti gums, Karaya gums, locust bean gums, gellan gums, curdlan gums, xanthan gums;
- les galactomannanes telles que les gommes de guar et leurs dérivés, notamment l'hydroxypropylguar).galactomannans such as guar gums and their derivatives, in particular hydroxypropylguar).
Ces saccharides ou polysaccharides peuvent éventuellement être modifiés par voie chimique ou enzymatique pour introduire des groupements hydroxyethyl, hy- droxypropyl, oligo (oxyethyl), oligo (oxypropyl), carboxyliques et dérivés, sulfates
et dérivés, phosphates et dérivés, amino et dérivés (dont nitro), esters, éther, ami- des. Ces groupements peuvent aussi être présents naturellement dans les poly- saccharides considérés ou présents sous forme protégées (N-acetyl dans le cas de la chitine).These saccharides or polysaccharides may optionally be modified chemically or enzymatically to introduce hydroxyethyl, hydroxypropyl, oligo (oxyethyl), oligo (oxypropyl), carboxylic and derivatives, sulphates groups. and derivatives, phosphates and derivatives, amino and derivatives (including nitro), esters, ether, amides. These groups can also be naturally present in the polysaccharides considered or present in protected form (N-acetyl in the case of chitin).
Ces (poly)saccharides PS sont constitués d'association de motifs furanosiques et pyranosiques, et peuvent donc être définis par l'enchaînement d'unités (I) et/ou (II) de formule :These (poly) saccharides PS consist of a combination of furanosic and pyranosic units, and can therefore be defined by the sequence of units (I) and / or (II) of formula:
(I) (") dans laquelle Ra à Re représentent, indépendamment les uns des autres,(I) (") in which Ra to Re represent, independently of one another,
-OH,-OH,
-O- (unité répétitive du polysaccharide)-O- (repeating unit of the polysaccharide)
-CH3 -CH 3
-NHCOCH3 -NH2-NHCOCH 3 -NH2
-OCH2COOH-OCH 2 COOH
-COOHCOOH
-OSO3H-OSO 3 H
-OPO 3H étant entendu qu'au moins un des Ra à Re représente -O- (unité répétitive du polysaccharide) ou OH, et qu'un des Ra à Re est une liaison covalente avec le Un- ker L; de préférence un seul des Ra à Re sur l'ensemble du (poly)saccharide est une liaison covalente.-OPO 3 H provided that at least one of Ra to Re is -O- (repeating unit of the polysaccharide) or OH, and one of Ra to Re is a covalent bond with the One- ker L; preferably only one of Ra to Re across the (poly) saccharide is a covalent bond.
De préférence, les polysaccharides selon l'invention sont constitués par l'enchaînement d'unités (la) et/ou (Ma) de formule, seules ou en mélange :Preferably, the polysaccharides according to the invention are constituted by the sequence of units (Ia) and / or (Ma) of formula, alone or as a mixture:
dans laquelle Rb à Rd représentent, indépendamment les uns des autres, -OH, - CH3, NHCOCH3, NH2, OCH2COOH, COOH, OSO3H, OPO 3H, et de préférence Rb=Rc=Rd=OH; A titre d'illustration, on peut notamment citer les unités répétitives suivantes :
in which Rb to Rd represent, independently of each other, -OH, -CH 3 , NHCOCH 3 , NH 2 , OCH 2 COOH, COOH, OSO 3 H, OPO 3 H, and preferably Rb = Rc = Rd = OH ; By way of illustration, the following repetitive units may be mentioned in particular:
Les groupements acides (-OCH2COOH, -COOH, -OSO3H, -OPO 3H), qu'ils soient présents dans le polysaccharide, le linker ou le squelette polymérique, peuvent être neutralisés par une base minérale, telle que LiOH, NaOH, KOH, Ca(OH)2, Ba(OH)2, NH4OH ou Zn(OH)2; ou par une base organique telle qu'une alkylamine primaire, secondaire ou tertiaire, notamment la triéthylamine, l'isopropylamine ou la butylamine. Cette alkylamine primaire, secondaire ou tertiaire peut comporter un ou plusieurs atomes d'azote et/ou d'oxygène et peut donc comporter par exemple une ou plusieurs fonctions alcool; on peut notamment citer l'amino-2-méthyl-2- propanol, la triéthanolamine et la diméthylamino-2-propanol. On peut encore citer la lysine ou la 3-(diméthylamino)propylamine.The acid groups (-OCH 2 COOH, -COOH, -OSO 3 H, -OPO 3 H), whether they are present in the polysaccharide, the linker or the polymer backbone, may be neutralized with a mineral base, such as LiOH NaOH, KOH, Ca (OH) 2 , Ba (OH) 2 , NH 4 OH or Zn (OH) 2 ; or with an organic base such as a primary, secondary or tertiary alkylamine, especially triethylamine, isopropylamine or butylamine. This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and / or oxygen atoms and may therefore comprise, for example, one or more alcohol functions; mention may especially be made of 2-amino-methyl-2-propanol, triethanolamine and dimethylamino-2-propanol. Mention may also be made of lysine or 3- (dimethylamino) propylamine.
Les groupements -NH2 peuvent être neutralisés par des sels d'acides minéraux, tels que l'acide sulfurique, l'acide chlorhydrique, l'acide bromhydrique, l'acide iod- hydrique, l'acide phosphorique et l'acide borique. On peut également citer les sels d'acides organiques, qui peuvent comporter un ou plusieurs groupes acide car- boxylique, sulfonique ou phosphonique. Il peut s'agir d'acides aliphatiques linéaires, ramifiés ou cycliques ou encore d'acides aromatiques. Ces acides peuvent comporter, en outre, un ou plusieurs hétéroatomes choisis parmi O et N, par exemple sous la forme de groupes hydroxyle. On peut notamment citer l'acide propionique, l'acide acétique, l'acide téréphtalique, l'acide citrique, l'acide tartri- que, l'acide lactique, l'acide succinique, l'acide benzène sulfonique, l'acide para- toluène sulfonique, l'acide formique et l'acide méthanesulfonique. Les groupes aminés peuvent être quaternisés par des composés à halogène mo- bile, notamment :The -NH 2 groups can be neutralized with salts of mineral acids, such as sulfuric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, phosphoric acid and boric acid. Mention may also be made of organic acid salts, which may comprise one or more carboxylic acid, sulfonic or phosphonic acid groups. It may be linear, branched or cyclic aliphatic acids or aromatic acids. These acids may furthermore comprise one or more heteroatoms chosen from O and N, for example in the form of hydroxyl groups. These include propionic acid, acetic acid, terephthalic acid, citric acid, tartaric acid, lactic acid, succinic acid, benzenesulphonic acid, para-toluene sulfonic acid, formic acid and methanesulfonic acid. Amino groups may be quaternized with mobile halogen compounds, including:
- des halogénures d'alkyles tels que des chlorures ou des bromures d'alkyles en Ci à Ci2, par exemple le bromure de méthyle, le iodure de méthyle ou le chlorure d'éthyle,- halides such as alkyl chlorides or alkyl bromides Ci-Ci 2, for example methyl bromide, methyl iodide or ethyl chloride,
- des composés à halogène mobile comportant des fonctions acides carboxyliques ou sulfoniques (éventuellement salifiées). Ainsi sont obtenus des monomères hydrophiles amphotères (encore dénommés bétaïnes). On peut notamment comme quaternisant, le chloroacétate de sodium, le diméthylsulfate, le diéthylsulfate, ou des sulfones cycliques, par exemple la propanesulfone.- Mobile halogen compounds containing carboxylic or sulfonic acid functions (optionally salified). Thus amphoteric hydrophilic monomers (also called betaines) are obtained. Quaternizing agents include, for example, sodium chloroacetate, dimethyl sulphate, diethyl sulphate or cyclic sulphones, for example propanesulphone.
Préférentiellement, les greffons polysaccharidiques sont choisis parmi les dextra- nes et leurs dérivés (dextrane sulfate, dextrane diethylaminoethyl, carboxymethyl dextrane), les glycosaminoglucanes et leurs dérivés (l'acide hyaluronique, les chondroitines et les chondroitines sulfates ), les celluloses et leurs dérivés (mé- thylcelluloses, hydroxyalkylcelluloses, éthylhydroxyéthylcelluloses, carboxymethyl-
celluloses), l'amylose et ses dérivés, les chitines et leurs dérivés, les carraghéni- nes et leurs dérivés, les oligomaltoses et leurs dérivés; et leurs mélanges.Preferably, the polysaccharide grafts are chosen from dextrans and their derivatives (dextran sulfate, dextran diethylaminoethyl, carboxymethyl dextran), glycosaminoglucans and their derivatives (hyaluronic acid, chondroitins and chondroitin sulphates), celluloses and their derivatives (methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses, carboxymethyl- celluloses), amylose and its derivatives, chitins and their derivatives, carrageenans and their derivatives, oligomaltoses and their derivatives; and their mixtures.
Les greffons polysaccharides peuvent être de même nature ou de nature diffé- rente.The polysaccharide grafts may be of the same nature or of different natures.
Chaque greffon (poly)saccharide PS possède de préférence une masse moléculaire en nombre (Mn) comprise entre 100 et 100,000 g/mol, notamment entre 150 et 50,000 g/mol et préférentiellement entre 200 et 20,000 g/mol.Each (poly) saccharide graft PS preferably has a number-average molecular weight (Mn) of between 100 and 100,000 g / mol, in particular between 150 and 50,000 g / mol and preferably between 200 and 20,000 g / mol.
La nature du linker L est conditionnée par la réaction chimique mise en jeu pour greffer les (poly)saccharides sur l'unité répétitive du squelette polymérique. Toutes les réactions chimiques connues par l'homme du métier peuvent être mises en œuvre. Différents types de réactions chimiques peuvent être mises en œuvre pour greffer les (poly)saccharides sur le squelette polymérique.The nature of the linker L is conditioned by the chemical reaction involved in grafting the (poly) saccharides onto the repeating unit of the polymeric backbone. All chemical reactions known to those skilled in the art can be implemented. Different types of chemical reactions can be used to graft the (poly) saccharides onto the polymeric backbone.
Parmi les réactions susceptibles d'être employées, entre une fonction réactive du squelette polymérique et une fonction réactive du (poly)saccharide PS, on peut citer de façon non limitative : - la formation de liaisons ester ou amide par réaction entre une fonction hydroxyle ou une aminé primaire ou secondaire, et un dérivé acide, un halogénure d'acide, un ester, un ester activé (ester de N-hydroxysuccinimide, ester de p-nitrophényl, imidazole, etc.), une lactone, un anhydride, une mono, di ou tri chlorotriazine, une thiolactone par exemple; - la formation d'une liaison carbamate entre un alcool et un isocyanate ou d'une liaison urée entre une aminé et un isocyanate;Among the reactions that may be employed, between a reactive function of the polymer backbone and a reactive functional group of the (poly) saccharide PS, mention may be made without limitation of: the formation of ester or amide bonds by reaction between a hydroxyl function or a primary or secondary amine, and an acid derivative, an acid halide, an ester, an activated ester (N-hydroxysuccinimide ester, p-nitrophenyl ester, imidazole, etc.), a lactone, an anhydride, a mono , di or tri chlorotriazine, a thiolactone for example; the formation of a carbamate bond between an alcohol and an isocyanate or a urea bond between an amine and an isocyanate;
- la formation d'éther par réaction entre 2 alcools en présence d'une phosphine (réaction de Mitsunobu), par addition d'un alcool sur un halogénure d'alkyle;the formation of ether by reaction between 2 alcohols in the presence of a phosphine (Mitsunobu reaction), by addition of an alcohol to an alkyl halide;
- une addition de Michael entre un thiol, une aminé ou un alcool et un acrylate, un maléimide ou tout autre composé porteur d'une insaturation;a Michael addition between a thiol, an amine or an alcohol and an acrylate, a maleimide or any other compound carrying an unsaturation;
- une réaction de Diels-Alder entre un diène (cyclopentadiène, dérivés furaniques, dérivés anthracène..) et un diénophile (maléimide, acrylate...).a Diels-Alder reaction between a diene (cyclopentadiene, furan derivatives, anthracene derivatives, etc.) and a dienophile (maleimide, acrylate, etc.).
Toutefois, dans un mode de réalisation préféré, les polymères selon l'invention sont préparés par réaction de Ligation Chimio-Sélective entre des fonctions aldéhydes ou cétones notamment portées par le (poly)saccharide ou le squelette polymérique et l'un au moins des composés suivants : H2N-LI -R, HR1 N-L1 -R, H2N- O-L1 -R, H2N-O-(O)C-LI -R, H2N-O-(O)C-NH-LI-R, H2N-O-(S)C-NH-LI -R, HR1 N- O-L1 -R, HR1 N-O-(O)C-LI -R, HR1 N-O-(O)C-NH-LI -R, HR1 N-O-(S)C-NH-LI -R, H2N-NH-LI -R , H2N-NH-(O)C-LI -R, H2N-NH-(O)CO-LI -R, H2N-NH-(O)C-NH-LI- R, H2N-NH-(S)C-LI-R, H2N-NH-(S)CO-LI -R, H2N-NH-(S)C-NH-LI -R, H2N-CHRI - CH(LI -R)-SH, H2N-CH(LI -RI )-CHR-SH, H2N-NH-SO2-LI-R, X-CH2-X'-L1 -R oùHowever, in a preferred embodiment, the polymers according to the invention are prepared by Chemo-Selective Ligation reaction between aldehyde or ketone functions carried especially by the (poly) saccharide or the polymer backbone and at least one of the compounds following: H 2 N-LI-R, HR 1 N-L 1 -R, H 2 N-O-L 1 -R, H 2 NO- (O) C-LI-R, H 2 NO- (O) C-NH -LI-R, H 2 NO- (S) C-NH-LI-R, HR 1 N-O-L 1 -R, HR 1 NO- (O) C-LI-R, HR 1 NO- (O) C-NH 1H-R, HR 1 NO- (S) C-NH-Li-R, H 2 N-NH-LI-R, H 2 N-NH- (O) C-LI-R, H 2 N-NH- (O) CO-LI-R, H 2 N-NH- (O) C-NH-Li-R, H 2 N-NH- (S) C-Li-R, H 2 N-NH- (S) CO-LI-R, H 2 N-NH- (S) C-NH-LI-R, H 2 N-CHR-CH (LI-R) -SH, H 2 N-CH (LI-IR) -CHR -SH, H 2 N-NH-SO 2 -LI-R, X-CH 2 -X'-L 1 -R where
- X et X' sont des groupements électro-attracteurs (esters, cétones, acides, nitro,
halogènes notamment);X and X 'are electron-withdrawing groups (esters, ketones, acids, nitro, halogens in particular);
- L1 est une liaison covalente ou un groupement choisi parmi (i) alkyle linéaire, ramifié ou cyclique en C1 -C30, de préférence linéaire ou ramifié en C1 -C10; (ii) alcényle linéaire, ramifié ou cyclique en C2-C30, de préférence linéaire ou ramifié en C1 -C10, (iii) alcynyle linéaire, ramifié ou cyclique en C2-C30; de préférence linéaire ou ramifié en C1 -C10; ce groupement pouvant comprendre un ou plusieurs hétéroatomes choisis parmi O, N, S, Cl, Br, I, F, P et/ou un ou plusieurs substituants choisis parmi CO2H, SO3H, PO3H, NH2, OH, SH;- L1 is a covalent bond or a group selected from (i) linear, branched or cyclic C1 to C30 alkyl, preferably linear or branched C1 to C10; (ii) linear, branched or cyclic C2-C30 alkenyl, preferably linear or branched C1-C10, (iii) linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; this group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH , SH;
- R ou R1 représentent, indépendamment l'un de l'autre, le squelette polymérique POL ou un greffon (poly)saccharide PS ou un atome d'hydrogène ou un groupement choisi parmi (i) alkyle linéaire, ramifié ou cyclique en C1 -C30, de préférence linéaire ou ramifié en C1-C10; (ii) alcényle linéaire, ramifié ou cyclique en C2-C30, de préférence linéaire ou ramifié en C1 -C10, (iii) alcynyle linéaire, ramifié ou cyclique en C2-C30; de préférence linéaire ou ramifié en C1-C10; ce groupement pou- vant comprendre un ou plusieurs hétéroatomes choisis parmi O, N, S, Cl, Br, I, F, P et/ou un ou plusieurs substituants choisis parmi CO2H, SO3H, PO3H, NH2, OH, SH; étant entendu que l'un et un seul des groupements R ou R1 représente un (poly)saccharide PS ou un squelette polymérique POL.- R or R1 represent, independently of one another, the polymeric backbone POL or a (poly) saccharide graft PS or a hydrogen atom or a group chosen from (i) linear, branched or cyclic C1-C alkyl C30, preferably linear or branched C1-C10; (ii) linear, branched or cyclic C2-C30 alkenyl, preferably linear or branched C1-C10, (iii) linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; this group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH, SH; it being understood that only one of the groups R or R1 represents a (poly) saccharide PS or a polymeric backbone POL.
De manière préférentielle, les polymères selon l'invention sont préparés par réaction de Ligation Chimio-Sélective entre des fonctions aldéhydes ou cétones portées par le (poly)saccharide et l'un au moins des composés suivants:Preferably, the polymers according to the invention are prepared by Chemo-Selective Ligation reaction between aldehyde functions or ketones carried by the (poly) saccharide and at least one of the following compounds:
- les dérivés d'hydroxylamine H2N-O-LI -R, H2N-O-(O)C-LI -R, H2N-O-(O)C-NH- L1 -R, H2N-O-(S)C-NH-LI -R, HR1 N-O-L1 -R, HR1 N-O-(O)C-LI-R, HRI N-O-(O)C- NH-L1 -R, HR1 N-O-(S)C-NH-LI -R,hydroxylamine derivatives H 2 NO-LI -R, H 2 NO- (O) C-LI-R, H 2 NO- (O) C -NH-L 1 -R, H 2 NO- (S) C -NH-LI-R, HR1 NO-L1-R, HR1 NO- (O) C-LI-R, HRI NO- (O) C-NH-L1-R, HR1 NO- (S) C-NH- LI -R,
- les dérivés de β-aminothiols H2N-CHRI -CH(LI -R)-SH, H2N-CH(LI -RI )-CHR-SH.derivatives of β-aminothiols H 2 N -CHRI-CH (LI-R) -SH, H 2 N-CH (LI-IR) -CHR-SH.
- les composés suivants : H2N-NH-(O)C-LI-R et H2N-NH-(S)C-NH-LI -R. dans lesquels L1 est de préférence une liaison covalente simple (C-C), R est le squelette polymérique, et R1 est H ou un groupement alkyle tel que défini ci- dessusthe following compounds: H 2 N -NH- (O) C-LI-R and H 2 N -NH- (S) C-NH-LI-R. in which L1 is preferably a single covalent bond (CC), R is the polymeric backbone, and R1 is H or an alkyl group as defined above
Dans ces réactions de Ligation Chimio-Sélective, l'extrémité réductrice des (poly)saccharides peut jouer le rôle d'aldéhyde et de façon préférentielle, le rôle d'aldéhyde est joué par l'extrémité réductrice du (poly)saccharide PS.In these Chemo-Selective Ligation reactions, the reducing end of the (poly) saccharides may act as an aldehyde and, preferably, the role of aldehyde is played by the reducing end of the (poly) saccharide PS.
Dans le cas de réactions entre l'extrémité réductrice des polysaccharides et des composés préférés, notamment dérivés d'hydroxylamines ou de β-aminothiols ci- dessus, on peut schématiser le linker par les formules générales suivantes :
In the case of reactions between the reducing end of the polysaccharides and preferred compounds, in particular derivatives of hydroxylamines or β-aminothiols above, the linker can be schematised by the following general formulas:
dans lesquelles :in which :
- Ra à Re représentent, indépendamment les uns des autres, -OH, -CH3, NHCOCH3, NH2, OCH2COOH, COOH, OSO3H, OPO 3H, ou -O-relié au greffon polysaccharide; l'un au moins des Ra à Re représentant -O-relié au greffon poly- saccharide;Ra to Re represent, independently of each other, -OH, -CH 3 , NHCOCH 3 , NH 2 , OCH 2 COOH, COOH, OSO 3 H, OPO 3 H, or -O-linked to the polysaccharide graft; at least one of Ra to Re representing -O-linked to the polysaccharide graft;
- Rf représente (i) une liaison covalente avec le squelette polymérique POL ou (ii) un groupement lié audit squelette polymérique POL choisi parmi les groupements divalents alkyle linéaire, ramifié ou cyclique en C1 -C30, de préférence linéaire ou ramifié en C1 -C10; alcényle linéaire, ramifié ou cyclique en C2-C30, de préférence linéaire ou ramifié en C1 -C10; et alcynyle linéaire, ramifié ou cyclique en C2-C30;
de préférence linéaire ou ramifié en C1 -C10; ledit groupement pouvant comprendre un ou plusieurs hétéroatomes choisis parmi O, N, S, Cl, Br, I, F, P et/ou un ou plusieurs substituants choisis parmi CO2H, SO3H, PO3H, NH2, OH, SH.Rf represents (i) a covalent bond with the polymeric backbone POL or (ii) a group bonded to said polymeric backbone POL chosen from linear, branched or cyclic C1-C30, preferably linear or branched C1-C10 alkyl divalent groups; ; linear, branched or cyclic C 2 -C 30, preferably linear or branched C 1 -C 10 alkenyl; and linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; said group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH , SH.
Dans le cas d'une réaction entre l'extrémité réductrice d'un monosaccharide et des dérivés d'hydroxylamine ou de β-aminothiol, Ra à Re représentent, indépendamment les uns des autres, -OH, -CH3, NHCOCH3, NH2, OCH2COOH, COOH, OSO3H, OPO 3H; et Rf est tel que défini ci-dessus, et donc les formules (III), (MIa), (IV), (Iva), (V), (Va), (Vl) et (VIa) représentent L-PS.In the case of a reaction between the reducing end of a monosaccharide and derivatives of hydroxylamine or β-aminothiol, Ra to Re represent, independently of each other, -OH, -CH 3 , NHCOCH 3 , NH 2, OCH 2 COOH, COOH, OSO 3 H, OPO 3 H; and Rf is as defined above, and therefore formulas (III), (MIa), (IV), (Iva), (V), (Va), (VI) and (VIa) represent L-PS.
Préférentiellement, les polymères selon la présente invention comprennent :Preferably, the polymers according to the present invention comprise:
- un squelette polymérique POL issu de la (co)polymérisation de (méth)acrylates, (méth)acrylamides et/ou monomères styréniques, ou bien POL représente un po- lysaccharide, de préférence ledit squelette ayant une masse moléculaire en nom- bre (Mn) comprise entre 2000g/mol et 100,000 g/mol aveca polymeric backbone POL resulting from the (co) polymerization of (meth) acrylates, (meth) acrylamides and / or styrenic monomers, or else POL represents a polysaccharide, preferably said backbone having a number-average molecular weight ( Mn) between 2000g / mol and 100,000 g / mol with
- des greffons polysaccharides PS choisis parmi les dextranes et leur dérivés (dextrane sulfate, dextrane diethylaminoethyl, carboxymethyl dextrane), les gly- cosaminoglucanes et leurs dérivés (acide hyaluronique, les chondroitines et les chondroitines sulfates), les celluloses et leurs dérivés (méthylcelluloses, hy- droxyalkylcelluloses, éthylhydroxyéthylcelluloses, carboxyméthylcelluloses), l'amylose et ses dérivés, les chitines et leurs dérivés, les carraghénines et leurs dérivés, les oligomaltoses et leurs dérivés, et leur mélange; lesdits greffons ayant de préférence une masse moléculaire en nombre (Mn) comprise entre 200 et 20000 g/mol; - un taux de greffage compris entre 1 et 100%, notamment entre 20 et 100%, et encore plus préférentiellement entre 40 et 100%; etPS polysaccharide grafts chosen from dextrans and their derivatives (dextran sulfate, dextran diethylaminoethyl, carboxymethyl dextran), glycosaminoglucans and their derivatives (hyaluronic acid, chondroitins and chondroitin sulphates), celluloses and their derivatives (methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses, carboxymethylcelluloses), amylose and its derivatives, chitins and their derivatives, carrageenans and their derivatives, oligomaltoses and their derivatives, and their mixtures; said grafts preferably having a number-average molecular weight (Mn) of between 200 and 20000 g / mol; a grafting rate of between 1 and 100%, especially between 20 and 100%, and even more preferentially between 40 and 100%; and
- un linker défini par l'une des formules (III) à (Vl) ou (MIa) à (VIa).a linker defined by one of formulas (III) to (VI) or (MIa) to (VIa).
De préférence, le polymère selon l'invention répond à l'une des structures suivan- tes :Preferably, the polymer according to the invention corresponds to one of the following structures:
dans lesquelles PS représente le greffon polysaccharide et R le squelette polymérique (R=POL). in which PS represents the polysaccharide graft and R the polymeric backbone (R = POL).
Notamment, on peut illustrer la préparation des polymères selon l'invention, et leur structure de la manière suivante :
In particular, it is possible to illustrate the preparation of the polymers according to the invention, and their structure as follows:
Très préférentiellement, le polymère selon l'invention comprend au moins un motif de répétition représenté par l'une des formules suivantes, dans lesquelles le squelette a une masse moléculaire en nombre (Mn) comprise entre 2000g/mol et 100,000 g/mol et les greffons ont une masse moléculaire en nombre (Mn) comprise entre 200 et 20000 g/mol :Very preferably, the polymer according to the invention comprises at least one repeating unit represented by one of the following formulas, in which the backbone has a number-average molecular mass (Mn) of between 2000 g / mol and 100,000 g / mol and the grafts have a number-average molecular mass (Mn) of between 200 and 20000 g / mol:
II est clair que le polymère peut comprendre en outre tout comonomère notamment éthylénique.It is clear that the polymer may further comprise any comonomer including ethylenic.
Les greffons (poly)saccharides PS peuvent être introduits dans le polymère final par toute méthode connue de l'homme du métier, et notamment : - par réaction directe sur le squelette polymérique POL déjà formé, ainsi que cela est illustré par le schéma 1 ; il s'agit alors d'une synthèse dite de 'grafting onto'; - par polymérisation de monomères portant un greffon polysaccharide PS, seul ou en mélange avec d'autres monomères (copolymérisation); il s'agit d'une synthèse à partir de macromonomères tel qu'illustrée par le schéma 2; - par croissance d'un greffon polysaccharide PS à partir d'un précurseur de polysaccharide greffé sur le squelette polymérique POL ou greffé sur un ou plusieurs monomères constitutifs dudit squelette polymérique POL; ceci est illustré par le schéma 3, il s'agit d'une synthèse dite de 'grafting from'.The (poly) saccharide PS grafts may be introduced into the final polymer by any method known to those skilled in the art, and in particular: by direct reaction on the already formed polymeric POL skeleton, as illustrated by Scheme 1; it is then a synthesis called 'grafting onto'; by polymerization of monomers carrying a PS polysaccharide graft, alone or in admixture with other monomers (copolymerization); it is a synthesis from macromonomers as illustrated by Scheme 2; by growth of a PS polysaccharide graft from a polysaccharide precursor grafted onto the POL polymer backbone or grafted onto one or more constituent monomers of said polymeric backbone POL; this is illustrated by diagram 3, it is about a synthesis known as 'grafting from'.
On peut ainsi schématiser de façon non limitative l'obtention des polymères à greffons polysaccharide par réaction entre un monomère ou le squelette polymérique en dérivant, fonctionnalisé par un dérivé d'hydroxylamine ou un dérivé de β- aminothiol avec l'extrémité réductrice d'un ou plusieurs polysaccharides et formant respectivement une liaison oxime ou thiazolidine :
It is thus possible to schematize in a nonlimiting manner the obtaining of polysaccharide graft polymers by reaction between a monomer or the polymeric backbone derived from it, functionalized with a hydroxylamine derivative or a β-aminothiol derivative with the reducing end of a or several polysaccharides and respectively forming an oxime or thiazolidine bond:
Dans les trois schémas ci-dessus, Rf a la même signification que précédemment. Pour des raisons de simplicité, le dextrane et l'amylose y ont été utilisés, mais cela ne représente nullement une limitation de la portée de l'invention.In the three diagrams above, Rf has the same meaning as before. For the sake of simplicity, dextran and amylose have been used, but this in no way represents a limitation of the scope of the invention.
Certains procédés de préparation sont connus de l'art antérieur. On peut notamment citer la demande WO05014035 qui décrit l'utilisation de Galactose Oxidase pour introduire des fonctions aldéhydes sur des glycoprotéines portant des groupes galactose. L'utilisation de polymères porteurs de fonctions capables de réagir de façon sélective avec ces aldéhydes permet d'obtenir de nouvelles glycoprotéines fonctionnalisées par ces mêmes polymères, améliorant ainsi leur temps de rétention dans le corps humain. Ce brevet met en évidence l'intérêt des réactions de Ligation Chimio-Sélective pour fonctionnaliser de façon sélective et dans des conditions douces des molécules fragiles. Le brevet EP1731540 décrit la synthèse de polymères porteurs de fonctions hy- droxylamines et leur utilisation dans le domaine de l'analyse des glycoprotéines. Les différents sucres présents sur une protéine sont libérés par traitement avec une protéase et une Glycopeptidase. Ces sucres sont ensuite immobilisés sur le polymère par réaction entre leur extrémité réductrice et le groupement -ONH2 pré- sent sur le polymère.Some methods of preparation are known from the prior art. One can quote the application WO05014035 which describes the use of Galactose Oxidase to introduce aldehyde functions on glycoproteins carrying galactose groups. The use of polymers carrying functional groups capable of selectively reacting with these aldehydes makes it possible to obtain new glycoproteins functionalized by these same polymers, thus improving their retention time in the human body. This patent highlights the interest of Chemo-Selective Ligation reactions to functionally and selectively functionalize fragile molecules. EP1731540 discloses the synthesis of polymers carrying hydroxylamine functions and their use in the field of glycoprotein analysis. The various sugars present on a protein are released by treatment with a protease and a glycopeptidase. These sugars are then immobilized on the polymer by reaction between their reducing end and the group -ONH 2 present on the polymer.
La demande US2002/0016304 décrit la synthèse de polypeptides cationiques à greffons 'hydrophiles utilisés pour véhiculer des acides nucléiques. Parmi les greffons hydrophiles sont cités les dextranes, les glycosaminoglycans et les polyethy- lèneglycols. Ici, le dextrane est greffé sur le polyaminoacide cationique par amina- tion réductrice. Or cette amination réductrice nécessite l'utilisation de réducteurs (NaCNBH3) ce qui peut poser des problèmes de toxicité, de dégradation du squelette polymérique et de purification du polymère synthétisé. Le polymère selon la présente invention peut être obtenu de différentes manières.US2002 / 0016304 discloses the synthesis of cationic hydrophilic graft polypeptides used to carry nucleic acids. Among the hydrophilic grafts are dextrans, glycosaminoglycans and polyethylene glycols. Here, the dextran is grafted onto the cationic polyamino acid by reductive amination. However, this reductive amination requires the use of reducing agents (NaCNBH 3 ), which can pose problems of toxicity, degradation of the polymer backbone and purification of the synthesized polymer. The polymer according to the present invention can be obtained in different ways.
FEUILLE DE REMPLACEMENT (RÈGLE 26)
Dans un premier mode de préparation, on peut préparer dans un premier temps un squelette polymérique fonctionnalisé, c'est-à-dire portant les fonctions chimiques réactives décrites précédemment, puis, dans un second temps, greffer les greffons polysaccharides, fonctionnalisés ou non, en faisant réagir les fonctions réactives portées par les greffons polysaccharide ou leur extrémité réductrice avec les fonctions réactives portées par le squelette polymérique. Cette technique est connue par l'homme du métier sous le nom de 'grafting onto'. Dans un second mode de préparation, il est possible de préparer dans un premier temps un monomère fonctionnalisé, c'est-à-dire portant les fonctions chimiques réactives décrites précédemment, puis, dans un second temps, de greffer les greffons polysaccharides fonctionnalisés ou non, en faisant réagir les fonctions réactives portées par les greffons polysaccharide ou leur extrémité réductrice avec les fonctions réactives portées par le monomère. On obtient ainsi un "macromonomère" porteur du greffon polysaccharide qui est ensuite polymérisé pour donner le polymère de l'invention. Ce macromonomère peut être copolymérisé en présence d'un ou plusieurs autres monomères ou macromonomères porteurs de greffons polysaccharides.SUBSTITUTE SHEET (RULE 26) In a first mode of preparation, it is possible, in a first step, to prepare a functionalized polymer skeleton, that is to say carrying the reactive chemical functions described above, then, in a second step, to graft the functionalized or non-functionalized polysaccharide grafts. reacting the reactive functions carried by the polysaccharide grafts or their reducing end with the reactive functions carried by the polymer backbone. This technique is known to those skilled in the art under the name of 'grafting onto'. In a second mode of preparation, it is possible to prepare in a first stage a functionalized monomer, that is to say carrying the reactive chemical functions described above, then, in a second step, to graft the functionalized or non-functionalized polysaccharide grafts. by reacting the reactive functions carried by the polysaccharide grafts or their reducing end with the reactive functions carried by the monomer. Thus, a "macromonomer" carries the polysaccharide graft which is then polymerized to give the polymer of the invention. This macromonomer may be copolymerized in the presence of one or more other monomers or macromonomers carrying polysaccharide grafts.
Les polysaccharides peuvent être polymérisés par voie enzymatique à partir d'un précurseur oligosaccharide. A titre d'exemple, de l'amylose peut être obtenue par polymérisation enzymatique en utilisant du maltoheptaose comme précurseur, du sel de potassium de α-(D)-glucose-1 -phosphate comme monomère et une phos- phorylase de pomme de terre comme catalyseur (voir BioMacromolecules 2002, 3, pp. 368-373). Un troisième mode de préparation peut consister à polymériser un monomère por- teur d'un précurseur de polymérisation de polysaccharide: on obtient ainsi un squelette polymérique porteur de greffons précurseurs de polysaccharide. Le polymère à greffons polysaccharides est alors obtenu par polymérisation à partir du squelette polymérique porteur des greffons précurseurs, catalysée par une enzyme ou une bactérie en présence d'un sucre qui joue le rôle de monomère. Dans un quatrième mode de préparation, on peut synthétiser un squelette polymérique fonctionnalisé, c'est-à-dire portant les fonctions chimiques réactives décrites précédemment, puis, dans un second temps, on peut greffer un précurseur de polysaccharide fonctionnalisé ou non, en faisant réagir les fonctions réactives portées par ce précurseur de polysaccharide ou son extrémité réductrice (s'il s'agit d'un oligosaccharide tel que le maltoheptaose) avec les fonctions réactives portées par le squelette polymérique. On obtient ainsi un squelette polymérique porteur de greffons précurseurs de polysaccharide. Le polymère à greffons polysaccharides est alors obtenu par polymérisation à partir du squelette polymérique porteur des greffons précurseurs, catalysée par une enzyme ou une bactérie en pré- sence d'un sucre qui joue le rôle de monomère.Polysaccharides can be polymerized enzymatically from an oligosaccharide precursor. For example, amylose can be obtained by enzymatic polymerization using maltoheptaose as a precursor, potassium salt of α- (D) -glucose-1-phosphate as a monomer and a potato phosphorylase. as a catalyst (see BioMacromolecules 2002, 3, pp. 368-373). A third mode of preparation may consist in polymerizing a monomer carrying a polysaccharide polymerization precursor: a polymeric backbone carrying polysaccharide precursor grafts is thus obtained. The polymer with polysaccharide grafts is then obtained by polymerization from the polymer skeleton carrying the precursor grafts, catalyzed by an enzyme or a bacterium in the presence of a sugar which acts as a monomer. In a fourth mode of preparation, it is possible to synthesize a functionalized polymeric backbone, that is to say carrying the reactive chemical functions described above, then, in a second step, a functionalised polysaccharide precursor can be grafted, while react the reactive functions carried by this polysaccharide precursor or its reducing end (if it is an oligosaccharide such as maltoheptaose) with the reactive functions carried by the polymer backbone. A polymeric backbone carrying polysaccharide precursor grafts is thus obtained. The polymer with polysaccharide grafts is then obtained by polymerization from the polymer skeleton carrying the precursor grafts, catalyzed by an enzyme or a bacterium in the presence of a sugar which acts as a monomer.
Le troisième et quatrième modes de réalisation sont connus par l'homme du métier sous le nom de 'grafting from'.
Le polymère selon l'invention trouve une application toute particulière dans le domaine cosmétique, notamment dans le domaine capillaire.The third and fourth embodiments are known to those skilled in the art as 'grafting from'. The polymer according to the invention finds a very particular application in the cosmetic field, particularly in the hair field.
La quantité de polymère présent dans les compositions dépend bien entendu du type de composition et des propriétés recherchées et peut varier à l'intérieur d'une gamme très large, comprise généralement entre 0,01 et 30% en poids, de préférence entre 0,1 et 20% en poids, notamment entre 0,5 et 10% en poids, voire entre 1 et 5% en poids, par rapport au poids de la composition cosmétique finale.The amount of polymer present in the compositions depends, of course, on the type of composition and the desired properties and can vary within a very wide range, generally between 0.01 and 30% by weight, preferably between 0, 1 and 20% by weight, especially between 0.5 and 10% by weight, or even between 1 and 5% by weight, relative to the weight of the final cosmetic composition.
Les compositions selon l'invention peuvent se présenter sous toutes les formes galéniques classiquement utilisées pour une application topique et notamment sous forme d'une solution ou suspension aqueuse, alcoolique ou hydroalcoolique, ou d'une solution ou suspension huileuse, ou d'une solution ou d'une dispersion du type lotion ou sérum, d'une émulsion de consistance liquide ou semi-liquide du type lait, obtenues par dispersion d'une phase grasse dans une phase aqueuse (H/E) ou inversement (E/H), ou d'une suspension ou émulsion de consistance molle de type crème (H/E) ou (E/H), ou d'un gel aqueux ou anhydre, d'un onguent, d'une poudre libre ou compactée à utiliser telle quelle ou à incorporer dans un excipient, ou de toute autre forme cosmétique.The compositions according to the invention may be in any of the galenical forms conventionally used for topical application and especially in the form of an aqueous or alcoholic or aqueous-alcoholic solution or suspension, or of an oily solution or suspension, or of a solution. or a dispersion of the lotion or serum type, of a liquid or semi-liquid consistency emulsion of the milk type, obtained by dispersion of a fatty phase in an aqueous phase (O / W) or conversely (W / O) , or a suspension or emulsion of soft consistency of the cream (O / W) or (W / O) type, or of an aqueous or anhydrous gel, of an ointment, of a free or compacted powder to be used such which or to incorporate in an excipient, or any other cosmetic form.
Les compositions cosmétiques selon l'invention comprennent, outre lesdits polymères, un milieu cosmétiquement acceptable, notamment cosmétiquement acceptable, c'est-à-dire un milieu compatible avec les tissus cutanés comme la peau du visage ou du corps, et les matières kératiniques telles que les cheveux, les cils, les sourcils et les ongles. De préférence, le milieu cosmétiquement acceptable comprend un milieu solvant ou de dispersion des polymères selon l'invention, qui peut comprendre au moins un composé choisi parmi l'eau, les alcools, les polyols, les esters, les huiles carbonées, les huiles de silicone, les huiles de silicone fluorées, et leurs mélanges.The cosmetic compositions according to the invention comprise, in addition to said polymers, a cosmetically acceptable medium, in particular a cosmetically acceptable medium, that is to say a medium which is compatible with cutaneous tissues such as the skin of the face or of the body, and keratin materials such as hair, eyelashes, eyebrows and nails. Preferably, the cosmetically acceptable medium comprises a solvent or dispersion medium of the polymers according to the invention, which may comprise at least one compound chosen from water, alcohols, polyols, esters, carbonaceous oils, silicone, fluorinated silicone oils, and mixtures thereof.
De préférence, le milieu cosmétiquement acceptable des compositions selon l'invention peut comprendre de l'eau ou un mélange d'eau et de solvant(s) organique^) hydrophile(s) comme les alcools et notamment les monoalcools, linéaires ou ramifiés en Ci-Ce, comme l'éthanol, le tert-butanol, le n-butanol, l'isopropanol ou le n-propanol, ou le 2-butoxy-éthanol; et les polyols comme la glycérine, la di- glycérine, l'éthylène glycol, le propylène glycol, le sorbitol, le pentylène glycol, et les polyéthylène glycols, ou bien encore les éthers de polyols ou de glycols notamment en C2 tel que le monoéthyléther et le monométhyléther de diéthylènegly- col, et les aldéhydes en C2-C4 hydrophiles.Preferably, the cosmetically acceptable medium of the compositions according to the invention may comprise water or a mixture of water and hydrophilic organic solvent (s), such as alcohols and especially linear or branched monoalcohols. C, Ce, such as ethanol, tert-butanol, n-butanol, isopropanol or n-propanol, or 2-butoxyethanol; and polyols such as glycerine, di-glycerine, ethylene glycol, propylene glycol, sorbitol, pentylene glycol, and polyethylene glycols, or alternatively ethers of polyols or glycols, especially C2, such as monoethyl ether. and diethylene glycol monomethyl ether and hydrophilic C 2 -C 4 aldehydes.
La composition selon l'invention peut comprendre en outre au moins un adjuvant cosmétiquement acceptable classiquement utilisé dans les compositions cosmétiques, notamment destinées à être appliquées sur les fibres kératiniques. On peut citer en particulier, à titre d'adjuvant cosmétiquement acceptable, les géli-
fiants et/ou épaississants; les polymères, associatifs ou non; les tensioactifs anio- niques, non ioniques, cationiques et/ou amphotères; les agents propénétrants, les émulsionnants, les parfums, les conservateurs, les charges, les filtres solaires; les matières colorantes, les protéines, les vitamines, les provitamines; les polymères, fixants ou non fixants, anioniques, non ioniques, cationiques ou amphotères; les agents hydratants, les émollients, les agents adoucissants; les huiles minérales, végétales ou synthétiques; les actifs hydrophiles ou lipophiles comme les cérami- des et les pseudocéramides; les agents anti-mousse, les agents antiperspirants, les agents anti-radicaux libres, les agents bactéricides et les agents antipelliculai- res.The composition according to the invention may also comprise at least one cosmetically acceptable adjuvant conventionally used in cosmetic compositions, in particular intended to be applied to keratinous fibers. In particular, as a cosmetically acceptable adjuvant, it is possible to mention thickeners and / or thickeners; polymers, associative or not; anionic, nonionic, cationic and / or amphoteric surfactants; propenetrating agents, emulsifiers, perfumes, preservatives, fillers, sunscreens; dyestuffs, proteins, vitamins, provitamins; polymers, fixing or non-fixing, anionic, nonionic, cationic or amphoteric; moisturizing agents, emollients, softening agents; mineral, vegetable or synthetic oils; hydrophilic or lipophilic active agents such as ceramics and pseudoceramides; anti-foam agents, antiperspirants, anti-free radical agents, bactericidal agents and anti-dandruff agents.
L'homme de métier veillera à choisir les éventuels additifs et leur quantité de manière à ce qu'ils ne nuisent pas aux propriétés des compositions de la présente invention.Those skilled in the art will take care to choose the possible additives and their amount so that they do not adversely affect the properties of the compositions of the present invention.
De préférence, la composition selon l'invention peut se présenter sous la forme d'une lotion, épaissie ou non, d'une crème, épaissie ou non, d'un gel, d'une mousse ou de toute autre forme appropriée. Elle peut éventuellement être conditionnée dans un flacon pompe ou dans un récipient aérosol.Preferably, the composition according to the invention may be in the form of a lotion, thickened or not, a cream, thickened or not, a gel, a foam or any other suitable form. It can optionally be packaged in a pump bottle or in an aerosol container.
La composition cosmétique selon l'invention peut se présenter sous la forme d'un produit de soin, de nettoyage et/ou de maquillage de la peau du corps ou du visage, des lèvres, des cils, des ongles et des cheveux, d'un produit solaire ou autobronzant, d'un produit d'hygiène corporelle, d'un produit capillaire, notamment de soin, de nettoyage, de coiffage ou de coloration des cheveux.The cosmetic composition according to the invention may be in the form of a product for the care, cleaning and / or make-up of the skin of the body or of the face, the lips, the eyelashes, the nails and the hair, a suntan or self-tanning product, a personal hygiene product, a hair product, especially care, cleaning, styling or hair dyeing.
Elle trouve notamment une application particulièrement intéressante dans le domaine capillaire, notamment pour le maintien de la coiffure ou la mise en forme des cheveux, ou encore le nettoyage des cheveux. Les compositions capillaires sont de préférence des shampooings, des après-shampooings, des gels de coif- fage ou de soin, des lotions ou crèmes de soin, des conditionneurs, des lotions de mise en plis, des lotions pour le brushing, des compositions de fixation et de coiffage telles que les laques ou spray. Les lotions peuvent être conditionnées sous diverses formes, notamment dans des vaporisateurs, des flacons-pompe ou dans des récipients aérosol afin d'assurer une application de la composition sous forme vaporisée ou sous forme de mousse.It finds particularly a particularly interesting application in the hair field, including the maintenance of the hairstyle or the shaping of the hair, or the cleaning of the hair. The hair compositions are preferably shampoos, conditioners, body care or gelling gels, lotions or care creams, conditioners, styling lotions, blow-dry lotions, fixing and styling such as lacquers or spray. The lotions may be packaged in various forms, in particular in vaporizers, pump-bottles or in aerosol containers to ensure application of the composition in vaporized form or in the form of foam.
Elle peut notamment se présenter sous la forme d'un produit de coloration capillaire; ou sous forme de composition pour permanente, défrisage, ou décoloration, ou encore sous forme de compositions à rincer, à appliquer avant ou après une coloration, une décoloration, une permanente ou un défrisage ou encore entre les deux étapes d'une permanente ou d'un défrisage.It may especially be in the form of a hair coloring product; or in the form of a composition for permanent, straightening, or discoloration, or in the form of compositions to be rinsed, to be applied before or after a coloring, a discoloration, a permanent or a straightening or between the two stages of a permanent or a straightening.
La composition selon l'invention peut également se présenter sous la forme d'une composition de soin, notamment hydratant, pour la peau, les lèvres et/ou les pha- nères, ou sous forme d'une composition de nettoyage de la peau, par exemple un
produit démaquillant ou un gel pour le bain ou la douche.The composition according to the invention may also be in the form of a care composition, in particular a moisturizing composition, for the skin, the lips and / or the phageres, or in the form of a composition for cleaning the skin, for example a makeup remover or a gel for the bath or shower.
Elle peut aussi se présenter sous forme d'un produit de soin, non coloré, destiné à traiter la peau et notamment à l'hydrater, la lisser, la dépigmenter, la nourrir, la protéger des rayons solaires, ou lui conférer un traitement spécifique. Elle peut également se présenter sous forme d'une composition d'hygiène corporelle notamment sous forme de produit déodorant, anti-transpirant, ou encore sous forme d'une composition dépilatoire.It can also be in the form of a care product, not colored, intended to treat the skin and in particular to moisturize it, smooth it, depigment it, nourish it, protect it from the sun's rays, or give it a specific treatment. . It may also be in the form of a personal hygiene composition, especially in the form of a deodorant product, antiperspirant, or in the form of a depilatory composition.
Elle peut encore se présenter sous la forme d'un produit de maquillage, en particulier coloré, de la peau du corps ou du visage, ou des cheveux, en particulier un fond de teint, présentant éventuellement des propriétés de soin, un blush, un fard à joues ou à paupières, un produit anti-cernes, un eye-liner; un produit de maquillage des lèvres comme un rouge à lèvres, présentant éventuellement des propriétés de soin, un brillant à lèvres, les crayons à lèvres; un produit de maquillage des phanères comme les ongles, les cils en particulier sous forme d'un mascara pain, les sourcils et les cheveux; un produit de tatouage temporaire de la peau du corps.It may also be in the form of a makeup product, in particular colored, the skin of the body or face, or hair, especially a foundation, possibly with care properties, a blush, a blush, eye shadow, concealer, eye liner; a lipstick makeup product such as a lipstick, possibly with skincare properties, a lip gloss, lip pencils; a make-up product of integuments such as nails, eyelashes, in particular in the form of bread mascara, eyebrows and hair; a temporary tattoo product of the body skin.
Avantageusement, la composition selon l'invention est une composition capillaire de coiffage ou de conditionnement des cheveux, et peut se présenter sous forme de gel, de mousse, de lotion, de crème ou de spray; de shampoings ou d'après- shampoings.Advantageously, the composition according to the invention is a hair styling or conditioning hair composition, and may be in the form of a gel, a mousse, a lotion, a cream or a spray; shampoos or conditioners.
L'invention a aussi pour objet un procédé de traitement cosmétique, notamment de maquillage, de soin, de nettoyage, de coloration, de mise en forme des matières kératiniques, notamment de la peau du corps ou du visage, des ongles, des cheveux, des poils et/ou des cils, comprenant l'application sur lesdites matières d'une composition cosmétique telle que définie précédemment. De préférence, il s'agit d'un procédé de traitement cosmétique pour la mise en forme, le maintien, le soin et/ou le conditionnement des cheveux, comprenant l'application d'une composition selon l'invention sur lesdits cheveux; éventuelle- ment suivie d'une étape de rinçage.The subject of the invention is also a process for the cosmetic treatment, in particular of makeup, care, cleaning, coloring, shaping of keratin materials, in particular of the skin of the body or face, nails, hair, bristles and / or eyelashes, comprising the application on said materials of a cosmetic composition as defined above. Preferably, it is a cosmetic treatment method for shaping, holding, care and / or conditioning the hair, comprising applying a composition according to the invention to said hair; possibly followed by a rinsing step.
L'invention est illustrée plus en détails dans les exemples suivants, dans lesquels les abréviations suivantes ont été utilisées:The invention is illustrated in more detail in the following examples, in which the following abbreviations have been used:
AIBN : 2,2' Azobis(isobutyronitrile) Trigonox 21 S : Peroxy-2-éthylhexanoate de tert-butyleAIBN: 2,2 'Azobis (isobutyronitrile) Trigonox 21 S: tert-Butyl peroxy-2-ethylhexanoate
KPS : persulfate de potassiumKPS: potassium persulfate
DEAD : Diethyl AzodicarboxylateDEAD: Diethyl Azodicarboxylate
Dextran T1 : Dextrane de Mn=1000g/molDextran T1: Dextran of Mn = 1000g / mol
Dextran T5 : Dextrane de Mn=5000g/mol Dextran T10 : Dextrane de Mn=10000g/mol.Dextran T5: Dextran Mn = 5000g / mol Dextran T10: Dextran Mn = 10000g / mol.
EDC : N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimideEDC: N- (3-Dimethylaminopropyl) -N'-ethylcarbodiimide
DMAP : 4-(Dimethylamino)pyridineDMAP: 4- (Dimethylamino) pyridine
ABCVA : 4,4'-Azobis(4-cyanovaleric acid)
THF : TetrahydrofuraneABCVA: 4,4'-Azobis (4-cyanovaleric acid) THF: Tetrahydrofuran
Exemple 1 : Synthèse de polystyrène greffé maltotrioseExample 1 Synthesis of Grafted Polystyrene Maltotriose
1/ synthèse du N-(O-(p-vinylbenzyl)oxy)phtalimide1 / Synthesis of N- (O- (p-vinylbenzyl) oxy) phthalimide
Dans un ballon de 500 ml, on place 32.64 g de N-hydroxyphtalimide (0.2 mol) dans 300 ml de 1-méthyl-2-pyrrolidone. On met le mélange sous agitation. Après solubilisation de la N-hydroxyphtalimide dans le solvant, on ajoute petit à petit 5.76 g d'hydrure de sodium (1.2 eq, 0.24 mol). On observe un changement de couleur du jaune au rouge. On laisse agiter à température ambiante pendant 1 heure puis on ajoute 30.6 g de p-vinylbenzylchloride (1 eq, 0.20 mol) dans le milieu réaction- nel, et on porte la température à 500C. Après 9 heures, on précipite le mélange dans un grand volume d'eau glacée. On filtre le solide puis on le sèche à l'étuve. On obtient 53,5 g d'une poudre jaune claire soit un rendement de 96%. La structure du produit est confirmée par RMN 1H.In a 500 ml flask, 32.64 g of N-hydroxyphthalimide (0.2 mol) are placed in 300 ml of 1-methyl-2-pyrrolidone. The mixture is stirred. After solubilization of the N-hydroxyphthalimide in the solvent, 5.76 g of sodium hydride (1.2 eq, 0.24 mol) are added little by little. There is a change of color from yellow to red. Stirring is carried out at room temperature for 1 hour then 30.6 g of p-vinylbenzylchloride (1 eq, 0.20 mol) are added to the reaction medium, and the temperature is brought to 50 ° C. After 9 hours, the mixture is precipitated. in a large volume of ice water. The solid is filtered and then dried in an oven. 53.5 g of a light yellow powder is obtained, ie a yield of 96%. The structure of the product is confirmed by 1 H NMR.
2/ synthèse du [O-(p-vinylbenzyl)oxy1amine2 / synthesis of [O- (p-vinylbenzyl) oxyamine
On place 10 g de N-(O-(p-vinylbenzyl)oxy)phtalimide (35,8 mmol) dans un ballon de 250 ml en présence de 150 ml d'éthanol, sous agitation. On ajoute 5,3 ml de butylamine (1 ,5eq., 54mmol). Le milieu devient peu à peu homogène. On le laisse sous agitation pendant 4 heures à température ambiante. On élimine ensuite 50% du solvant au rotavapor puis on ajoute du diéthyléther pour obtenir une proportion 50/50 en volume avec l'éthanol. On ajoute ensuite 32,5 ml de HCI 5,5N (5eq., 178 mmol); on précipite ainsi le chlorhydrate de [O-(p-vinylbenzyl)oxy]amine. On filtre la poudre blanche ainsi obtenue puis on la sèche sous pression réduite. On récupère une masse de 5,4 g de produit soit un rendement de 81 %. Afin d'obtenir l'hydroxylamine libre, on disperse le chlorhydrate de [O-(p-
vinylbenzyl)oxy]amine dans du méthyl-THF puis on ajoute un excès de triéthyla- mine (5 ml). Dans un premier temps, le milieu s'homogénéise puis le chlorhydrate de triéthylamine précipite. On le filtre sous vide puis on évapore le filtrat sous vide. On obtient 3 g d'une huile transparente visqueuse (rendement 70%). La structure du produit est confirmée par RMN 1H.10 g of N- (O- (p-vinylbenzyl) oxy) phthalimide (35.8 mmol) are placed in a 250 ml flask in the presence of 150 ml of ethanol, with stirring. 5.3 ml of butylamine (1.5eq, 54mmol) are added. The environment becomes gradually homogeneous. It is left stirring for 4 hours at room temperature. 50% of the solvent is then removed by rotary evaporator and then diethyl ether is added to obtain a 50/50 volume proportion with the ethanol. 32.5 ml of 5.5N HCl (5 eq., 178 mmol) are then added; The [O- (p-vinylbenzyl) oxy] amine hydrochloride is thus precipitated. The white powder thus obtained is filtered and then dried under reduced pressure. A mass of 5.4 g of product is recovered, ie a yield of 81%. In order to obtain the free hydroxylamine, the hydrochloride of [O- (p- vinylbenzyl) oxy] amine in methyl-THF and then excess triethylamine (5 ml) is added. At first, the medium is homogenized and then the triethylamine hydrochloride precipitates. It is filtered under vacuum and then the filtrate is evaporated under vacuum. 3 g of a viscous transparent oil are obtained (yield 70%). The structure of the product is confirmed by 1 H NMR.
3/ synthèse du N-[Q-(p-vinylbenzyl)oxy1amine greffé maltotriose3 / synthesis of N- [Q- (p-vinylbenzyl) oxylamine grafted maltotriose
On place 2.8 g de maltotriose (5,5.mmol) dans 6 ml de solution tampon pH = 4. Après solubilisation, on ajoute 1 g de O-(p-vinylbenzyl)oxy]amine (6,7 mmol, 1.2 eq). On chauffe le milieu réactionnel à 75°C pendant 8 heures. Le milieu est ensuite précipité dans du THF et on obtient une poudre blanche que l'on filtre et sèche sous vide.2.8 g of maltotriose (5.5 mmol) are placed in 6 ml of pH = 4 buffer solution. After solubilization, 1 g of O- (p-vinylbenzyl) oxy] amine (6.7 mmol, 1.2 eq) are added. . The reaction medium is heated at 75 ° C. for 8 hours. The medium is then precipitated in THF and a white powder is obtained which is filtered and dried under vacuum.
On obtient 3,3 g de poudre blanche, soit un rendement de 95%. La structure du produit est confirmée par RMN 1H3.3 g of white powder is obtained, ie a yield of 95%. The structure of the product is confirmed by 1 H NMR
4/ polymérisation de la N-[Q-(p-vinylbenzyl)oxy1amine greffée maltotriose
4 / Polymerization of N- [4- (p-vinylbenzyl) oxyamine grafted maltotriose
On solubilise 0,5 g de N-[O-(p-vinylbenzyl)oxy]amine greffé maltotriose dans 1.16 g d'eau. Après solubilisation on ajoute 5 mg de persulfate de potassium. On porte le mélange à 900C. Au bout de 6 heures, on précipite le milieu réactionnel dans de l'éthanol.0.5 g of N- [O- (p-vinylbenzyl) oxy] amine grafted with maltotriose is solubilized in 1.16 g of water. After solubilization, 5 mg of potassium persulfate are added. The mixture is brought to 90 ° C. After 6 hours, the reaction medium is precipitated in ethanol.
Après filtration et séchage, on obtient 0,465 g de poly N-[O-(p- vinylbenzyl)oxy]amine greffée maltotriose soit un rendement de 93%. La structure du polymère est confirmée par RMN 1H.After filtration and drying, 0.465 g of poly (N- [O- (p-vinylbenzyl) oxy] amine grafted with maltotriose is obtained, ie a yield of 93%. The structure of the polymer is confirmed by 1 H NMR.
Exemple 2 : Synthèse de poly(méthacrylate de 2-aminooxyethyl) greffé maltotrioseExample 2 Synthesis of poly (2-aminooxyethyl methacrylate) grafted maltotriose
1/ synthèse du O-(2-hvdroxyethyl)phtalimide de méthacrylate1 / synthesis of methacrylate O- (2-hydroxyethyl) phthalimide
On solubilise 13.8 g d'hydroxyphtalimide (84.6 mmol, 1.1 eq) dans 240 ml de THF, dans un ballon de 500 ml. On ajoute 10 g de HEMA (76.8 mmol, 1 eq) et 22.15 g de triphénylphosphine (84.4 mmol, 1.1 eq). On place le ballon sous argon puis dans un bain d'eau glacée. Lorsque la température est proche de 100C, on ajoute
36.8 g de DEAD (84.5 mmol, 1.1 eq) petit à petit. On maintient la température entre 5 et 15°C puis on laisse réagir 12 heures à température ambiante. Le milieu réactionnel est ensuite dilué avec 1 litre de dichlorométhane puis lavé à l'eau jusqu'à disparition complète de la couleur orangé dans la phase aqueuse. La phase organique est alors concentrée sous pression réduite puis purifiée sur colonne de silice (éluant : 70/30 heptane/acétate d'éthyle).13.8 g of hydroxyphthalimide (84.6 mmol, 1.1 eq) are solubilized in 240 ml of THF in a 500 ml flask. 10 g of HEMA (76.8 mmol, 1 eq) and 22.15 g of triphenylphosphine (84.4 mmol, 1.1 eq) are added. The flask is placed under argon then in a bath of ice water. When the temperature is close to 10 0 C, we add 36.8 g of DEAD (84.5 mmol, 1.1 eq) little by little. The temperature is maintained between 5 and 15 ° C and then allowed to react for 12 hours at room temperature. The reaction medium is then diluted with 1 liter of dichloromethane and then washed with water until complete disappearance of the orange color in the aqueous phase. The organic phase is then concentrated under reduced pressure and then purified on a silica column (eluent: 70/30 heptane / ethyl acetate).
On obtient 11 ,4 g d'une huile incolore, d'où un rendement de 55%. La structure du produit est confirmée par RMN 1H.11.4 g of a colorless oil are obtained, giving a yield of 55%. The structure of the product is confirmed by 1 H NMR.
2/ synthèse du polyméthacrylate de (2-hvdroxyethyl)phthalimide2 / Synthesis of (2-hydroxyethyl) phthalimide polymethacrylate
On place 0,5 g de méthacrylate de (2-hydroxyéthyl)phthalimide précédemment synthétisé dans 0,5 g de N-méthylpyrrolidone. On ajoute 11 ,5 microlitre de Trigo- nox21 S puis on porte le mélange à 900C. La réaction est arrêtée au bout de 6 heures, puis le polymère est précipité dans l'éthanol et filtré.0.5 g of (2-hydroxyethyl) phthalimide methacrylate previously synthesized are placed in 0.5 g of N-methylpyrrolidone. 11.5 microliters of Trigonox21 S are added and the mixture is then heated at 90 ° C. The reaction is stopped after 6 hours, then the polymer is precipitated in ethanol and filtered.
On obtient une masse de 0,3 g soit un rendement de 60%. La structure du polymère est confirmée par RMN 1H.A mass of 0.3 g is obtained, ie a yield of 60%. The structure of the polymer is confirmed by 1 H NMR.
3/ synthèse du polyméthacrylate de 2-aminooxvethvl3 / Synthesis of 2-aminooxymethyl polymethacrylate
On solubilise 1 g de polyméthacrylate de (2-hydroxyethyl)phthalimide (3,63 mmol de groupements phthalimides) dans 6 ml de dichlorométhane, puis on ajoute 1 ,8 ml de butylamine (5eq., 18.1 mmol). Le milieu est placé sous argon à température ambiante; il reste homogène tout le long de la réaction. Au bout de 24 heures, le polymère est précipité dans du diéthyléther et on obtient 0,45 g de polyméthacrylate de 2-aminoxyéthyl, d'où un rendement de 85%. On constate par RMN 1H la disparition des groupements phthalimides ce qui per-
met de confirmer l'efficacité de la réaction.1 g of (2-hydroxyethyl) phthalimide polymethacrylate (3.63 mmol of phthalimide groups) are solubilized in 6 ml of dichloromethane, then 1.8 ml of butylamine (5 eq., 18.1 mmol) are added. The medium is placed under argon at room temperature; it remains homogeneous throughout the reaction. After 24 hours, the polymer is precipitated in diethyl ether and 0.45 g of 2-aminoxyethyl polymethacrylate is obtained, giving a yield of 85%. NMR 1 H shows the disappearance of the phthalimide groups which allows confirms the effectiveness of the reaction.
4/ synthèse du polyméthacrylate de 2-aminoxyethyl greffé maltotriose4 / synthesis of 2-aminoxyethyl polymethacrylate grafted maltotriose
On solubilise 920 mg de maltotriose (1.83 mmol) dans 2.14 ml d'eau tamponnée pH=4. On ajoute 300 mg de polymère (1.1 eq de fonctions hydroxylamines par rapport à l'extrémité réductrice du maltotriose). On laisse sous agitation durant 24 heures, à 75°C, puis on dilue le milieu dans 2 ml d'eau tamponnée pH=4 et on précipite le polymère deux fois dans du THF.920 mg of maltotriose (1.83 mmol) are solubilized in 2.14 ml of buffered water pH = 4. 300 mg of polymer (1.1 eq of hydroxylamine functions relative to the reducing end of maltotriose) are added. The mixture is left stirring for 24 hours at 75 ° C. and then the medium is diluted in 2 ml of buffered water pH = 4 and the polymer is precipitated twice in THF.
Après séchage à l'étuve, on récupère 1 ,1 g d'une poudre blanche, d'où un rendement de 90%. Le taux de greffage du maltotriose est évalué par RMN 1H à 83%.After drying in an oven, 1.1 g of a white powder is recovered, hence a yield of 90%. The grafting rate of maltotriose is evaluated by 1 H NMR at 83%.
Exemple 3 : synthèse de poly(méthacrylate de 2-aminooxyethyl) greffé par un Dextran de Mn 1000 q/mol (Dextran TDExample 3 Synthesis of poly (2-aminooxyethyl methacrylate) grafted with a Dextran of Mn 1000 q / mol (Dextran TD
On solubilise 1 ,1 g de Dextran T1 (1.1 mmol) dans 2,6 ml d'eau tamponnée pH=4. On ajoute 200 mg de polymère poly[O-(2-hydroxyethyl)amine] préparé ci-dessus (1.2 eq de fonctions hydroxylamines par rapport à l'extrémité réductrice du Dex- tran T1 ). On laisse sous agitation pendant 24 heures, à 75°C, puis on dilue le milieu dans 3 ml d'eau tamponnée pH=4, et on précipite le polymère deux fois dans du THF. 1.1 g of Dextran T1 (1.1 mmol) are solubilized in 2.6 ml of buffered water pH = 4. 200 mg of poly [O- (2-hydroxyethyl) amine] polymer prepared above (1.2 eq of hydroxylamine functions relative to the reducing end of Dextran T1) are added. The mixture is left stirring for 24 hours at 75 ° C. and then the medium is diluted in 3 ml of buffered water pH = 4, and the polymer is precipitated twice in THF.
Après séchage à l'étuve, on récupère 1 ,1 g d'une poudre blanche, d'où un rendement de 85%. Le taux de greffage du Dextran T1 est évalué par RMN 1H à 84%.After drying in an oven, 1.1 g of a white powder is recovered, hence a yield of 85%. The degree of grafting of Dextran T1 is evaluated by 1 H NMR at 84%.
Exemple 4 : synthèse de polv(méthacrylate de 2-(aminooxyacetamido) éthyl) greffé par un Dextran de Mn 1000q/mol (Dextran T1)Example 4 Synthesis of polv (2- (aminooxyacetamido) ethyl methacrylate) grafted with a dextran of Mn 1000q / mol (Dextran T1)
1/ synthèse du méthacrylate de 2-(aminooxyacetamido)éthvl1 / Synthesis of 2- (aminooxyacetamido) ethyl methacrylate
Dans un tricol de 500 ml, on place 260 g de dichlorométhane, 5 g de chlorhydrate de 2-aminoethylméthacrylate (30,2mmol, 1eq), 5,77g de (Boc-aminooxy) acetic
acid (30,2 mmol, 1 eq) et 4,59 g de K2CO3 (33,2mmol, 1 eq). On met ce mélange sous argon puis on refroidit avec un bain de glace avant d'ajouter 0,37 g de DMAP (3,02ITHTiOl, 0,1 eq) et 5,16 g d'EDC (33,2mmol, 1 ,1 eq). Une fois l'addition terminée, on laisse agiter à température ambiante pendant 48 heures puis on filtre le K2CO3, on évapore le dichlorométhane et on purifie le milieu réactionnel sur colonne de silice (éluant: 20/80 h epta ne/acétate d'éthyle).In a three-necked flask of 500 ml, 260 g of dichloromethane, 5 g of 2-aminoethylmethacrylate hydrochloride (30.2 mmol, 1 eq), 5.77 g of (Boc-aminooxy) acetic acid are added. acid (30.2 mmol, 1 eq) and 4.59 g K 2 CO 3 (33.2 mmol, 1 eq). This mixture is put under argon and then cooled with an ice bath before adding 0.37 g of DMAP (3.02 THTiOl, 0.1 eq) and 5.16 g of EDC (33.2 mmol, 1.1 g). eq). After the addition is complete, the mixture is stirred at room temperature for 48 hours, then the K 2 CO 3 is filtered, the dichloromethane is evaporated and the reaction medium is purified on a silica column (eluent: 20/80 h epta ne / ethyl acetate ).
On obtient ainsi 3,7 g d'une huile transparente (AE MA-Ac-O N H Boc), d'où un rendement de 45%, dont la structure est confirmée par RMN 1H. Ce monomère est déprotégé par traitement avec de l'acide trifluoroacétique (25eq molaire) en présence d'eau (TFA/eau : 5/1 en masse) pendant 24 heures à température ambiante. L'eau et le TFA sont ensuite évaporés sous pression réduite et on obtient de façon quantitative le méthacrylate de 2- (aminooxyacetamido)éthyl (AEMA-Ac-ONH2). La structure et l'efficacité de la déprotection sont confirmés par RMN 1H.There is thus obtained 3.7 g of a transparent oil (AE MA-Ac-O NH Boc), from which a yield of 45%, the structure of which is confirmed by 1 H NMR. This monomer is deprotected by treatment with sodium hydroxide. trifluoroacetic acid (25th molar) in the presence of water (TFA / water: 5/1 by mass) for 24 hours at room temperature. The water and TFA are then evaporated under reduced pressure and 2- (aminooxyacetamido) ethyl methacrylate (AEMA-Ac-ONH 2 ) is obtained quantitatively. The structure and efficiency of the deprotection are confirmed by 1 H NMR.
2/ greffage du Dextran T1 sur le méthacrylate de 2-(aminooxyacetamido)éthyl et polymérisation2 / grafting of Dextran T1 on 2- (aminooxyacetamido) ethyl methacrylate and polymerization
On solubilise 1 ,71 g de méthacrylate de 2-(aminooxyacetamido) éthyl (5,41 mmol; 3eq) dans 15 g d'eau. On ajuste le pH de la solution à 4 par addition d'une solution de soude 5N. On rajoute ensuite 1 ,8 g de Dextran T1 (1 ,8mmol; 1 eq) et on laisse agiter à température ambiante pendant 48 heures. On précipite ensuite le milieu réactionnel dans 100 ml de THF: le précipité blanc ainsi obtenu est filtré puis séché sous pression réduite. On récupère 1 ,8 g de monomère greffé Dextran T1. Le taux de fonctionnalisation est estimé à 91 % par RMN 1H. La polymérisation de ce monomère est effectuée en solubilisant 0,5 g de méthacrylate de 2-(aminooxyacetamido)éthyl greffé Dextran T1 dans 2 ml d'eau puis en rajoutant 10 mg de ABCVA. Le pH de la solution est ajusté à 7 par ajout d'une so-
lution de soude 1 N puis le milieu réactionnel est chauffé à 700C pendant 4 heures. La polymérisation est contrôlée par disparation des doubles liaisons en RMN 1H. On précipite ensuite le mélange dans 50 ml de THF et après filtration et séchage, on récupère 0,4 g d'une poudre blanche d'où un rendement de 80%.1.71 g of 2- (aminooxyacetamido) ethyl methacrylate (5.41 mmol, 3eq) are solubilized in 15 g of water. The pH of the solution is adjusted to 4 by addition of a 5N sodium hydroxide solution. 1.8 g of Dextran T1 (1.8 mmol, 1 eq) are then added and the mixture is stirred at room temperature for 48 hours. The reaction medium is then precipitated in 100 ml of THF: the white precipitate thus obtained is filtered and then dried under reduced pressure. 1.8 g of grafted monomer Dextran T1 are recovered. The degree of functionalization is estimated at 91% by 1 H NMR. The polymerization of this monomer is carried out by solubilizing 0.5 g of 2- (aminooxyacetamido) ethyl methacrylate grafted Dextran T1 in 2 ml of water and then adding 10 mg from ABCVA. The pH of the solution is adjusted to 7 by adding a solution 1 N sodium hydroxide solution and then the reaction medium is heated at 70 ° C. for 4 hours. The polymerization is controlled by the disappearance of the double bonds in 1 H NMR. The mixture is then precipitated in 50 ml of THF and after filtration and drying, 0.4 g of a white powder is recovered, giving a yield of 80%.
Exemple 5 : synthèse de poly(méthacrylate de 2-(aminooxyacetamido)éthyl) greffé par un Dextran de Mn 5000q/mol (Dextran T5)Example 5 Synthesis of poly (2- (aminooxyacetamido) ethyl methacrylate) grafted with a Dextran of Mn 5000q / mol (Dextran T5)
1/ polymérisation du méthacrylate de 2-(Boc-aminooxyacetamido)éthyl (AEMA-Ac- ONHBoc)1 / Polymerization of 2- (Boc-aminooxyacetamido) ethyl methacrylate (AEMA-Ac-ONHBoc)
On solubilise 1g de monomère protégé AE MA-Ac-O N H Boc préparé à l'étape 1 de l'exemple 4, (4,96 mmol) dans 2 g de N-méthylpyrrolidone puis on rajoute 40 mg d'AIBN (0,24mmol). On place le milieu sous argon puis on chauffe à 800C pendant 6h30. La polymérisation est contrôlée par disparation des doubles liaisons en RMN1H . En fin de réaction, on précipite le milieu réactionnel dans 50 ml d'eau. Après filtration et séchage sous pression réduite, on récupère 800 mg de poudre blanche, d'où un rendement de 80%.1 g of AE MA-Ac-O NH Boc protected monomer prepared in step 1 of example 4 (4.96 mmol) is solubilized in 2 g of N-methylpyrrolidone and then 40 mg of AIBN (0, 24mmol). The medium is placed under argon and then heated at 80 ° C. for 6h30. The polymerization is controlled by the disappearance of double bonds in 1 H NMR. At the end of the reaction, the reaction medium is precipitated in 50 ml of water. After filtration and drying under reduced pressure, 800 mg of white powder is recovered, hence a yield of 80%.
2/ déprotection du polyméthacrylate de 2-(Boc-aminooxyacetamido)éthyl et gref- faqe de Dextran T52 / deprotection of 2- (Boc-aminooxyacetamido) ethyl polymethacrylate and Dextran T5 graft
On place 800 mg du polymère synthétisé ci-dessus dans 3,7 ml d'eau et 3,7 ml d'acide trifluoroacétique. Après 24 heures, on confirme que la déprotection est totale par RMN1H. On évapore l'eau et l'acide trifluoroacétique, puis on place 550 mg du polymère déprotégé dans 8 ml d'eau. On ajuste le pH à 4 par ajout d'une solution de NaOH 5N et on rajoute 7,28 g de Dextran T5. Après 48 heures, on
précipite le milieu réactionnel dans 100 ml de THF, on filtre et on sèche sous pression réduite la poudre obtenue.800 mg of the polymer synthesized above are placed in 3.7 ml of water and 3.7 ml of trifluoroacetic acid. After 24 hours, it is confirmed that the deprotection is complete by 1 H NMR. The water and trifluoroacetic acid are evaporated, and then 550 mg of the deprotected polymer are placed in 8 ml of water. The pH is adjusted to 4 by adding a solution of 5N NaOH and 7.28 g of Dextran T5 are added. After 48 hours, we The reaction medium is precipitated in 100 ml of THF, filtered and the powder obtained is dried under reduced pressure.
On obtient 8 g de poly(méthacrylate de 2-(aminooxyacetamido)éthyl) greffé par du Dextran T5. La RMN 1H permet de confirmer que le taux de greffage est supérieur à 90%.8 g of poly (2- (aminooxyacetamido) methacrylate) grafted with Dextran T5 are obtained. 1 H NMR confirms that the grafting rate is greater than 90%.
Exemple 6 : synthèse de polv(méthacrylamide de 3- (aminooxyacetamido)propyl) greffé par un Dextran de Mn 5000q/mol (Dextran T5)Example 6 Synthesis of polv (3- (aminooxyacetamido) propyl methacrylamide) grafted with a Dextran of Mn 5000q / mol (Dextran T5)
1/ synthèse du méthacrylamide de 3-(Boc-aminooxyacetamido)propyl (APMAm- Ac-ON H Boc)1 / Synthesis of 3- (Boc-aminooxyacetamido) propyl methacrylamide (APMAm-Ac-ON H Boc)
Dans un tricol de 500 ml, on place 200 g de dichlorométhane, 4 g de chlorhydrate de N-3-(aminopropyl)méthacrylamide (22,4mmol, 0,92eq), 4,65 g de (Boc- aminooxy) acetic acid (24,3mmo, 1 eq), 3,7 g de K2CO3 (26,8mmol; 1 ,1 eq) et 297 mg de DMAP (2,43mmol; 0,1 eq). On met ce mélange sous argon puis on refroidit avec un bain de glace avant d'ajouter 4,16 g d'EDC (26,8mmol; 1 ,1 eq). Une fois l'addition terminée, on laisse agiter à température ambiante pendant 48 heures puis on filtre le K2CO3. On lave la phase organique 3 fois avec 100 ml de chlorhydrate d'ammonium et 2 fois avec 100 ml d'eau. On récupère la phase organique et
on évapore le dichlorométhane sous pression réduite. On purifie le milieu réac- tionnel sur colonne de silice (éluant: 50/50 heptane/isopropanol). On obtient 4,8 g d'une huile transparente d'où un rendement de 68%, et la structure est confirmée par RMN 1H.In a three-necked 500 ml, 200 g of dichloromethane, 4 g of N-3- (aminopropyl) methacrylamide hydrochloride (22.4 mmol, 0.92 eq), 4.65 g of (Boc-aminooxy) acetic acid ( 24.3 mmol, 1 eq), 3.7 g of K 2 CO 3 (26.8 mmol, 1 eq) and 297 mg of DMAP (2.43 mmol, 0.1 eq). This mixture is put under argon and then cooled with an ice bath before adding 4.16 g of EDC (26.8 mmol, 1.1 eq). After the addition is complete, the mixture is left to stir at room temperature for 48 hours and then the K2CO3 is filtered off. The organic phase is washed 3 times with 100 ml of ammonium hydrochloride and twice with 100 ml of water. The organic phase is recovered and the dichloromethane is evaporated under reduced pressure. The reaction medium is purified on a silica column (eluent: 50/50 heptane / isopropanol). 4.8 g of a transparent oil are obtained, giving a yield of 68%, and the structure is confirmed by 1 H NMR.
2/ polymérisation et déprotection du méthacrylamide de 3-(Boc-aminooxy aceta- mido)propyl2 / Polymerization and deprotection of 3- (Boc-aminooxyacetamido) propyl methacrylamide
On solubilise 1 g du monomère AP MAm -Ac-O N H Boc (3,17mmol) précédemment synthétisé dans 1 g d'éthanol puis on rajoute 20 mg d'AIBN (0,122mmol). On place le milieu réactionnel sous argon puis on chauffe à 700C pendant 8 heures. La polymérisation est contrôlée par disparation des doubles liaisons en RMN 1H. En fin de réaction, on précipite le polymère dans 50 ml de diéthyléther. Après fil- tration et séchage, on récupère 625 mg d'une poudre blanche dont la structure est confirmée par RMN 1H (rendement 90%) La déprotection est effectuée en solubilisant 330 mg du polymère ci-dessus dans 1g d'eau et 2,98 g d'acide trifluoroacétique. Après 5 heures, on évapore le milieu réactionnel; on confirme par RMN 1H une déprotection totale du polymère.1 g of the AP MAm -Ac-O NH Boc monomer (3.17 mmol) previously synthesized in 1 g of ethanol are solubilized and then 20 mg of AIBN (0.122 mmol) are added. The reaction medium is placed under argon and then heated at 70 ° C. for 8 hours. The polymerization is controlled by the disappearance of the double bonds in 1 H NMR. At the end of the reaction, the polymer is precipitated in 50 ml of diethyl ether. After filtration and drying, 625 mg of a white powder is obtained, the structure of which is confirmed by 1 H NMR (90% yield). The deprotection is carried out by solubilizing 330 mg of the above polymer in 1 g of water and 2 g of water. , 98 g of trifluoroacetic acid. After 5 hours, the reaction medium is evaporated; a total deprotection of the polymer is confirmed by 1 H NMR.
3/ greffage du Dextran T5000 sur le polyméthacrylamide de 3- (aminooxyacetamido)propyl3 / grafting Dextran T5000 to 3- (aminooxyacetamido) propyl polymethacrylamide
On solubilise la totalité du polyméthacrylamide de 3-(aminooxyacetamido)propyl ci-dessus dans 5 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 4,19 g de Dextran T5 puis on laisse réagir à température ambiante pendant 48 heures. On précipite le milieu réactionnel dans 50 ml d'éthanol. Après filtration et séchage, on récupère 4 g d'une poudre blanche. Le taux de greffage du Dextran T5 est estimé à 65% par RMN 1H.The whole of the above 3- (aminooxyacetamido) propyl polymethacrylamide is solubilized in 5 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. Then 4.19 g of Dextran T5 is added and then allowed to react at room temperature for 48 hours. The reaction medium is precipitated in 50 ml of ethanol. After filtration and drying, 4 g of a white powder are recovered. The degree of grafting of Dextran T5 is estimated at 65% by 1 H NMR.
Exemple 7: synthèse de polv(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par un Dextran de Mn 10000q/mol (Dextran T10) On répète le protocole de l'exemple 6 jusqu'au greffage du Dextran. Le greffage du polysaccharide est effectuée en solubilisant 330 mg de poly(méthacrylamide de 3-(aminooxyacetamido)propyl) dans 20 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 8,37 g de Dextran T10, puis on laisse réagir à température ambiante pendant 72 heures. On précipite en- suite le milieu réactionnel dans 600 ml d'éthanol. Après filtration et séchage, on récupère 8,1 g d'une poudre blanche. Le taux de greffage du Dextran T10 est estimé à 40% par RMN 1HExample 7 Synthesis of polv (methacrylamide of 3- (aminooxyacetamido) propyl) grafted with Dextran of Mn 10000q / mol (Dextran T10) The protocol of Example 6 is repeated until the grafting of Dextran. The grafting of the polysaccharide is carried out by solubilizing 330 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 20 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 8.37 g of Dextran T10 are then added and the mixture is left to react at ambient temperature for 72 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 8.1 g of a white powder are recovered. The degree of grafting of Dextran T10 is estimated at 40% by 1 H NMR
Exemple 8: synthèse d'un copolymère de méthacrylamide de 3- (aminooxyacetamido)propyl avec du méthacrylamide de diméthylaminopro- pyl puis greffage par un Dextran de Mn 5000q/mol (Dextran T5)
Example 8 Synthesis of a 3- (aminooxyacetamido) propyl methacrylamide copolymer with dimethylaminopropyl methacrylamide followed by grafting with a Dextran of Mn 5000q / mol (Dextran T5)
1/ copolymérisation du méthacrylamide de 3-(Boc-aminooxyacetamido)propyl avec du dimethylaminopropylméthacrylamide On solubilise 6 g de méthacrylamide de 3-(Boc-aminooxyacetamido)propyl (17,1 mmol; 0,75eq), 0,972 g de dimethylaminopropylméthacrylamide (5,71 mmol; 0,25eq) et 142 mg d'AIBN (0,038eq) dans 7 g d'éthanol. On place le milieu réac- tionnel sous argon puis on chauffe à 700C pendant 10 heures. La polymérisation est contrôlée par disparation des doubles liaisons en RMN 1H. En fin de réaction, on précipite le polymère dans 200 ml de diéthyléther. Après filtration et séchage, on récupère 5,3 g de polymère dont la RMN 1H permet de déterminer la composition: 76% molaire de méthacrylamide de 3-(Boc-aminooxyacetamido)propyl et 24% molaire de dimethylaminopropylméthacrylamide (rendement 76%).1 / copolymerization of 3- (Boc-aminooxyacetamido) propyl methacrylamide with dimethylaminopropylmethacrylamide 6 g of 3- (Boc-aminooxyacetamido) propyl methacrylamide (17.1 mmol, 0.75 eq), 0.972 g of dimethylaminopropylmethacrylamide (5, 71 mmol, 0.25 eq) and 142 mg of AIBN (0.038 eq) in 7 g of ethanol. The reaction medium is placed under argon and then heated at 70 ° C. for 10 hours. The polymerization is controlled by the disappearance of the double bonds in 1 H NMR. At the end of the reaction, the polymer is precipitated in 200 ml of diethyl ether. After filtration and drying, 5.3 g of polymer is recovered, the 1 H NMR of which makes it possible to determine the composition: 76 mol% of 3- (Boc-aminooxyacetamido) propyl methacrylamide and 24 mol% of dimethylaminopropylmethacrylamide (yield 76%).
2/ déprotection et greffage de Dextran T52 / deprotection and grafting of Dextran T5
On utilise 1 g de copolymère synthétisé ci-dessus que l'on dissout dans 3 g d'eau et 9 g d'acide trifluoroacétique. On laisse agiter pendant 20 heures à température ambiante puis on évapore le milieu réactionnel. On confirme par RMN 1H une déprotection totale du polymère. On redissout le milieu dans 10 g d'eau puis on ajuste le pH à 4 par ajout d'une solution de NaOH 5N. On ajoute ensuite 10,8g de Dextran T5 et on laisse agiter 48 heures à température ambiante. On précipite le milieu réactionnel dans 600 ml de THF; après filtration et séchage, on obtient 10 g d'un copolymère contenant 76% molaire de méthacrylamide de 3- (aminooxyacetamido)propyl et 24% molaire de dimethylaminopropylméthacryla- mide sur lequel on a greffé 59% de Dextran T5 (confirmé par RMN 1H).
Exemple 9: synthèse d'un copolvmère de méthacrylamide de 3- (aminooxyacetamido)propyl avec du méthacrylamide de diméthylaminopro- pyl puis greffage par un Dextran de Mn 10000q/mol (Dextran T10)1 g of the copolymer synthesized above is used which is dissolved in 3 g of water and 9 g of trifluoroacetic acid. Stirring is allowed for 20 hours at room temperature and then the reaction medium is evaporated. A total deprotection of the polymer is confirmed by 1 H NMR. The medium is redissolved in 10 g of water and then the pH is adjusted to 4 by adding a solution of 5N NaOH. 10.8 g of Dextran T5 are then added and the mixture is stirred for 48 hours at room temperature. The reaction medium is precipitated in 600 ml of THF; after filtration and drying, 10 g of a copolymer containing 76 mol% of 3- (aminooxyacetamido) propyl methacrylamide and 24 mol% of dimethylaminopropyl methacrylamide were grafted onto which 59% of Dextran T5 was grafted (confirmed by 1 H NMR). ). Example 9 Synthesis of a copolymer of 3- (aminooxyacetamido) propyl methacrylamide with dimethylaminopropyl methacrylamide followed by grafting with a Dextran of Mn 10,000q / mol (Dextran T10)
On répète le protocole de l'exemple 8 jusqu'au greffage du Dextran. Le greffage du polysaccharide est effectué en solubilisant 510 mg du copolymère de méthacrylamide de 3-(aminooxyacetamido)propyl (76%) et de méthacrylamide de dimé- thylaminopropyl (24%) dans 20 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On ajoute 15,2g de Dextran T10, puis on laisse réagir à température ambiante pendant 48 heures. On précipite ensuite le milieu réactionnel dans 600 ml de THF; après filtration et séchage, on obtient 16,3 g d'une poudre blanche. Le taux de greffage du Dextran T10 est estimé à 54% par RMN 1H.The protocol of Example 8 is repeated until the grafting of Dextran. The grafting of the polysaccharide is carried out by solubilizing 510 mg of the methacrylamide copolymer of 3- (aminooxyacetamido) propyl (76%) and dimethylaminopropyl methacrylamide (24%) in 20 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. Dextran T10 (15.2 g) is added and allowed to react at room temperature for 48 hours. The reaction medium is then precipitated in 600 ml of THF; after filtration and drying, 16.3 g of a white powder are obtained. The degree of grafting of Dextran T10 is estimated at 54% by 1 H NMR.
Exemple 10 : synthèse d'un copolvmère de méthacrylamide de 3- (aminooxyacetamido)propyl (76% mol) avec du méthacrylamide de diméthv- laminopropyl (24% mol) puis greffage par un Dextran de Mn 1000g/mol (Dextran TDEXAMPLE 10 Synthesis of a copolymer of 3- (aminooxyacetamido) propyl methacrylamide (76 mol%) with dimethylaminopropyl methacrylamide (24 mol%) and then grafting with a dextran of Mn 1000 g / mol (Dextran TD
On répète le protocole de l'exemple 8 jusqu'au greffage du Dextran. Le greffage du polysaccharide est effectuée en solubilisant 3 g du copolymère de méthacryla- mide de 3-(aminooxyacetamido)propyl (76%) et de méthacrylamide de diméthyla- minopropyl (24%) dans 17 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 6,2 g de Dextran T1 , puis on laisse la réaction à température ambiante pendant 24 heures. On précipite ensuite le milieu réactionnel dans 600 ml d'éthanol. Après filtration et séchage, on récu- père 8 g d'une poudre blanche. Le taux de greffage du Dextran T1 est estimé à 95% par RMN 1H.The protocol of Example 8 is repeated until the grafting of Dextran. The grafting of the polysaccharide is carried out by solubilizing 3 g of the methacrylamide copolymer of 3- (aminooxyacetamido) propyl (76%) and of dimethylaminopropyl methacrylamide (24%) in 17 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 6.2 g of Dextran T1 are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 8 g of a white powder are recovered. The degree of grafting of Dextran T1 is estimated at 95% by 1 H NMR.
Exemple 11 : synthèse d'un copolvmère de méthacrylamide de 3- (aminooxyacetamido)propyl (48% mol) avec du méthacrylamide de diméthv- laminopropyl (52% mol) puis greffage par un Dextran de Mn 1000g/mol (Dextran TDExample 11: Synthesis of a copolymer of 3- (aminooxyacetamido) propyl methacrylamide (48 mol%) with dimethylaminopropyl methacrylamide (52 mol%) and then grafting with a dextran of 1000 g / mol (Dextran TD
1/ copolymérisation du méthacrylamide de 3-(Boc-aminooxyacetamido)propyl avec du dimethylaminopropylméthacrylamide On solubilise 4 g de méthacrylamide de 3-(Boc-aminooxyacetamido)propyl (11 ,4mmol; 0,5eq), 1 ,94 g de dimethylaminopropylméthacrylamide (11 ,4mmol; 0,5eq) et 123 mg d'AIBN (0,033eq) dans 6 g d'éthanol. On place le milieu réactionnel sous argon puis on chauffe à 700C pendant 10 heures. La polymérisation est contrôlée par disparation des doubles liaisons en RMN 1H. En fin de réaction, on précipite le polymère dans 200 ml de diéthyléther. Après filtration et séchage, on récupère 4,2 g de polymère dont la RMN 1H permet de déterminer la composition: 48% molaire de méthacrylamide de 3-(Boc-aminooxyacetamido)propyl et 52% molaire de dimethylaminopropylméthacrylamide (rendement 71 %).
2/ déprotection et greffage de Dextran T11 / copolymerization of 3- (Boc-aminooxyacetamido) propyl methacrylamide with dimethylaminopropylmethacrylamide 4 g of 3- (Boc-aminooxyacetamido) propyl methacrylamide (11.4 mmol, 0.5 eq), 1.94 g of dimethylaminopropylmethacrylamide (11 4mmol, 0.5eq) and 123mg of AIBN (0.033eq) in 6g of ethanol. The reaction medium is placed under argon and then heated at 70 ° C. for 10 hours. The polymerization is controlled by the disappearance of the double bonds in 1 H NMR. At the end of the reaction, the polymer is precipitated in 200 ml of diethyl ether. After filtration and drying, 4.2 g of polymer are recovered, the 1 H NMR of which makes it possible to determine the composition: 48 mol% of 3- (Boc-aminooxyacetamido) propyl methacrylamide and 52 mol% of dimethylaminopropylmethacrylamide (yield 71%). 2 / deprotection and grafting of Dextran T1
On utilise 3 g de œpolymère synthétisé ci-dessus que l'on dissout dans 9,1 g d'eau et 27,1 g d'acide trifluoroacétique. On laisse agiter pendant 20 heures à température ambiante puis on évapore le milieu réactionnel. On confirme par RMN 1H une déprotection totale du polymère. On redissout le milieu dans 13 g d'eau puis on ajuste le pH à 4 par ajout d'une solution de NaOH 5N. On ajoute ensuite 4,57g de Dextran T1 et on laisse agiter 24 heures à température ambiante. On précipite le milieu réactionnel dans 600 ml d'éthanol; après filtration et séchage, on obtient 6,5 g d'un copolymère contenant 48% molaire de méthacrylamide de 3- (aminooxyacetamido)propyl et 52% molaire de dimethylaminopropylméthacryla- mide sur lequel on a greffé 89% de Dextran T1 (confirmé par RMN 1H).3 g of the above-synthesized ethers are used which are dissolved in 9.1 g of water and 27.1 g of trifluoroacetic acid. Stirring is allowed for 20 hours at room temperature and then the reaction medium is evaporated. A total deprotection of the polymer is confirmed by 1 H NMR. The medium is redissolved in 13 g of water and then the pH is adjusted to 4 by addition of a 5N NaOH solution. 4.57 g of Dextran T1 are then added and the mixture is stirred for 24 hours at room temperature. The reaction medium is precipitated in 600 ml of ethanol; after filtration and drying, 6.5 g of a copolymer containing 48 mol% of 3- (aminooxyacetamido) propyl methacrylamide and 52 mol% of dimethylaminopropylmethacrylamide were grafted onto which 89% of Dextran T1 (NMR-confirmed) was grafted. 1H).
Exemple 12: synthèse d'un copolymère de méthacrylamide de 3- (aminooxyacetamido)propyl (48% mol) avec du méthacrylamide de diméthv- laminopropyl (52% mol) puis greffage par un Dextran de Mn 5000q/mol (Dextran T5)Example 12 Synthesis of a methacrylamide copolymer of 3- (aminooxyacetamido) propyl (48 mol%) with dimethylaminopropyl methacrylamide (52 mol%) and then grafting with a Dextran of Mn 5000q / mol (Dextran T5)
On répète le protocole de l'exemple 11 jusqu'au greffage du Dextran. Le greffage du polysaccharide est effectuée en solubilisant 1g du copolymère de méthacryla- mide de 3-(aminooxyacetamido)propyl (48% molaire) et de méthacrylamide de diméthylaminopropyl (52% molaire) dans 17 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 6,58 g de Dextran T5, puis on laisse la réaction à température ambiante pendant 24 heures. On précipite ensuite le milieu réactionnel dans 600 ml d'éthanol. Après filtration et sé- chage on récupère 6,5 g d'une poudre blanche. Le taux de greffage du Dextran T5 est estimé à 76% par RMN 1H.The protocol of Example 11 is repeated until the grafting of Dextran. The grafting of the polysaccharide is carried out by solubilizing 1 g of the copolymer of 3- (aminooxyacetamido) propyl methacrylamide (48 mol%) and of dimethylaminopropyl methacrylamide (52 mol%) in 17 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 6.58 g of Dextran T5 are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 6.5 g of a white powder are recovered. The degree of grafting of Dextran T5 is estimated at 76% by 1 H NMR.
Exemple 13: synthèse de polv(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par de l'acide D-qlucuronique On répète le protocole de l'exemple 6 jusqu'au greffage du sucre. Le greffage de l'acide D-glucuronique est effectué en solubilisant 800 mg de poly(méthacrylamide de 3-(aminooxyacetamido)propyl) dans 4 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 475 mg de sel de sodium d'acide D-glucuronique, puis on laisse la réaction à température ambiante pendant 24 heures. On précipite ensuite le milieu réactionnel dans 600ml d'éthanol. Après filtration et séchage on récupère 650 mg d'une poudre blanche. Le greffage de l'acide D-glucuronique est total (confirmé par RMN 1H)Example 13 Synthesis of Polv (3- (Aminooxyacetamido) Propyl Methacrylamide) Grafted with D-Glucuronic Acid The procedure of Example 6 is repeated until the sugar is grafted. The grafting of D-glucuronic acid is carried out by solubilizing 800 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 475 mg of sodium salt of D-glucuronic acid are then added, and the reaction is then left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 650 mg of a white powder are recovered. The grafting of D-glucuronic acid is complete (confirmed by 1 H NMR)
Exemple 14 : synthèse de polv(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par du D-(+) mannoseExample 14 Synthesis of Polv (3- (Aminooxyacetamido) Propyl Methacrylamide) Grafted with D - (+) Mannose
On répète le protocole de l'exemple 6 jusqu'au greffage du sucre. Le greffage du D(+) mannose est effectué en solubilisant 800 mg de poly(méthacrylamide de 3- (aminooxyacetamido)propyl) dans 4ml d'eau. On ajuste le pH de la solution à 4
par ajout d'une solution de NaOH 5N. On rajoute ensuite 366mg de D-(+)- Mannose, puis on laisse la réaction à température ambiante pendant 24h. On précipite ensuite le milieu réactionnel dans 600ml d'éthanol. Après filtration et séchage on récupère 650mg d'une poudre blanche. Le greffage du D(+) mannose est total (confirmé par RMN 1H)The protocol of Example 6 is repeated until the sugar is grafted. The grafting of D (+) mannose is carried out by solubilizing 800 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by adding a solution of 5N NaOH. 366 mg of D - (+) - Mannose are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 650 mg of a white powder is recovered. The grafting of D (+) mannose is complete (confirmed by 1 H NMR)
Exemple 15 : synthèse de polv(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par du sel de sodium de D-(+) qlucose-6-phosphateExample 15 Synthesis of Poly (3- (Aminooxyacetamido) Propyl Methacrylamide) Grafted with D-(+) Glucose-6-Phosphate Sodium Salt
On répète le protocole de l'exemple 6 jusqu'au greffage du sucre. Le greffage du sel de sodium de D-(+) glucose-6-phosphate est effectué en solubilisant 800 mg de poly(méthacrylamide de 3-(aminooxyacetamido)propyl) dans 4ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 573 mg de sel de sodium de D-(+) glucose-6-phosphate, puis on laisse la réaction à température ambiante pendant 24h. On précipite ensuite le milieu réac- tionnel dans 600ml d'éthanol. Après filtration et séchage on récupère 1 ,24 g d'une poudre blanche. Le greffage du D-(+) glucose-6-phosphate est total (confirmé parThe protocol of Example 6 is repeated until the sugar is grafted. The grafting of the sodium salt of D - (+) glucose-6-phosphate is carried out by solubilizing 800 mg of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 573 mg of sodium salt of D - (+) glucose-6-phosphate are then added, and the reaction is then left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 1.24 g of a white powder are recovered. The grafting of D - (+) glucose-6-phosphate is complete (confirmed by
RMN 1H). 1 H NMR).
Exemple 16 : synthèse de polv(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par du D-(+) FucoseExample 16 Synthesis of Polv (3- (Aminooxyacetamido) Propyl Methacrylamide) Grafted with D - (+) Fucose
On répète le protocole de l'exemple 6 jusqu'au greffage du sucre. Le greffage du D(+) Fucose est effectué en solubilisant 1 ,5 g de poly(méthacrylamide de 3- (aminooxyacetamido)propyl) dans 8 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 915mg de D-(+)-Fucose, puis on laisse la réaction à température ambiante pendant 24h. On précipite ensuite le milieu réactionnel dans 600 ml d'éthanol. Après filtration et séchage on récupère 1 ,25g d'une poudre blanche. Le greffage du D(+) Fucose est total (confirmé par RMN 1H).The protocol of Example 6 is repeated until the sugar is grafted. The grafting of D (+) Fucose is carried out by solubilizing 1.5 g of poly (3- (aminooxyacetamido) propyl methacrylamide) in 8 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 915 mg of D - (+) - Fucose are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 1.25 g of a white powder are recovered. The grafting of D (+) Fucose is complete (confirmed by 1 H NMR).
Exemple 17 : synthèse de poly(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par du L-(-) FucoseExample 17 Synthesis of poly (3- (aminooxyacetamido) propyl methacrylamide) grafted with L - (-) Fucose
On répète le protocole de l'exemple 6 jusqu'au greffage du sucre. Le greffage du L(-) Fucose est effectué en solubilisant 1 ,5 g de poly(méthacrylamide de 3- (aminooxyacetamido)propyl) dans 8ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 915 mg de L-(-)-Fucose, puis on laisse la réaction à température ambiante pendant 24h. On précipite ensuite le milieu réactionnel dans 600ml d'éthanol. Après filtration et séchage on récupère 0,96g d'une poudre blanche. Le greffage du L(-) Fucose est total (confirmé par RMN 1H)The protocol of Example 6 is repeated until the sugar is grafted. The grafting of L (-) Fucose is carried out by solubilizing 1.5 g of poly (3- (aminooxyacetamido) propyl methacrylamide) in 8 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 915 mg of L - (-) - Fucose are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 600 ml of ethanol. After filtration and drying, 0.96 g of a white powder is recovered. The grafting of L (-) Fucose is total (confirmed by 1 H NMR)
Exemple 18 : synthèse d'un copolvmère de méthacrylamide de 3- (aminooxyacetamido)propyl (76% mol) avec du méthacrylamide de diméthy- laminopropyl (24%) puis greffage par un Dextran sulfaté de Mn=5000g/mol
(Dextran Sulfate T5)Example 18: Synthesis of a copolymer of 3- (aminooxyacetamido) propyl methacrylamide (76 mol%) with dimethylaminopropyl methacrylamide (24%) and then grafting with a sulfated Dextran of Mn = 5000 g / mol (Dextran Sulfate T5)
On répète le protocole de l'exemple 8 jusqu'au greffage du Dextran. Le greffage du polysaccharide est effectuée en solubilisant 90 mg du copolymère de métha- crylamide de 3-(aminooxyacetamido)propyl (76%) et de méthacrylamide de dimé- thylaminopropyl (24%) dans 2 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 930 mg de Dextran sulfate T5 (Dextran de Mn=5000 g/mol, avec un degré de substitution en groupements sulfates de 2,3), puis on laisse la réaction à température ambiante pendant 24 heures. On précipite ensuite le milieu réactionnel dans 60 ml d'éthanol. Après fil- tration et séchage, on récupère 700 mg d'une poudre blanche. Le taux de greffage du Dextran sulfate T5 est estimé à 33% par RMN 1 H.The protocol of Example 8 is repeated until the grafting of Dextran. The grafting of the polysaccharide is carried out by solubilizing 90 mg of the 3- (aminooxyacetamido) propyl methacrylamide copolymer (76%) and dimethylaminopropyl methacrylamide (24%) in 2 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 930 mg of Dextran sulfate T5 (Dextran of Mn = 5000 g / mol, with a degree of substitution of sulphate groups of 2.3) are then added, and the reaction is then left at room temperature for 24 hours. The reaction medium is then precipitated in 60 ml of ethanol. After filtration and drying, 700 mg of a white powder are recovered. The degree of grafting of Dextran sulfate T5 is estimated at 33% by 1 H NMR.
Exemple 19 : synthèse de polv(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par du L(+) Rhamnose On répète le protocole de l'exemple 6 jusqu'au greffage du sucre. Le greffage du L(+) Rhamnose est effectué en solubilisant 1 ,5 g de poly(méthacrylamide de 3- (aminooxyacetamido)propyl) dans 4 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 970 mg de L(+) Rhamnose, puis on laisse la réaction à température ambiante pendant 24 heures. On précipite ensuite le milieu réactionnel dans 300ml d'éthanol. Après filtration et séchage on récupère 1 ,9 g d'une poudre blanche. Le greffage du L(+) Rhamnose est total (confirmé par RMN 1 H).EXAMPLE 19 Synthesis of Polv (3- (Aminooxyacetamido) Propyl Methacrylamide) Grafted with L (+) Rhamnose The protocol of Example 6 is repeated until the sugar is grafted. The grafting of L (+) Rhamnose is carried out by solubilizing 1.5 g of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 970 mg of L (+) Rhamnose are then added, and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 300 ml of ethanol. After filtration and drying, 1.9 g of a white powder are recovered. The grafting of L (+) Rhamnose is complete (confirmed by 1 H NMR).
Exemple 20 : synthèse de poly(méthacrylamide de 3-(aminooxyacetamido) propyl) greffé par du D(+) GalactoseExample 20 Synthesis of poly (3- (aminooxyacetamido) propyl methacrylamide) grafted with D (+) Galactose
On répète le protocole de l'exemple 6 jusqu'au greffage du sucre. Le greffage du D(+) Galactose est effectué en solubilisant 1 ,5 g de poly(méthacrylamide de 3- (aminooxyacetamido)propyl) dans 4 ml d'eau. On ajuste le pH de la solution à 4 par ajout d'une solution de NaOH 5N. On rajoute ensuite 970 mg de D(+) Galac- tose, puis on laisse la réaction à température ambiante pendant 24 heures. On précipite ensuite le milieu réactionnel dans 300 ml d'éthanol. Après filtration et séchage on récupère 2 g d'une poudre blanche. Le greffage du D(+) Galactose est total (confirmé par RMN 1 H).The protocol of Example 6 is repeated until the sugar is grafted. The grafting of D (+) Galactose is carried out by solubilizing 1.5 g of poly (3- (aminooxyacetamido) propyl methacrylamide) in 4 ml of water. The pH of the solution is adjusted to 4 by addition of a solution of 5N NaOH. 970 mg of D (+) Galactose are then added and the reaction is left at room temperature for 24 hours. The reaction medium is then precipitated in 300 ml of ethanol. After filtration and drying, 2 g of a white powder are recovered. The grafting of D (+) Galactose is complete (confirmed by 1 H NMR).
Exemple 21 : Résultats d'évaluationExample 21: Evaluation Results
Le caractère glissant des polymères selon l'invention est évalué en utilisant un tribomètre de type pion-disque; une solution à 3% en poids de polymère est déposée sur un substrat en mouvement qui est mis en contact avec une bille. La force de frottement entre la bille et le substrat en mouvement est alors mesu- rée. Plus la force de frottement entre les deux surfaces est faible et plus le caractère glissant du polymère est important.The sliding character of the polymers according to the invention is evaluated using a pion-disk type tribometer; a solution of 3% by weight of polymer is deposited on a moving substrate which is brought into contact with a ball. The friction force between the ball and the moving substrate is then measured. The lower the friction force between the two surfaces, the greater the slipperiness of the polymer.
On prend comme référence le frottement en présence d'eau (en l'absence de polymère).
Friction in the presence of water (in the absence of polymer) is used as a reference.
On observe notamment une forte diminution des forces de frottement pour les polymères à greffons maltotriose ou Dextran T1 par rapport au Maltotriose et au Dextran T1 non greffés. Les polymères selon l'invention présentent un bon caractère glissant.In particular, there is a marked decrease in frictional forces for polymers with grafted maltotriose or Dextran T1 grafts compared to ungrafted maltotriose and dextran T1. The polymers according to the invention have a good sliding character.
Exemple 22 : Composition cosmétique lavanteExample 22: Washing Cosmetic Composition
On prépare un shampooing comprenant (% en poids):A shampoo comprising (% by weight) is prepared:
- 1 % MA (matière active) de polymère de l'exemple 61% MA (active ingredient) of polymer of Example 6
- 12,5 % de lauryl éther sulfate.12.5% of lauryl ether sulfate.
On obtient une solution moussante, que l'on applique sur des mèches de cheveuxWe obtain a foaming solution, which is applied to locks of hair
SA 20 de 1g, à raison de 0,3 g de solution par mèche. On laisse poser 3 minutes et on rince à l'eau; on démêle les cheveux.SA 20 of 1g, at a rate of 0.3 g of solution per wick. Leave for 3 minutes and rinse with water; we untangle the hair.
On peut préparer une composition similaire avec les polymères des exemples 1 àA similar composition can be prepared with the polymers of Examples 1 to
5 et 7 à 20.
Exemple 23 : Lotion de coiffage5 and 7 to 20. Example 23: Styling Lotion
On introduit dans un flacon-pompe :We introduce into a pump bottle:
- 1 % MA (matière active) de polymère de l'exemple 61% MA (active ingredient) of polymer of Example 6
- 6% polymère fixant Styleze W 20 - 2% glycérol- 6% fixing polymer Styleze W 20 - 2% glycerol
- qs conservateur - qsp 100% eau- conservative qs - qs 100% water
On obtient une lotion de coiffage.A styling lotion is obtained.
On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 24 : Spray aérosol de coiffageEXAMPLE 24 Aerosol Styling Spray
On prépare une solution hydroalcoolique comprenant, en g de matière active: - polyvinylpyrrolidone 2,5 g - polymère de l'exemple 6 0,65 gA hydroalcoholic solution comprising, in g of active material: polyvinylpyrrolidone 2.5 g - polymer of Example 6 0.65 g
- glycérol 10 g- glycerol 10 g
- éthanol 15 g- ethanol 15 g
- eau 36 g - DME 36 g On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.water 36 g - DME 36 g A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 25 : MascaraExample 25: Mascara
On prépare un mascara ayant la composition suivante : - Cires 24 gA mascara is prepared having the following composition: - waxes 24 g
- Amino-2 méthyl-2 propanediol-1 ,3 0,2 g - Triéthanolamine 2,4 g- Amino-2-methyl-2-propanediol-1, 3 0.2 g - Triethanolamine 2.4 g
- Acide stéarique 5,4 g- Stearic acid 5.4 g
- Diméthicone copolyol (Q2-5220 de DOW-CORNING) 0,2 g - Polyméthacrylate de sodium 0,25 g MA- Dimethicone copolyol (DOW-CORNING Q2-5220) 0.2 g - Sodium polymethacrylate 0.25 g MA
- Polymère de l'exemple 6 (MA) 2 gPolymer of Example 6 (MA) 2 g
- Pigments 6 g- Pigments 6 g
- Conservateurs qs - Eau qsp 100 g On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.Preservatives qs - Water qs 100 g A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 26 : Crème moussante de nettoyageExample 26: Foaming cream for cleaning
On prépare une composition comprenant (% en poids): - polymère de l'exemple 6 (MA) 7 %A composition comprising (% by weight) is prepared: polymer of Example 6 (MA) 7%
- PEG-8 7 %- PEG-8 7%
- Acides gras 29 %- fatty acids 29%
- Acide n-octanoyl-5-salicylique (Mexoryl SAB de CHIMEX) 0,3 %
- Glycéryl stéarate SE 5 %N-octanoyl-5-salicylic acid (Mexoryl SAB from CHIMEX) 0.3% - Glyceryl stearate SE 5%
- cocoyl-glucoside (à 50% en matière active) (soit 1 % de MA) 2 %cocoyl-glucoside (at 50% active ingredient) (ie 1% of MA) 2%
- Tétrasodium EDTA 0,2 %Tetrasodium EDTA 0.2%
- KOH 7 %- KOH 7%
- Conservateur qs- Conservative qs
- Eau qsp 100 %- Water qs 100%
La phase aqueuse constituée des ingrédients hydrosolubles (eau, conservateurs, EDTA, PEG-8, polymère de l'exemple 1 ) est portée à 800C. La phase grasse, constituée des acides gras, du glycéryl stéarate et de l'acide n-octanoyl-5 salicyli- que, est chauffée à 800C et ajoutée sous agitation à la phase aqueuse. Le cocoyl glucoside est ensuite additionné puis le KOH est solubilisé dans une partie de l'eau. L'agitation est maintenue 10 minutes à 80°C, puis l'ensemble est refroidi sous agitation. On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.The aqueous phase consisting of water-soluble ingredients (water, preservatives, EDTA, PEG-8, polymer of example 1) is brought to 80 ° C. The fatty phase, consisting of fatty acids, glyceryl stearate and n -octanoyl-5 salicylic, is heated to 80 0 C and added with stirring to the aqueous phase. The cocoyl glucoside is then added and the KOH is solubilized in part of the water. Stirring is maintained for 10 minutes at 80 ° C., then the mixture is cooled with stirring. A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 27 : Gel nettoyant pour le corpsExample 27: Cleansing gel for the body
On prépare une composition comprenant (% en poids de MA):A composition comprising (% by weight of MA) is prepared:
- polymère de l'exemple 6 (MA) 3% - Acides gras 7%polymer of example 6 (MA) 3% - fatty acids 7%
- Hydroxyde de potassium 2,1 %- Potassium hydroxide 2.1%
- Laureth sulfate de sodium 1 %- Laureth sodium sulfate 1%
- Cocobétaïne 5%- Cocobetaine 5%
- Glycérine 4% - Chlorure de potassium 2,5%- Glycerin 4% - Potassium chloride 2.5%
- Chlorure de sodium 1 %- Sodium chloride 1%
- Cocamide MEA 0,5%- Cocamide MEA 0,5%
- Hydroxypropylméthylcellulose 0,25%- Hydroxypropyl methylcellulose 0,25%
- Parfum, colorant qs - eau qsp 100%- Perfume, dye qs - water qs 100%
On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 28 : Composition de déformation permanente des cheveux On prépare une composition comprenant (% en poids) :EXAMPLE 28 Composition for Permanent Hair Deformation A composition comprising (% by weight) is prepared:
- Acide thioglycolique 9%- Thioglycolic acid 9%
- Ammoniaque à 20% de NH3 9%- Ammonia at 20% of NH 3 9%
- Carbonate d'ammonium 4,5%- Ammonium carbonate 4.5%
- Cocoylamidopropylbétaine /monolaurate de glycérol (25/5) 0,4% MA - EDTA 0,4%- Cocoylamidopropylbetaine / glycerol monolaurate (25/5) 0.4% MA - 0.4% EDTA
- Polymère de l'exemple 6 (MA) 2% - Eau qsp 100%Polymer of Example 6 (MA) 2% - Water qs 100%
Les compositions de déformation permanente ci-dessus sont appliquées 15 minu-
tes sur des cheveux mouillés préalablement enroulés sur des rouleaux de mise en plis, puis rincées abondamment à l'eau. On applique alors pendant 5 minutes une solution d'eau oxygénée à 8 volumes et de pH 3, puis on rince à nouveau, on enlève les rouleaux et on sèche. On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.The permanent deformation compositions above are applied for 15 minutes. on wet hair previously wrapped on styling rollers, then rinsed thoroughly with water. A solution of oxygenated water at 8 volumes and pH 3 is then applied for 5 minutes, then rinsed again, the rollers are removed and dried. A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 29 : Huile de soin pour le corpsExample 29: Body care oil
On prépare une huile hydratante pour peaux sèches à l'aide des constituants sui- vants :A moisturizing oil for dry skin is prepared using the following constituents:
- triglycérides caprylique/caprique 6,5 gcaprylic / capric triglycerides 6.5 g
- propylène glycol dicaprylate/dicaprate 22 g- propylene glycol dicaprylate / dicaprate 22 g
- octanoate de cétéaryle et myristate d'isopropyle 5 gcetearyl octanoate and isopropyl myristate 5 g
- néopentanoate d'isostéaryle 2,5 g - huile d'arachide 5,25 g- isostearyl neopentanoate 2.5 g - peanut oil 5.25 g
- polymère de l'exemple 6 (MA) 0,5 gpolymer of Example 6 (MA) 0.5 g
- acide palmitique 0,2 gpalmitic acid 0.2 g
- antioxydant, conservateurs, parfum qs- antioxidant, preservatives, perfume qs
- cyclométh icône qsp 100 g On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.cyclometh icon qs 100 g A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 30 : crème de soin du visageExample 30: Facial Cream
On prépare une crème de soin hydratante pour peaux normales et mixtes à l'aide des constituants suivants :A moisturizing care cream for normal and combination skin is prepared using the following constituents:
- pétrolatum 4 g- petrolatum 4 g
- polyisobutène hydrogéné 6,5 g- hydrogenated polyisobutene 6.5 g
- cétyl alcool 2,7 g- cetyl alcohol 2.7 g
- tristéarate de sorbitan 0,5 g - stéarate de PEG 40 3,2 g- sorbitan tristearate 0.5 g - PEG 40 stearate 3.2 g
- myristate de myristyle 3 g- myristyl myristate 3 g
- stéarate de glycéryle 3 g- glyceryl stearate 3 g
- beurre de karité 2 g- shea butter 2 g
- cyclométh icône 5 g - acide stéarique 0,2 g- cyclometh icon 5 g - stearic acid 0.2 g
- hydroxyde de sodium 0,5 g - citrate de sodium 0,1 g- sodium hydroxide 0.5 g - sodium citrate 0.1 g
- polymère de l'exemple 6 (MA) 1 gpolymer of Example 6 (MA) 1 g
- antioxydant, conservateurs, parfum qs - eau qsp 100 g- antioxidant, preservatives, perfume qs - water qs 100 g
On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.
Exemple 31 : Composition cosmétique hydratanteA similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20. Example 31: Moisturizing cosmetic composition
On prépare une composition hydratante à l'aide des constituants suivaniA moisturizing composition is prepared using the following constituents
Phase A1 :Phase A1:
- Distéarate de sucrose 2 %- Sucrose distearate 2%
- Stéarate de sorbitane oxyéthyléné à 4 OE (TWEEN 61 ) 1 ,4 %- Sorbitan stearate oxyethylenated with 4 EO (TWEEN 61) 1, 4%
- Acide stéarique 0,75 %- Stearic acid 0.75%
- heptanoate de stéaryle (PCL solide®) 5,5 %- stearyl heptanoate (PCL solid®) 5.5%
- Vaseline 2,1 %- Vaseline 2.1%
- Huiles (avocat et jojoba) 8,6 %- Oils (avocado and jojoba) 8.6%
- Huile de silicone volatile 3,7 %- 3.7% volatile silicone oil
Phase A2 :Phase A2:
- Gomme de silicone (Q2-1403 Fluid) 4 %- Silicone Gum (Q2-1403 Fluid) 4%
- Parfum, conservateur qs- Perfume, preservative qs
Phase B :Phase B:
- Méthyl paraben 0,3 %- Methyl paraben 0.3%
- Triéthanolamine 0,4 %- 0.4% Triethanolamine
- polymère de l'exemple 6 (MA) 1 %polymer of Example 6 (MA) 1%
- Eau qsp 100 %- Water qs 100%
Phase C :Phase C:
- Polymères carboxyvinyliques (CARBOPOL 980) 0,3 %- Carboxyvinyl polymers (CARBOPOL 980) 0.3%
- Eau 9,7 %- Water 9.7%
Les phases A1 et B sont portées à 65°C avant d'être mélangées sous agitation. On homogénéise la dispersion (entre 20.106 Pa et 60.106 Pa), pour obtenir une dispersion dont la taille des globules d'huile est inférieure à 500 nm. On disperse à température ambiante la phase A2 dans la première dispersion, sous vive agitation. La phase C, préalablement préparée, est ensuite ajoutée. On obtient une émulsion hydratante adaptée pour les peaux sèches. On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.Phases A1 and B are brought to 65 ° C before being mixed with stirring. The dispersion is homogenized (between 20 × 10 6 Pa and 60 × 10 6 Pa) to obtain a dispersion whose oil globule size is less than 500 nm. Phase A2 is dispersed at room temperature in the first dispersion, with vigorous stirring. Phase C, previously prepared, is then added. A moisturizing emulsion adapted for dry skin is obtained. A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Exemple 32 : Après-shampooingExample 32: Conditioner
On prépare une composition comprenant (% en poids):A composition comprising (% by weight) is prepared:
- chlorure de béhényl triméthylammonium à 80% dans un mélange eau/isopropanol (15/85) 1 % - émulsion cationique DC 929 (Dow Corning) 4%- Behenyl trimethylammonium chloride 80% in a mixture of water / isopropanol (15/85) 1% - cationic emulsion DC 929 (Dow Corning) 4%
- p-hydroxybenzoate de méthyle 0,2%methyl p-hydroxybenzoate 0.2%
- polymère de l'exemple 6 (MA) 3% - eau qsp 100%polymer of Example 6 (MA) 3% - water qs 100%
On applique l'après-shampooing sur cheveux humides. On laisse poser 2 minutes et on rince.The conditioner is applied to damp hair. Let it sit for 2 minutes and rinse.
On peut préparer une composition similaire avec les polymères des exemples 1 à 5 et 7 à 20.
A similar composition can be prepared with the polymers of Examples 1 to 5 and 7 to 20.
Claims
1. Polymère de structure : (POL)-(L-PS)x où1. Polymer structure: (POL) - (L-PS) x where
- POL représente un squelette polymérique ayant un poids moléculaire en nombre (Mn) compris entre 1000 et 5,000,000 g/mol.,POL represents a polymeric backbone having a number-average molecular weight (Mn) of between 1000 and 5,000,000 g / mol.
- PS représente un (poly)saccharide greffé sur POL via un linker L,PS represents a (poly) saccharide grafted onto POL via a linker L,
- x représente un entier non nul caractéristique du nombre de greffons PS etx represents a non-zero integer characteristic of the number of PS grafts and
- L représente un linker choisi parmi ceux de formule :L represents a linker chosen from those of formula:
dans lesquelles : - Ra à Re représentent, indépendamment les uns des autres, -OH, -CH3, NHCOCH3, NH2, OCH2COOH, COOH, OSO3H, OPO 3H, ou -O-relié au greffon polysaccharide; l'un au moins des Ra à Re représentant -O-relié au greffon poly- saccharide;in which : Ra to Re represent, independently of each other, -OH, -CH 3 , NHCOCH 3 , NH 2 , OCH 2 COOH, COOH, OSO 3 H, OPO 3 H, or -O-linked to the polysaccharide graft; at least one of Ra to Re representing -O-linked to the polysaccharide graft;
- Rf représente- Rf represents
(i) une liaison covalente avec le squelette polymérique POL ou (ii) un groupement lié audit squelette polymérique POL choisi parmi les groupements divalents alkyle linéaire, ramifié ou cyclique en C1-C30, de préférence Ii- néaire ou ramifié en C1 -C10; alcényle linéaire, ramifié ou cyclique en C2-C30, de préférence linéaire ou ramifié en C1 -C10; et alcynyle linéaire, ramifié ou cyclique en C2-C30; de préférence linéaire ou ramifié en C1-C10; ledit groupement pouvant comprendre un ou plusieurs hétéroatomes choisis parmi O, N, S, Cl, Br, I, F, P et/ou un ou plusieurs substituants choisis parmi CO2H, SO3H, PO3H, NH2, OH, SH.(i) a covalent bond with the polymeric backbone POL or (ii) a group bonded to said polymeric backbone POL selected from divalent linear, branched or cyclic C1-C30, preferably linear or branched C1-C10 alkyl groups; linear, branched or cyclic C 2 -C 30, preferably linear or branched C 1 -C 10 alkenyl; and linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; said group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH , SH.
2. Polymère selon la revendication 1 , dans lequel le squelette polymérique est issu de la polymérisation d'un ou de plusieurs monomères éthyléniques choisis parmi ceux de formule : R1R2C=CR3R4 dans laquelle R1, R2, R3 et R4 représentent indépendamment l'un de l'autre,2. Polymer according to claim 1, in which the polymer backbone is derived from the polymerization of one or more ethylenic monomers chosen from those of formula: R 1 R 2 C = CR 3 R 4 in which R 1 , R 2 , R 3 and R 4 represent independently of one another,
- un atome d'hydrogène ou d'halogène,a hydrogen or halogen atom,
- un groupe alkyle en C1 -20, linéaires, ramifiés et/ou cycliques, saturés ou insaturés, pouvant être substitués par 1 ou plusieurs atomes d'halogène et/ou un ou plu- sieurs groupes OH,a linear, branched and / or cyclic, saturated or unsaturated C 1 -C 20 alkyl group, which may be substituted by one or more halogen atoms and / or one or more OH groups,
- un groupe alcényle ou alcynyle, linéaire ou ramifié, en C2-C10, pouvant être substitué par un ou plusieurs atomes d'halogène,a C2-C10 linear or branched alkenyl or alkynyl group, which may be substituted with one or more halogen atoms,
- un groupe cycloalkyle en C3-8 pouvant être substitué par un ou plusieurs atomes d'halogène, - un groupe cyano,a C 3 -C 8 cycloalkyl group which may be substituted with one or more halogen atoms, a cyano group,
- un groupe aryle,an aryl group,
- un groupe hétérocyclique à 4 à 12 chaînons comprenant un ou plusieurs atomes de N, O, S et P,a 4- to 12-membered heterocyclic group comprising one or more N, O, S and P atoms,
- un groupe -C(=Y)R5, -CH2C(=Y)R5, -C(=Y)NR6R7, -YC(=Y)R5, -NR6C(=Y)R5, - SOR5, -SO2R5, -OSO2R5, -NR8SO2R5, -P(R5)2, -P(=Y)(R5)2, -YP(R5)2, -YP(=Y)(R5)2 ou -N(R8)2 éventuellement quaternisé par un R8 supplémentaire, dans lequel : Y représente un groupe NR8, S ou O,a group -C (= Y) R 5 , -CH 2 C (= Y) R 5 , -C (= Y) NR 6 R 7 , -YC (= Y) R 5 , -NR 6 C (= Y) ) R 5 , -OR 5 , -SO 2 R 5 , -OSO 2 R 5 , -NR 8 SO 2 R 5 , -P (R 5 ) 2 , -P (= Y) (R 5 ) 2 , -YP (R 5 ) 2 , -YP (= Y) (R 5 ) 2 or -N (R 8 ) 2 optionally quaternized with an additional R 8 , wherein: Y is NR 8 , S or O,
R5 représente un groupe alkyle, alcoxy ou alkylthio, linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-2O éventuellement hydroxylé, mono- ou poly(alkylèneoxy) éventuellement éthérifié, hydroxylé, -OM (avec M = métal alcalin), aryloxy ou hété- rocyclyloxy,R 5 represents a linear, branched or cyclic, saturated or unsaturated, optionally hydroxylated C 1 -2 O, mono- or poly (alkyleneoxy) alkyl group, optionally etherified, hydroxylated, -OM (with M = alkali metal); aryloxy or heterocyclyloxy,
R6 et R7 représentent indépendamment l'un de l'autre, un atome d'hydrogène ou un groupe alkyle, linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-20 ou for- ment avec l'atome d'azote auquel ils sont liés un cycle à 3 à 8 chaînons, R8 représente un atome d'hydrogène, un groupe alkyle linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-2o, ou un groupe aryle,R 6 and R 7 independently of one another, a hydrogen atom or an alkyl group, linear, branched or cyclic, saturated or unsaturated Ci -20 or for- 3 to 8-membered ring, R 8 represents a hydrogen atom, a linear, branched or cyclic, saturated or unsaturated C 1 -C 20 alkyl group or a aryl,
- un groupe -C(=O)-X-R9-Z ou bien -R9-Z dans lequel R9 représente un radical di- valent (hydro)carboné en Ci-2O saturé ou insaturé, linéaire, ramifié ou cyclique, éventuellement halogène et pouvant comporter un ou plusieurs hétéroatomes, X représente un groupe NR10 ou un atome d'oxygène, et Z représente un groupe - N(R10)2, -S-R10 ou P(R10)2 avec R10 représentant, indépendamment l'un de l'autre, un atome d'hydrogène ou un groupe hydrocarboné en Ci-2O saturé ou insaturé, linéaire, ramifié ou cyclique, éventuellement halogène et pouvant comporter un ou plusieurs hétéroatomes, l'atome d'azote présent dans X et/ou Z (quand il est présent) pouvant être protoné ou quaternisé par des radicaux alkyle en Ci-2O,- -C (= O) -XR 9 -Z or -Z -R 9 wherein R 9 represents a radical valent di- (hydro) carbonaceous Cl O -2 saturated or unsaturated, linear, branched or cyclic, optionally halogenated and possibly containing one or more heteroatoms, X represents a NR 10 group or an oxygen atom, and Z represents a group - N (R 10 ) 2 , -SR 10 or P (R 10 ) 2 with R 10 representing , independently of one another, a hydrogen atom or a saturated or unsaturated, linear, branched or cyclic, optionally halogenated C 2 -C hydrocarbon-based group which may comprise one or more heteroatoms, the nitrogen atom or present in X and / or Z (when present) capable of being protonated or quaternized by C 1 -C 2 alkyl radicals,
- un groupe -R9-NR10-Acide ou -C(=O)-X-R9-NR10-Acide dans lequel X, R9 et R10 sont tels que définis ci-dessus, et Acide représente une fonction acide carboxyli- que, sulfonique ou phosphonique;a group -R 9 -NR 10 -Acide or -C (= O) -XR 9 -NR 10 -Acide in which X, R 9 and R 10 are as defined above, and Acid represents a carboxylic acid function - that, sulfonic or phosphonic;
- un radical comprenant au moins un atome de silicium et notamment un radical - R-siloxane, -CONHR-siloxane, -COOR-siloxane, ou OCO-R-siloxane, dans lequel R est un radical alkyle, alkylthio ou alcoxy, linéaire, ramifié ou cyclique, saturé ou insaturé, en Ci-20, aryloxy ou hétérocyclyloxy.a radical comprising at least one silicon atom and in particular a radical-R-siloxane, -CONHR-siloxane, -COOR-siloxane, or OCO-R-siloxane, in which R is a linear alkyl, alkylthio or alkoxy radical, branched or cyclic, saturated or unsaturated, C 1-20 , aryloxy or heterocyclyloxy.
3. Polymère selon la revendication 2, dans lequel le squelette polymérique est issu de la polymérisation d'un ou de plusieurs monomères éthyléniques choisis parmi, seul ou en mélange:3. Polymer according to claim 2, in which the polymer backbone is derived from the polymerization of one or more ethylenic monomers chosen from, alone or as a mixture:
- l'acide acrylique, l'acide méthacrylique, - les (méth)acrylates d'alkyle en Ci-20 à chaîne linéaire, ramifiée ou cyclique, tels que le méthacrylate de méthyle, le méthacrylate d'éthyle, le méthacrylate de pro- pyle, le méthacrylate de butyle, le méthacrylate d'isobutyle, le méthacrylate de tert- butyle et le méthacrylate de cyclohexyle; l'acrylate de méthyle, l'acrylate d'éthyle, l'acrylate de propyle, l'acrylate de butyle, l'acrylate de 2-éthylhexyle, l'acrylate d'isobutyle et l'acrylate de tert-butyle,acrylic acid, methacrylic acid, straight-chain, branched or cyclic C 1 -C 20 alkyl (meth) acrylates, such as methyl methacrylate, ethyl methacrylate, methacrylate; pyl, butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate and cyclohexyl methacrylate; methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, isobutyl acrylate and tert-butyl acrylate,
- les (méth)acrylates d'aryle en C6-20,C 6-20 aryl (meth) acrylates,
- les (méth)acrylates d'hydroxyalkyle en C1 -4, tel que le (méth)acrylate de 2- hydroxyéthyle, le (méth)acrylate de 2-hydroxypropyle,C1-4 hydroxyalkyl (meth) acrylates, such as 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate,
- les esters de vinyle et notamment l'acétate de vinyle, le propionate de vinyle, le benzoate de vinyle et le tert-butylbenzoate de vinyle,vinyl esters and especially vinyl acetate, vinyl propionate, vinyl benzoate and vinyl tert-butylbenzoate,
- les éthers de vinyle tels que le vinylisobutyléther,vinyl ethers, such as vinylisobutyl ether,
- les monomères hétérocycliques tels que la N-vinylpyrrolidone, le vinylcaprolac- tame, les vinyl-N-(alkyle en C1 -6)-pyrroles, les vinyloxazoles, les vinylthiazoles, les vinylpyrimidines, les vinylimidazoles, - le (méth)acrylamide,heterocyclic monomers such as N-vinylpyrrolidone, vinylcaprolactam, vinyl-N- (C 1-6 alkyl) -pyrroles, vinyloxazoles, vinylthiazoles, vinylpyrimidines, vinylimidazoles, (meth) acrylamide,
- les (méth)acrylamides aliphatiques, cycloaliphatiques ou aromatiques, tels que le tert-butylacrylamide, l'undécylacrylamide ou le N-octylacrylamide; et les di(alkyle en C1 -4) (méth)acrylamides, - le styrène et ses dérivés,aliphatic, cycloaliphatic or aromatic (meth) acrylamides, such as tert-butylacrylamide, undecylacrylamide or N-octylacrylamide; and di (C 1-4 alkyl) (meth) acrylamides, styrene and its derivatives,
- les monomères (méth)acryliques, (méth)acrylamides ou vinyliques à groupe fluoré ou perfluoré, notamment les esters (méth)acryliques à chaîne perfluoroalkyle tels que le (méth)acrylate de perfluorooctyléthyle, - les monomères (méth)acryliques, (méth)acrylamides ou vinyliques siliconés tels que le (méth)acryloxypropyltris(triméthylsiloxy)silane,- (meth) acrylic monomers, (meth) acrylamides or vinyl fluorinated or perfluorinated group, especially perfluoroalkyl chain (meth) acrylic esters such as perfluorooctylethyl (meth) acrylate, - (meth) acrylic monomers, (meth) ) silicone acrylamides or vinyls, such as (meth) acryloxypropyltris (trimethylsiloxy) silane,
- les monomères (méth)acryliques ou vinyliques comportant une fonction aminé éventuellement neutralisée ou quaternisée, tels que le (méth)acrylate de diméthy- laminoéthyle, le diméthylaminoéthylméthacrylamide, la vinylamine, la vinylpyridine, le chlorure de diallyldiméthylammonium, le diméthylaminopropyl méthacrylamide, le 3-aminopropyl méthacrylamide, le 2-aminoéthyl méthacrylate;the (meth) acrylic or vinyl monomers comprising an optionally neutralized or quaternized amine functional group, such as dimethylaminoethyl (meth) acrylate, dimethylaminoethylmethacrylamide, vinylamine, vinylpyridine, diallyldimethylammonium chloride, dimethylaminopropyl methacrylamide, aminopropyl methacrylamide, 2-aminoethyl methacrylate;
- les carboxybétaïnes ou sulfobétaïnes éthyléniques obtenues par exemple par quaternisation de monomères à insaturation éthylénique comportant une fonction aminé par des sels de sodium d'acide carboxylique à halogène mobile (p. ex. chlo- roacétate de sodium) ou par des sulfones cycliques (p. ex. propanesultone).the ethylenic carboxybetaines or sulfobetaines obtained, for example, by quaternization of ethylenically unsaturated monomers containing an amine function by sodium salts of a mobile halogen carboxylic acid (for example sodium chloroacetate) or by cyclic sulphones (p. eg propanesultone).
4. Polymère selon la revendication 1 , dans lequel le squelette polymérique représente un polyester, un polycarbonate, un polyamide, un polyimide, un polyuré- thane, une polyurée, un polysaccharide, un polysiloxane, un polyphénol, un poly- éther, un polypeptide.The polymer of claim 1, wherein the polymeric backbone is a polyester, polycarbonate, polyamide, polyimide, polyurethane, polyurea, polysaccharide, polysiloxane, polyphenol, polyether, polypeptide. .
5. Polymère selon l'une des revendications précédentes, dans lequel le squelette polymérique a un poids moléculaire en nombre (Mn) compris entre 2000 et 1 ,000,000, préférentiellement entre 2000 et 100,000 g/mol.5. Polymer according to one of the preceding claims, wherein the polymeric backbone has a number-average molecular weight (Mn) of between 2,000 and 1,000,000, preferably between 2,000 and 100,000 g / mol.
6. Polymère selon l'une des revendications précédentes, dans lequel le taux de greffage est compris entre 1 et 100%, notamment entre 20 et 100%, et encore plus préférentiellement entre 40 et 100%; ledit taux de greffage étant le rapport (x 100) entre le nombre d'unités répétitives du squelette polymérique POL greffées par des greffons polysaccharides (x), et le nombre total d'unités répétitives du squelette polymérique (ou degré de polymérisation).6. Polymer according to one of the preceding claims, wherein the degree of grafting is between 1 and 100%, especially between 20 and 100%, and even more preferably between 40 and 100%; said grafting ratio being the ratio (x 100) between the number of repeating units of the POL polymer backbone grafted by polysaccharide grafts (x), and the total number of repeating units of the polymer backbone (or degree of polymerization).
7. Polymère selon l'une des revendications précédentes, dans lequel le greffon (poly)saccharide est choisi parmi, seuls ou en mélange : - des fructanes dont l'inuline; - des glucanes;7. Polymer according to one of the preceding claims, wherein the (poly) saccharide graft is selected from, alone or in mixture: - fructans including inulin; glucans;
- des amidons modifiés ou non, tels que ceux issus, par exemple, de céréales comme le blé, le maïs ou le riz, de légumes comme le pois blond, de tubercules comme les pommes de terre ou le manioc; - l'amylose, l'amylopectine, le glycogène;modified or unmodified starches, such as those derived, for example, from cereals such as wheat, corn or rice, from vegetables such as sweet pea, from tubers such as potatoes or cassava; amylose, amylopectin, glycogen;
- les dextranes et leurs dérivés, tels que le dextrane sulfate, le dextrane diethyla- minoethyl et le carboxymethyl dextrane;dextrans and their derivatives, such as dextran sulfate, dextran diethylaminoethyl and carboxymethyl dextran;
- les celluloses et leurs dérivés tels que les méthylcelluloses, les hydroxyalkylcellu- loses, les éthylhydroxyéthylcelluloses, les carboxyméthylcelluloses;celluloses and their derivatives such as methylcelluloses, hydroxyalkylcelluloses and loses, ethylhydroxyethylcelluloses, carboxymethylcelluloses;
- les mannanes, les xylanes, les lignines, les arabanes, les galactanes, les galac- turonanes, la chitine, les chitosanes, les glucoronoxylanes, les arabinoxylanes, les xyloglucanes, les glucomannanes, les acides pectiques et les pectines, l'acide al- ginique et les alginates, les arabinogalactanes, les carraghénines, les agars,mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucoronoxylans, arabinoxylans, xyloglucans, glucomannans, pectic acids and pectins; - ginic and alginates, arabinogalactans, carrageenans, agars,
- les glycosaminoglucanes tels que l'acide hyaluronique, les chondroitines et les chondroitines sulfates;glycosaminoglucans such as hyaluronic acid, chondroitins and chondroitin sulphates;
- les gommes arabiques, les gommes Tragacanthe, les gommes Ghatti, les gommes Karaya, les gommes de caroube, les gommes de gellane, les gommes de curdlan, les gommes de xanthane;- Arabic gums, Tragacanth gums, Ghatti gums, Karaya gums, locust bean gums, gellan gums, curdlan gums, xanthan gums;
- les galactomannanes telles que les gommes de guar et leurs dérivés, notamment l'hydroxypropylguar).galactomannans such as guar gums and their derivatives, in particular hydroxypropylguar).
8. Polymère selon l'une des revendications précédentes, dans lequel les greffons (poly)saccharides sont définis par l'enchaînement d'unités (I) et/ou (II) de formule:8. Polymer according to one of the preceding claims, wherein the (poly) saccharide grafts are defined by the sequence of units (I) and / or (II) of formula:
(D (") dans laquelle Ra à Re représentent, indépendamment les uns des autres, -OH, -O- (unité répétitive du polysaccharide) -CH3 (D ( " ) in which Ra to Re represent, independently of each other, -OH, -O- (repeating unit of the polysaccharide) -CH 3
-NHCOCH3 -NH2-NHCOCH 3 -NH2
-OCH2COOH -COOH -OSO3H -OPO 3H étant entendu qu'au moins un des Ra à Re représente -O- (unité répétitive du polysaccharide) ou OH, et qu'un des Ra à Re est une liaison covalente avec le Un- ker L; de préférence un seul des Ra à Re sur l'ensemble du (poly)saccharide est une liaison covalente.-OCH 2 COOH -COOH -OSO 3 H -OPO 3 H with the proviso that at least one of Ra to Re is -O- (repeating unit of polysaccharide) or OH, and that one of Ra to Re is a covalent bond with Unker L; preferably only one of Ra to Re across the (poly) saccharide is a covalent bond.
9. Polymère selon l'une des revendications précédentes, dans lequel les greffons polysaccharidiques sont choisis parmi les dextranes et leurs dérivés (dextrane sulfate, dextrane diethylaminoethyl, carboxymethyl dextrane), les glycosamino- glucanes et leurs dérivés (l'acide hyaluronique, les chondroitines et les chondroitines sulfates ), les celluloses et leurs dérivés (méthylcelluloses, hydroxyalkylcellu- loses, éthylhydroxyéthylcelluloses, carboxyméthylcelluloses), l'amylose et ses dérivés, les chitines et leurs dérivés, les carraghénines et leurs dérivés, les oligomal- toses et leurs dérivés; et leurs mélanges.9. Polymer according to one of the preceding claims, wherein the polysaccharide grafts are selected from dextrans and their derivatives (dextran sulfate, dextran diethylaminoethyl, carboxymethyl dextran), glycosaminoglycans and derivatives thereof (hyaluronic acid, chondroitins and chondroitin sulphates), celluloses and their derivatives (methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses, carboxymethylcelluloses), amylose and its derivatives, chitins and their derivatives, carrageenans and derivatives thereof, oligomers and toses and their derivatives; and their mixtures.
10. Polymère selon l'une des revendications précédentes, dans lequel chaque greffon (poly)saccharide PS possède une masse moléculaire en nombre (Mn) comprise entre 100 et 100,000 g/mol, notamment entre 150 et 50,000 g/mol et préférentiellement entre 200 et 20,000 g/mol.10. Polymer according to one of the preceding claims, wherein each (poly) saccharide graft PS has a number-average molecular weight (Mn) of between 100 and 100,000 g / mol, in particular between 150 and 50,000 g / mol and preferably between 200 and and 20,000 g / mol.
11. Polymère de structure : (POL)-(L-PS)x où11. Polymer structure: (POL) - (L-PS) x where
- POL représente un squelette polymérique, - L représente un linker,POL represents a polymeric backbone, L represents a linker,
- PS représente un (poly)saccharide greffé sur POL via le linker L, etPS represents a (poly) saccharide grafted onto POL via the linker L, and
- x représente un entier non nul caractéristique du nombre de greffons PS; susceptible d'être obtenu par réaction de Ligation Chimio-Sélective entre des fonctions aldéhydes ou cétones portées par le (poly)saccharide ou le squelette poly- mérique et l'un au moins des composés suivants : H2N-LI -R, HR1 N-L1-R, H2N-O- L1 -R, H2N-O-(O)C-LI-R, H2N-O-(O)C-NH-LI -R, H2N-O-(S)C-NH-LI -R, HR1 N-O- L1 -R, HR1 N-O-(O)C-LI -R, HR1 N-O-(O)C-NH-LI -R, HR1 N-O-(S)C-NH-LI -R, H2N- NH-L1 -R , H2N-NH-(O)C-LI -R, H2N-NH-(O)CO-LI -R, H2N-NH-(O)C-NH-LI -R, H2N-NH-(S)C-LI -R, H2N-NH-(S)CO-LI-R, H2N-NH-(S)C-NH-LI -R, H2N-CHRI - CH(LI -R)-SH, H2N-CH(LI -RI )-CHR-SH, H2N-NH-SO2-LI-R, X-CH2-X'-L1 -R, dans lesquels :x represents a non-zero integer characteristic of the number of PS grafts; obtainable by Chemo-Selective Ligation reaction between aldehyde functions or ketones carried by the (poly) saccharide or the polymer backbone and at least one of the following compounds: H 2 N-LI-R, HR 1 N-L1-R, H 2 NO- L1 -R, H 2 NO- (O) C-TA-R, H 2 NO- (O) C-NH-LI -R, H 2 NO- (S) C -NH-LI-R, HR1 NO-L1-R, HR1 NO- (O) C-LI-R, HR1 NO- (O) C-NH-LI-R, HR1 NO- (S) C-NH- LI-R, H 2 N-NH-L 1 -R, H 2 N-NH- (O) C-LI-R, H 2 N-NH- (O) CO-LI-R, H 2 N-NH- (O) C-NH-LI-R, H 2 N-NH- (S) C-LI-R, H 2 N-NH- (S) CO-LI-R, H 2 N-NH- (S) C-NH-LI-R, H 2 N-CHRI-CH (LI-R) -SH, H 2 N-CH (LI-IR) -CHR-SH, H 2 N-NH-SO 2 -LI-R , X-CH 2 -X'-L 1 -R, in which:
- X et X' sont des groupements électro-attracteurs (esters, cétones, acides, nitro, halogènes notamment);X and X 'are electron-withdrawing groups (esters, ketones, acids, nitro, halogens in particular);
- L1 est une liaison covalente ou un groupement choisi parmi (i) alkyle linéaire, ramifié ou cyclique en C1 -C30, de préférence linéaire ou ramifié en C1 -C10; (ii) alcényle linéaire, ramifié ou cyclique en C2-C30, de préférence linéaire ou ramifié en C1 -C10, (iii) alcynyle linéaire, ramifié ou cyclique en C2-C30; de préférence linéaire ou ramifié en C1 -C10; ce groupement pouvant comprendre un ou plusieurs hétéroatomes choisis parmi O, N, S, Cl, Br, I, F, P et/ou un ou plusieurs substituants choisis parmi CO2H, SO3H, PO3H, NH2, OH, SH;- L1 is a covalent bond or a group selected from (i) linear, branched or cyclic C1 to C30 alkyl, preferably linear or branched C1 to C10; (ii) linear, branched or cyclic C2-C30 alkenyl, preferably linear or branched C1-C10, (iii) linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; this group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH , SH;
- R ou R1 représentent, indépendamment l'un de l'autre, le squelette polymérique POL ou un greffon (poly)saccharide PS ou un atome d'hydrogène ou un groupement choisi parmi (i) alkyle linéaire, ramifié ou cyclique en C1 -C30, de préférence linéaire ou ramifié en C1-C10; (ii) alcényle linéaire, ramifié ou cyclique en C2-C30, de préférence linéaire ou ramifié en C1 -C10, (iii) alcynyle linéaire, ramifié ou cyclique en C2-C30; de préférence linéaire ou ramifié en C1-C10; ce groupement pouvant comprendre un ou plusieurs hétéroatomes choisis parmi O, N, S, Cl, Br, I, F, P et/ou un ou plusieurs substituants choisis parmi CO2H, SO3H, PO3H, NH2, OH, SH; étant entendu que l'un et un seul des groupements R ou R1 représente un (poly)saccharide PS ou un squelette polymérique POL.- R or R1 represent, independently of one another, the polymeric backbone POL or a (poly) saccharide graft PS or a hydrogen atom or a group chosen from (i) linear, branched or cyclic C1-C alkyl C30, preferably linear or branched C1-C10; (ii) linear, branched or cyclic C2-C30 alkenyl, preferably linear or branched C1-C10, (iii) linear, branched or cyclic C2-C30 alkynyl; preferably linear or branched C1-C10; this group may comprise one or more heteroatoms chosen from O, N, S, Cl, Br, I, F, P and / or one or more substituents chosen from CO 2 H, SO 3 H, PO 3 H, NH 2 , OH , SH; it being understood that only one of the groups R or R1 represents a (poly) saccharide PS or a polymeric backbone POL.
12. Composition cosmétique, comprenant, dans un milieu cosmétiquement acceptable, au moins un polymère tel que défini à l'une des revendications 1 à 11. 12. Cosmetic composition comprising, in a cosmetically acceptable medium, at least one polymer as defined in one of claims 1 to 11.
13. Composition selon la revendication 12, dans laquelle le polymère est présent en une quantité comprise entre 0,01 et 30% en poids, de préférence entre 0,1 et 20% en poids, notamment entre 0,5 et 10% en poids, voire entre 1 et 5% en poids, par rapport au poids de la composition cosmétique.13. The composition of claim 12, wherein the polymer is present in an amount of between 0.01 and 30% by weight, preferably between 0.1 and 20% by weight, especially between 0.5 and 10% by weight. or between 1 and 5% by weight, relative to the weight of the cosmetic composition.
14. Composition selon l'une des revendications 12 à 13, dans laquelle le milieu cosmétiquement acceptable comprend au moins un composé choisi parmi l'eau, les alcools, les polyols, les esters, les huiles carbonées, les huiles de silicone, les huiles de silicone fluorées, les gélifiants et/ou épaississants; les polymères, associatifs ou non; les tensioactifs anioniques, non ioniques, cationiques et/ou ampho- tères; les agents propénétrants, les émulsionnants, les parfums, les conservateurs, les charges, les filtres solaires; les matières colorantes, les protéines, les vitamines, les provitamines; les polymères, fixants ou non fixants, anioniques, non ioniques, cationiques ou amphotères; les agents hydratants, les émollients, les agents adoucissants; les huiles minérales, végétales ou synthétiques; les actifs hydrophiles ou lipophiles comme les céramides et les pseudocéramides; les agents anti-mousse, les agents antiperspirants, les agents anti-radicaux libres, les agents bactéricides et les agents antipelliculaires.14. Composition according to one of Claims 12 to 13, in which the cosmetically acceptable medium comprises at least one compound chosen from water, alcohols, polyols, esters, carbonaceous oils, silicone oils and oils. fluorinated silicone, gelling agents and / or thickeners; polymers, associative or not; anionic, nonionic, cationic and / or ampho- tological surfactants; propenetrating agents, emulsifiers, perfumes, preservatives, fillers, sunscreens; dyestuffs, proteins, vitamins, provitamins; polymers, fixing or non-fixing, anionic, nonionic, cationic or amphoteric; moisturizing agents, emollients, softening agents; mineral, vegetable or synthetic oils; hydrophilic or lipophilic active agents such as ceramides and pseudoceramides; anti-foam agents, antiperspirants, anti-free radical agents, bactericidal agents and anti-dandruff agents.
15. Composition selon l'une des revendications 12 à 14, se présentant sous la forme d'un produit de soin, de nettoyage et/ou de maquillage de la peau du corps ou du visage, des lèvres, des cils, des ongles et des cheveux, d'un produit solaire ou autobronzant, d'un produit d'hygiène corporelle, d'un produit capillaire, notam- ment de soin, de nettoyage, de coiffage ou de coloration des cheveux.15. Composition according to one of claims 12 to 14, being in the form of a care product, cleaning and / or makeup of the skin of the body or face, lips, eyelashes, nails and hair, a sunscreen or self-tanning product, a personal care product, a hair product, in particular care, cleaning, styling or hair dyeing.
16. Procédé de traitement cosmétique des matières kératiniques comprenant l'application sur lesdites matières d'une composition cosmétique telle que définie à l'une des revendications 12 à 15. 16. A process for the cosmetic treatment of keratin materials comprising the application on said materials of a cosmetic composition as defined in one of claims 12 to 15.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0855072A FR2934268B1 (en) | 2008-07-24 | 2008-07-24 | POLYSACCHARIDE GRAFT POLYMERS, COSMETIC COMPOSITIONS AND PROCESSING PROCESS. |
FR0855072 | 2008-07-24 | ||
US9503108P | 2008-09-08 | 2008-09-08 | |
US61/095,031 | 2008-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010009938A1 true WO2010009938A1 (en) | 2010-01-28 |
Family
ID=40278701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/057039 WO2010009938A1 (en) | 2008-07-24 | 2009-06-08 | Polymers with polysaccharide grafts, cosmetic compositions and treatment method |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2934268B1 (en) |
WO (1) | WO2010009938A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2972111A1 (en) * | 2011-03-01 | 2012-09-07 | Oreal | Composition, useful e.g. for caring, cleansing and/or making up the skin of the body or face, lips, eyelashes, nails and the hair, and as sunscreen or self-tanning agent, comprises a polymer sequence in a medium |
US20180312634A1 (en) * | 2017-05-01 | 2018-11-01 | Florida State University Research Foundation, Inc. | Functional Bottlebrush Polymers |
JP2020055928A (en) * | 2018-09-28 | 2020-04-09 | 株式会社トレスバイオ研究所 | Cured material and manufacturing method thereof |
CN112175189A (en) * | 2020-09-30 | 2021-01-05 | 中国人民解放军国防科技大学 | Aminated carboxymethyl chitosan thiourea resin and its preparation method and application |
CN114230678A (en) * | 2021-12-13 | 2022-03-25 | 珠海通桥医疗科技有限公司 | Photocrosslinking hydrogel embolization system for intravascular treatment and use method |
CN115232316A (en) * | 2022-07-22 | 2022-10-25 | 上海臻臣化妆品有限公司 | Organic silicon elastomer and preparation method thereof |
CN117511230A (en) * | 2023-11-23 | 2024-02-06 | 湖南杰伟新材料有限公司 | Bio-based degradable composite material and preparation method thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115427008B (en) * | 2020-03-24 | 2024-06-14 | 罗门哈斯公司 | Hair care formulation |
KR20220156876A (en) * | 2020-03-24 | 2022-11-28 | 유니온 카바이드 코포레이션 | Formulation for hair washing |
CN112500507A (en) * | 2020-12-02 | 2021-03-16 | 瑞希(重庆)生物科技有限公司 | Modified polyhydroxyethyl methacrylate gel, preparation method, pharmaceutical excipient and external gel |
FR3154116A1 (en) | 2023-10-16 | 2025-04-18 | Snf Sa | OLIGO-INITIATOR AND ITS USE FOR PRODUCING WATER-SOLUBLE HYBRID POLYMERS |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5632998A (en) * | 1996-03-15 | 1997-05-27 | The Procter & Gamble Company | Personal care compositions containing hydrophobic graft copolymer and hydrophobic, volatile solvent |
WO2002055034A2 (en) * | 2001-01-12 | 2002-07-18 | L'oreal | Cosmetic compositions containing a fructan, a polysaccharide and a beneficial agent, and uses thereof |
EP1577293A1 (en) * | 2002-12-26 | 2005-09-21 | Shionogi Co., Ltd. | Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure |
WO2006017589A2 (en) * | 2004-08-03 | 2006-02-16 | Rhodia Inc., | Polysaccharide graft copolymers and their use in personal car eapplications |
-
2008
- 2008-07-24 FR FR0855072A patent/FR2934268B1/en not_active Expired - Fee Related
-
2009
- 2009-06-08 WO PCT/EP2009/057039 patent/WO2010009938A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5632998A (en) * | 1996-03-15 | 1997-05-27 | The Procter & Gamble Company | Personal care compositions containing hydrophobic graft copolymer and hydrophobic, volatile solvent |
WO2002055034A2 (en) * | 2001-01-12 | 2002-07-18 | L'oreal | Cosmetic compositions containing a fructan, a polysaccharide and a beneficial agent, and uses thereof |
EP1577293A1 (en) * | 2002-12-26 | 2005-09-21 | Shionogi Co., Ltd. | Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure |
WO2006017589A2 (en) * | 2004-08-03 | 2006-02-16 | Rhodia Inc., | Polysaccharide graft copolymers and their use in personal car eapplications |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2972111A1 (en) * | 2011-03-01 | 2012-09-07 | Oreal | Composition, useful e.g. for caring, cleansing and/or making up the skin of the body or face, lips, eyelashes, nails and the hair, and as sunscreen or self-tanning agent, comprises a polymer sequence in a medium |
US11958928B2 (en) | 2017-05-01 | 2024-04-16 | Florida State University Research Foundation, Inc. | Functional bottlebrush polymers |
US20180312634A1 (en) * | 2017-05-01 | 2018-11-01 | Florida State University Research Foundation, Inc. | Functional Bottlebrush Polymers |
US10894854B2 (en) * | 2017-05-01 | 2021-01-19 | Florida State University Research Foundation, Inc. | Functional bottlebrush polymers |
JP2020055928A (en) * | 2018-09-28 | 2020-04-09 | 株式会社トレスバイオ研究所 | Cured material and manufacturing method thereof |
JP7491518B2 (en) | 2018-09-28 | 2024-05-28 | 株式会社トレスバイオ研究所 | Cured product and method for producing same |
CN112175189A (en) * | 2020-09-30 | 2021-01-05 | 中国人民解放军国防科技大学 | Aminated carboxymethyl chitosan thiourea resin and its preparation method and application |
CN114230678A (en) * | 2021-12-13 | 2022-03-25 | 珠海通桥医疗科技有限公司 | Photocrosslinking hydrogel embolization system for intravascular treatment and use method |
CN114230678B (en) * | 2021-12-13 | 2023-09-01 | 珠海通桥医疗科技有限公司 | Photocrosslinked hydrogel embolism system for intravascular treatment and application method |
CN115232316A (en) * | 2022-07-22 | 2022-10-25 | 上海臻臣化妆品有限公司 | Organic silicon elastomer and preparation method thereof |
CN115232316B (en) * | 2022-07-22 | 2024-03-29 | 上海臻臣化妆品有限公司 | Organic silicon elastomer and preparation method thereof |
CN117511230B (en) * | 2023-11-23 | 2024-05-24 | 湖南杰伟新材料有限公司 | Bio-based degradable composite material and preparation method thereof |
CN117511230A (en) * | 2023-11-23 | 2024-02-06 | 湖南杰伟新材料有限公司 | Bio-based degradable composite material and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
FR2934268A1 (en) | 2010-01-29 |
FR2934268B1 (en) | 2012-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010009938A1 (en) | Polymers with polysaccharide grafts, cosmetic compositions and treatment method | |
EP1323753A1 (en) | Self-adhesive cationic or amphoteric radical polymers and their use in cosmetic | |
EP1769011B1 (en) | Ethylene copolymers, compositions containing said copolymers and treatment method | |
EP2124875A2 (en) | Method for the cosmetic treatment of keratinic materials and composition containing a grafted amino acid polymer | |
EP0859581B1 (en) | Composition for treating keratinous material, including at least one silicone-grafted polymer with a polysiloxane backbone grafted by non-silicone organic monomers and at least one c 11-26 liquid hydrocarbon | |
EP2039343B1 (en) | Cosmetic compositions containing a cationic copolymer and a particular amino silicone and uses thereof | |
EP1768643B1 (en) | Cosmetic compositions containing at least one surfactant and at least one ethylene copolymer with polyethylene glycol grafts | |
EP1632508B1 (en) | New ethylene copolymeres, compositions comprising the same and treatment method | |
WO2010009937A1 (en) | Block polymers, cosmetic compositions containing same, and cosmetic treatment method | |
EP1499280B1 (en) | Use of beta-cyclodextrine with surfatants as a pearly-lustring agent | |
WO2010116063A1 (en) | Ethylene copolymer with peg, cationic and anionic units, cosmetic composition including same and treatment method | |
EP1457195B1 (en) | Cosmetic compositions containing a copolymer of methacrylic acid, cyclodextrine and a surfactant as well as their uses | |
FR2955255A1 (en) | COSMETIC COMPOSITION COMPRISING A HYDROPHILIC GRAFT POLYSACCHARIDE AND COSMETIC TREATMENT METHOD | |
EP1637189B1 (en) | Cosmetic compositions containing a salt, a cyclodextrine and an anionic surfactant as well as their uses | |
FR2934777A1 (en) | Composition, useful as e.g. sun product, comprises new or known polyurethane comprising e.g. cationic unit of tertiary- or quaternary amine, and unit derived from compound comprising at least two isocyanate functions, in medium | |
FR2952535A1 (en) | COSMETIC COMPOSITION COMPRISING, IN SOLUTION OR DISPERSION, A LINEAR DIBLOC POLYMER AND METHOD OF COSMETIC TREATMENT | |
FR2972111A1 (en) | Composition, useful e.g. for caring, cleansing and/or making up the skin of the body or face, lips, eyelashes, nails and the hair, and as sunscreen or self-tanning agent, comprises a polymer sequence in a medium | |
FR2957791A1 (en) | Composition, useful as e.g. sunscreen or self-tanning product, comprises aqueous dispersion of polymer particles in medium, where the polymer comprises ethylene monomers, and additional monomer e.g. vinyl acetate | |
CN117377455A (en) | Aqueous personal care compositions containing carboxymethylcellulose (CMC) with optimized degree of substitution | |
FR2922448A1 (en) | Cosmetic composition, useful e.g. as personal care product for cleaning and/or make-up of skin of body/face, lips and nails, comprises polymer consisting of acid function, and amino neutralizing agent to neutralize part of polymer | |
FR2940099A1 (en) | COSMETIC COMPOSITION COMPRISING, IN SOLUTION OR DISPERSION, A LINEAR DIBLOC POLYMER AND METHOD OF COSMETIC TREATMENT | |
FR2933607A1 (en) | Cosmetic composition, useful e.g. in personal care product and hair product, comprises, in medium, polymer comprising polymeric backbone comprising amine monomer units and hydrophilic grafts linked covalently with the polymeric backbone | |
FR3004925A1 (en) | COMPOSITION FOR SMOOTHING KERATIN FIBERS COMPRISING A UREA AND / OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC OR AMPHOTERIC POLYMERIC THICKENER, METHOD AND USE | |
FR2948873A1 (en) | Composition, useful e.g. as care product, sunscreen product, and personal hygiene product, comprises polymer, which is at least partially neutralized, comprising diallyl-amine monomers and/or diallyl-amine salt monomers in a medium | |
FR2947820A1 (en) | ETHYLENE COPOLYMER HAVING PEG, CATIONIC AND ANIONIC PATTERNS, COSMETIC COMPOSITION COMPRISING SAME, AND TREATMENT METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09779674 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09779674 Country of ref document: EP Kind code of ref document: A1 |